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Abstract.
The ephrin-A family of axon guidance cues, which activate the EphA family of 
receptor tyrosine kinases, guide the axons of many types of neuron to the correct 
target during embryonic development. One particularly well-studied example is the 
projection of RGC processes to precise positions in the midbrain target that reflect 
the position of the RGC in the retina. Ephrin-As are membrane-tethered molecules 
expressed in a gradient in the midbrain, and they govern the formation of the 
retinotectal map by differential, contact-mediated repulsion of Eph-A-expressing 
RGC axons. In order to identify signalling molecules that mediate ephrin-A induced 
repulsion of RGCs, I have developed a novel co-culture assay in which contact with 
a single non-neuronal cell that expresses endogenous levels of ephrin-A induces 
rapid loss of RGC growth cone lamella, followed by axon retraction. I have 
confirmed that these cellular responses are mediated by neuronal EphA receptor 
signalling and, in combination with the traditional soluble collapse assay, have used 
this physiologically relevant co-culture assay to identify a more specific role for the 
Rho effector ROCK in ephrin-A-induced RGC responses than has previously been 
published. Specifically ROCK activity mediates ephrin-A-induced RGC axon 
retraction, but not loss of growth cone lamella. I have also identified the non-receptor 
tyrosine kinase Abl as having a major role in the ephrin-A-induced RGC repulsive 
response, as the Abl kinase inhibitor STI571 prevents both the ephrin-A-induced loss 
of RGC lamella and axon retraction. I have demonstrated the existence of a protein 
complex containing active Eph receptors, Abl and Mena, and shown that disruption 
of this complex correlates with STI571-dependent inhibition of the ephrin-A-induced 
RGC repulsive responses. These results comprise the first evidence that Abl plays a 
role in mediating Eph receptor signals, and is involved in the cytoskeletal 
rearrangements that underlie ephrin-A-induced growth cone collapse in vitro, and 
thus both complement and extend the published evidence demonstrating a role for 
Abl in mediating axon guidance in vivo.
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Chapter 1. Introduction
1.1. Introduction.
During development neuronal processes must extend, often over great distances, to 
reach their correct target and produce a functional adult nervous system. The 
neuronal growth cone at the leading edge of an extending axon senses extracellular 
guidance cues, and transduces intracellular signals that ultimately regulate the speed 
and direction of axon outgrowth in response to these cues. The Eph receptor family 
of tyrosine kinases direct many critical process during embryogenesis, and they have 
a particularly well studied role in axon guidance (Kullander and Klein, 2002; 
Wilkinson, 2001). Co-ordinated changes in cell shape and motility underlie many of 
the morphogenic events controlled by Eph receptors and this is reflected in the fact 
that intracellular pathways initiated by Eph receptor activation ultimately converge 
on the actin cytoskeleton and cellular adhesion machinery (Kullander and Klein, 
2002; Murai and Pasquale, 2003; Wilkinson, 2001). However the signalling 
pathways that mediate cellular responses during Eph receptor dependent axon 
guidance decisions remain incompletely characterised.
1.2. Eph receptor and ephrin families.
All ligands for the Eph family of receptor tyrosine kinases (RTKs) are membrane- 
bound molecules, known as ephrins, and this family of proteins is split into two 
classes, ephrin-As and ephrin-Bs (1997; Gale et al., 1996b). Ephrin-B molecules 
contain a transmembrane region and a short but highly conserved cytoplasmic tail, 
whereas ephrin-A molecules are attached to the outer leaflet of the cell membrane via 
a GPI linkage (Fig 1.1). Eph receptors are similarly divided into two classes based on 
their sequence similarity and ligand binding affinity. Although there is significant 
promiscuity in the binding of Eph receptors and ephrins within classes, interactions 
are restricted such that EphB receptors bind only to ephrin-B ligands and EphA 
receptors bind ephrin-A ligands. The exception is EphA4, which is known to bind 
members of both the ephrin-A and ephrin-B classes (Gale et al., 1996b). Eph-ephrin 
interaction results in phosphorylation of tyrosine residues within the Eph receptor
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Fig 1.1. Structure of Eph receptors and ephrins.
ephrin-A 1 
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Ephrin-As are attached to the membrane via a G PI-linkage, ephrin-Bs are 
transmembrane proteins. Eph receptors have an extracellular globular domain 
(GB), a cysteine-rich motif (Cys), and two fibronectin type III motifs (FN III). The 
intracellular Eph receptor tail contains two highly conserved tyrosine residues in 
the juxtam em brane region (Y), a central tyrosine kinase domain (TK) a sterile 
alpha motif domain (SAM) and at the C-terminus there is a PDZ-domain-binding 
motif.
cytoplasmic domain (Davis et al., 1994). Eph receptor phosphorylation is required 
for Eph kinase activity and the recruitment of SH2- (Src homology 2) containing 
molecules, and both are thought to contribute to the induction of Eph receptor 
dependent signalling cascades (Binns et al., 2000; Ellis et al., 1996; Holland et al., 
1997; Yu et al., 2001; Zisch et al., 1998; Zisch et al., 2000). Interestingly ephrin-Bs 
also become phosphorylated following Eph receptor binding, and there is increasing 
evidence that signals can also be transduced by the ephrin-expressing cell (Cowan 
and Henkemeyer, 2002; Murai and Pasquale, 2003).
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1.2.1. Eph receptor structure and binding partners.
Like all known RTKs, Eph receptors are type 1 transmembrane proteins (Fig 1.1). 
They consist of a N-terminal globular domain that is both necessary and sufficient 
for ligand binding followed by a cysteine-rich domain and two fibronectin type III 
repeats, which might be involved in receptor clustering (Himanen et al., 1998; 
Labrador et al., 1997; Lackmann et al., 1998). Just inside the membrane is a pair of 
tyrosine residues that are highly conserved throughout the Eph receptor family (Fox 
et al., 1995; Sajjadi and Pasquale, 1993). These juxtamembrane tyrosines are major 
autophosphorylation sites, and Eph receptors are phosphorylated on these residues in 
vivo at sites of potential Eph receptor-ephrin interaction. (Choi and Park, 1999; Ellis 
et al., 1996; Kalo et al., 2001; Kalo and Pasquale, 1999; Zisch et al., 1998). For 
example ephrin-B 1 is expressed in the chick retina, and EphB2 isolated from this 
region is highly phosphorylated on the two juxtamembrane tyrosines (Braisted et al., 
1997; Hindges et al., 2002; Kalo and Pasquale, 1999). The juxtamembrane tyrosines 
have recently been shown to have a major role in regulating the Eph receptor kinase 
activity (Binns et al., 2000; Wybenga-Groot et al., 2001; Zisch et al., 1998; Zisch et 
al., 2000) (see section 1.2.3). In addition the juxtamembrane tyrosine residues are 
docking sites for the SH2 domains of many signalling proteins, including members 
of the Src family of non receptor tyrosine kinases (Ellis et al., 1996; Hock et al., 
1998a; Zisch et al., 1998), Abl (Yu et al., 2001) and RasGAP (Hock et al., 1998a; 
Holland et al., 1997), as well as adaptor molecules such as Nek and Crk (Hock et al., 
1998a; Stein et al., 1998a).*1
Centrally located within the Eph receptor cytoplasmic tail is the kinase domain (Ellis 
et al., 1996; Zisch et al., 1998), which has been shown to interact with the SH2 
domains of Grb2 and both subunits of PI3 kinase (Gu and Park, 2001; Pandey et al., 
1994; Stein et al., 1996). C-terminal to the catalytic domain is a sterile alpha motif 
(SAM) domain that may contribute to receptor clustering (Stapleton et al., 1999; 
Thanos et al., 1999) and a conserved tyrosine motif within the SAM domain is 
required for interaction with the SH2 domain of GrblO (Stein et al., 1996) and 
docking of the low molecular weight protein-tyrosine phosphatase (LMW-PTP) 
(Stein et al., 1998b) The C-terminal PDZ-binding domain may influence receptor 
clustering in addition to mediating interactions between Eph receptors and PDZ- 
containing signalling proteins (Buchert et al., 1999; Cowan et al., 2000; Hock et al.,
14 * See Fig. 1.1 A
Fig 1.1A. Activation of Eph receptor signalling.
P Abl kinases 
p Src kinases
— Crk 
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Cell migration 
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A. In the inactive conformation, the Eph receptor juxtamembrane region is involved 
in a hydrophobic interaction with the kinase domain. B. Upon ephrin binding, the two 
highly conserved juxtamem brane tyrosine residues become phosphorylated, 
disrupting the intramolecular interaction, allowing the kinase domain to become 
activated, and inducing phosphorylation at other residues within the Eph receptor 
intracellular domain. Some o f the known Eph receptor binding partners and their 
interaction positions with in the receptor are shown in C, together with the cellular 
responses these binding partners mediate downstream of active Eph receptors.
Kfi
1998b; Lin et al., 1999; Torres et al., 1998). The physiological relevance of many of 
these interactions is unknown, but some have been implicated in Eph receptor signals 
that converge on the actin cytoskeleton and/or adhesion machinery. For example 
RasGAP activity has been functionally linked to EphB-mediated neurite retraction, 
and EphA8-mediated increases in cell adhesion require interactions between EphA8 
and the catalytic subunit of PI3 kinase (Elowe et al., 2001; Gu and Park, 2001). Eph 
receptor signalling cascades are discussed in section 1.5.
1.2.2. Ligand-receptor binding and clustering.
During Eph receptor-ephrin binding the hydrophobic receptor-binding domain of the 
ephrin molecule tucks into the cleft between two antiparallel p sheets at the N- 
terminus of the cognate Eph receptor, and the Eph receptor ligand-binding domain 
then folds to increase the extent of the ligand-receptor interface (Himanen et al., 
1998; Himanen et al., 2001). The interaction between side chains at the receptor 
ligand interface is likely the basis for subclass specificity of ligand binding. Ephrin- 
Bs have bulky polar residues that are positioned against smaller polar residues in 
EphB receptors (Himanen et al., 2001). Ephrin-A side chains can be polar or 
hydrophobic but are small, whereas EphA side chains are large. This means that 
mixed combinations of receptor-ligand would either result in a hydrophobic residue 
aligned with a polar residue, or the alignment of two bulky residues, either of which 
is an energetically unfavourable situation (Himanen et al., 2001).
Isolated extracellular domains of Eph receptors in solution form high affinity 
heterodimers with ephrins over a large concentration range, but at higher 
concentrations a tetramer consisting 2 receptor-ligand dimers can form (Himanen 
and Nikolov, 2002; Lackmann et al., 1997). Crystal structure of an ephrin-B2-EphB2 
complex reveals just such a tetrameric structure arranged in a ring with each receptor 
interacting with 2 ligands, and vice versa (Himanen et al., 2001). Two of the four 
receptor-ligand interfaces are extensive, and so presumably represent the initial high 
affinity receptor-ligand interaction. The tetrameric structure is arranged so that the C- 
terminals of the receptor molecules are on the opposite side of the complex to the C- 
terminals of the ligand molecules, allowing signals to be transduced in opposite 
directions at the cell-cell interface (Himanen et al., 2001). The tetrameric 
arrangement may be relevant to Eph receptor signalling. It has long been known that
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ephrin monomers cannot phosphorylate Eph receptors, and unless they are clustered, 
either artificially or as a consequence of membrane tethering, will not induce a 
cellular response (Davis et al., 1994). Ephrin-B 1 fused to the Fc fragment of human 
IgG (ephrin-B 1-Fc) and presented as a dimer elicits different cellular responses to 
those induced by ephrin-B 1-Fc multimers (Stein et al., 1998b).
1.2.3. Eph receptor activation.
Generally RTKs are activated by ligand binding forcing two catalytically inactive 
kinase domains into close proximity to favour transphosphorylation. One receptor 
then phosphorylates regulatory sites on a second receptor, usually within the kinase 
domain, leading to de-repression of its kinase activity. This in turn allows 
phosphorylation of other molecules, including the kinase domain of the first receptor, 
and so a signalling cascade is initiated (van der Geer et al., 1994).
Substitution of the conserved juxtamembrane tyrosine residues with phenylalanine 
impairs Eph receptor kinase activity against autophosphorylation sites and exogenous 
substrates, and this observation suggests that these residues have a regulatory 
function within the Eph receptor (Binns et al., 2000; Wybenga-Groot et al., 2001; 
Zisch et al., 1998; Zisch et al., 2000). This idea is supported by the fact that mutation 
of the regulatory tyrosine residue within the kinase domain of EphA4 does not fully 
inhibit kinase activity, while mutation of the juxtamembrane tyrosines does (Binns et 
al., 2000). Examination of the crystal structure of EphB2 reveals a hydrophobic 
interaction between the unphosphorylated juxtamembrane region and the kinase 
domain, forcing the Eph receptor into an inactive conformation (Wybenga-Groot et 
al., 2001). Phosphorylation of the juxtamembrane region is thought to disrupt the 
hydrophobic interaction with the kinase domain and relieve the structural constraints 
on the activation loop and active site, and consistent with this mutations in which the 
interaction is artificially disrupted lead to an increase in kinase activity (Wybenga- 
Groot et al., 2001). In the current model of Eph receptor activation ligand binding 
brings Eph receptors into sufficiently close proximity to transphosphorylate each 
other in the juxtamembrane region, which in turn allows the kinase domain to 
become active and phosphorylate downstream targets. In addition the exposed 
phosphorylated juxtamembrane tyrosines are made available for binding to SH2- 
containing molecules.
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1.3. Eph receptors and ephrins in axon guidance.
The production of neuronal connections with appropriate targets during 
embryogenesis is crucial for a functioning adult nervous system, and navigation of a 
growing neuronal axon to its target during development is dependent on the neuronal 
growth cone. The growth cone is a highly dynamic structure constructed of a veil­
like lamella strung between finger-like filopodia. As the growth cone advances, 
receptors on its surface respond to guidance molecules in the embryonic environment 
by initiating signalling cascades that ultimately converge on the cytoskeleton and 
cellular adhesions (Dickson, 2002; Mueller, 1999).
Axonal guidance cues are categorised as attractive or repulsive depending on the 
axonal response. Cues that lead to net addition of cytoskeletal components are 
thought to promote growth cone advance, and are hence classed as attractive 
guidance cues. Conversely net disassembly of the cytoskeleton by repulsive axon 
guidance cues may lead to axon retraction (Mueller, 1999; Tessier-Lavigne and 
Goodman, 1996). Asymmetric signalling across the growth cone can result in the 
axon turning towards an attractive guidance cue, or away from a repulsive guidance 
cue. Axonal guidance molecules may be presented on the surface of other cells, or 
the extracellular matrix, or may be soluble secreted molecules (Mueller, 1999; 
Tessier-Lavigne and Goodman, 1996).
Ephrins act as contact-dependent axon guidance cues for many types of neuron, and 
mostly, but not exclusively, induce repulsive guidance signals downstream of axonal 
Eph receptors. Interestingly reverse signalling through ephrins may also guide axons 
in some situations.
1.3.1. Topographic mapping of the Retinotectai projection.
During embryonic development many sensory neuronal projections terminate in a 
spatial order that reflects the arrangement of the neurons from which they arise. This 
allows the spatial content of information to be preserved between the projecting and 
target areas. The pre-eminent model for studies on these topographic maps is the 
projection of retinal axons to the midbrain, where they terminate in the optic tectum 
(OT) in avians, amphibians and fish, or the superior colliculus (SC) in mammals. 
Retinal ganglion cell (RGC) axons innervate the OT/SC in a pattern determined by 
their positions in the retina and this topographic mapping of the
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retinotectal/retinocollicular projections occurs along two axes. Axons arising from 
the temporal retina map to termination zones in the anterior OT/SC, while nasal RGC 
axons terminate in increasingly posterior positions (Holt and Harris, 1993; Mey and 
Thanos, 1992) (Fig 1.2). Along the second axis, RGCs from dorsal retina terminate 
in the lateral OT/SC and ventral RGC axons map to the medial OT/SC (Holt and 
Harris, 1993; Mey and Thanos, 1992) (Fig 1.2). In chicks, mice and rats, RGCs enter 
the OT/SC at the anterior pole and grow along the anterior-posterior axis. The 
primary axons initially overshoot their ultimate target position, and interstitial 
branches are sent out at the anterior-posterior level corresponding to the final 
termination position (Hindges et al., 2002; McLaughlin et al., 2003; Nakamura and 
O'Leary, 1989; Simon and O'Leary, 1992a; Simon and O'Leary, 1992c). These 
branches then extend laterally or medially towards the termination zone appropriate 
to the nasal-temporal and dorso-ventral retinal origin, where they finally arborize. 
Eph receptor-ephrin interactions have been shown to be crucial for all of these steps 
during development; initial guidance of the primary axon to a particular anterior- 
posterior position, restriction of the subsequent interstitial branches to appropriate 
anterior-posterior region, and guidance of the interstitial branches along the lateral- 
medial axis towards the correct termination zone.
I.3.I.I. Retinotopic mapping along the anterior-posterior axis.
Early studies suggested that the differential distribution of nasal and temporal RGC 
termination zones in the tectum is a result of differential repulsion of these RGC 
axons by molecules expressed on the surface of tectal cells (Walter et al., 1987a; 
Walter et al., 1990b). In vitro, temporal axons avoid growing on tectal cell 
membranes that show no repellent activity for nasal axons (Bonhoeffer and Huf, 
1982; Walter et al., 1987a; Walter et al., 1987b; Walter et al., 1990b), and temporal 
axons respond to soluble tectal membrane portions by collapsing their growth cone 
and retracting, while nasal RGC axons do not (Cox et al., 1990).
Sperry’s chemoaffinity hypothesis suggested that the retinotectai map could result 
from complementary gradients of receptors and ligands along the nasotemporal 
retinal and anterioposterior tectal axes, conferring precise positional information for 
the RGC axons growing into the tectum (Sperry, 1963). EphA receptors and their 
ephrin-A ligands meet these criteria (Flanagan and Vanderhaeghen, 1998; O'Leary
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Figure 1.2. Topographic mapping of the retinotectai projection 
during development occurs along 2 axes.
Retina O T/SC
V ------------ -------
M
RGC axons that originate in the nasal (N) retina terminate in the posterior (P) optic 
tectum /superior colliculus (OT/SC). Temporal (T) RGC axons terminate in the 
anterior (A) tectum. Dorsal (D) and ventral (V) RGC axons project to the lateral 
(L) and medial (M) OT/SC respectively.
and W ilkinson, 1999). EphA3 is expressed in an increasing nasal to temporal 
gradient in the chick RGC layer (Cheng et al., 1995; Connor et al., 1998; Monschau 
et al., 1997), while ephrin-A2 and ephrin-A5 are both expressed in an increasing 
anterior to posterior gradient in the chick tectum (Cheng et al., 1995; Connor et al., 
1998; D rescher et al., 1995; Monschau et al., 1997) (Fig 1.3A). Ephrin-A2 is 
expressed in a shallow gradient across the entire tectum whereas ephrin-A5 is 
restricted to the posterior half where it’s expression gradient is relatively steep 
(Cheng et al., 1995; Drescher et al., 1995; Monschau et al., 1997) (Fig 1.3A).
1.3.1.2. Differential repulsion of RGC projections.
The mapping of temporal RGCs, expressing high levels of EphA receptor, to the 
anterior region of the tectum which expresses low levels of ephrin-A ligand suggests 
that repulsive signalling by EphA receptors underlies the retinotopic mapping along 
the anterioposterior tectal axis. Genetic manipulations of ephrin-A2 and ephrin-A5 
expression in the chick and mouse have demonstrated that these molecules govern 
retinotectal/retinocollicular mapping along the anterioposterior axis by differential 
repulsion of nasal and temporal RGC projections. Temporal RGCs in mice lacking 
ephrin-A2 and/or ephrin-A5 project to ectopic termination zones located posterior to
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the appropriate position, whereas ephxin-A2'/' nasal RGCs projections are not 
effected (Feldheim et al., 2000; Frisen et al., 1998) (Fig 1.2B). Conversely 
expression of an avian retrovirus encoding ephrin-A2 in the anterior tectum, such 
that the expression level is comparable to that of wild-type posterior tectum, results 
in temporal RGCs targeting abnormally anterior positions, while nasal RGCs project 
normally (Nakamoto et al., 1996) (Fig 1.3C).
Ephrin-A2 and ephrin-A5 also differentially repel RGC axons in vitro. Ephrin-A2 
selectively inhibits outgrowth of temporal axons in vitro, and causes temporal growth 
cone collapse with no effect on nasal axons (Monschau et al., 1997; Nakamoto et al., 
1996). Ephrin-A5 is repulsive to both nasal and temporal axons in vitro, but again 
temporal axons are more sensitive to ephrin-A5 than nasal (Nakamoto et al., 1996).
Underlying the difference in sensitivity between nasal and temporal axons to ephrin- 
A stimulation is the increasing nasal to temporal expression of EphA3, the preferred 
receptor for ephrin-A2 and ephrin-A5, in the chick retina (Cheng et al., 1995; Connor 
et al., 1998; Monschau et al., 1997). In the mouse RGCs do not express EphA3. 
Instead EphA5 and EphA6 are expressed in a nasal to temporal gradient. Expression 
of EphA3 in small ectopic patches of the mouse retina renders nasal RGCs more 
sensitive to ephrin-As, causing them to terminate in the anterior SC (Brown et al., 
2000) (Fig 1.2D), whereas expression of dominant negative EphA3 induces aberrant 
temporal RGC projections to the posterior SC (Feldheim et al, 2004). EphA4 also 
plays a role in the differential sensitivity of RGCs to Ephrin-A ligands. Although 
expressed uniformly across the nasal-temporal retinal axis, EphA4 is normally highly 
phosphorylated in nasal but not temporal retina (Connor et al., 1998; Homberger et 
al., 1999). The phosphorylation gradient of EphA4 corresponds to the high nasal to 
low temporal expression of ephrin-As in the retina (Connor et al., 1998; Marcus et 
al., 1996). Over-expression of ephrin-A5 in the temporal retina leads to 
corresponding high levels of phosphorylated EphA4 in the temporal retina 
(Homberger et al., 1999) suggesting that EphA4 phosphorylation seen in wild-type 
nasal RGC axons is a consequence of co-expression of ephrin-As and EphA4 on 
these axons (Homberger et al., 1999). Persistent phosphorylation of retinal EphA4 
inversely correlates with RGC axon sensitivity to exogenous ephrin, probably via a 
desensitisation mechanism (Homberger et al., 1999). As described above, nasal RGC 
axons are normally insensitive to exogenous ephrin-A2 (Monschau et al., 1997;
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Figure 1.3. EphA receptors and ephrin-As control retinotectai 
mapping along the anterior-posterior (A-P) axis.
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A, Axons from temporal (T) retina express relatively high levels of EphA receptor 
and project to regions of the optic tectum/superior colliculus (OT/SC) that express 
correspondingly low levels of ephrin-A molecules. Nasal (N) RGC axons, which 
express lower levels of EphA, terminate in the posterior (P) OT/SC. B, Temporal 
RGC axons project to abnormally posterior positions in ephrin-A 27 mice (* 
indicates appropriate termination zone). C, Over-expression of ephrin-A2 in the 
retina causes temporal RGCs to project to abnorm ally anterior positions (* 
indicates appropriate termination zone). D, Axons arising from ectopically high 
areas of EphA receptor expression project to ectopic positions in the anterior 
tectum.
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Nakamoto et al., 1996), but removal of ephrin-A on nasal RGC axons results in their 
being repelled by substrate-bound ephrin-A2 (Homberger et al., 1999). Conversely 
over-expression of ephrin-A5 in the temporal retina abolishes the preferential growth 
of temporal RGC axons on anterior rather than posterior tectal membranes 
(Homberger et al., 1999). Genetic studies have also demonstrated that nasal RGCs 
from ephrin-A2'/'/A5'/‘ knockout mice terminate in abnormally anterior positions, and 
that these axons are more sensitive than wild-type to ephrin-A in vitro (Feldheim et 
al., 2000). Overall the data support a model in which phosphorylation of EphA4 on 
nasal RGC axons reflects the expression of ephrin-As on neighbouring RGC axons, 
and by reducing the number of EphA receptors available, this accounts for the lower 
sensitivity of nasal RGCs to ephrin-As expressed in the tectum, or exogenously 
added in vitro.
These mechanisms play complimentary roles in the differential sensitivity of nasal 
and temporal RGCs to ephrin-A. Loss of both ephrin-A2 and ephrin-A5 from the 
retina does not abolish the relative difference in sensitivity of temporal axons to wild 
type posterior SC membrane, presumably since EphA3 is differentially expressed in 
these axons (Feldheim et al., 2000). Blocking EphA4 activity abolishes sensitivity of 
nasal axons to exogenous ephrin-A5, but not temporal axons (Walkenhorst et al., 
2000). The apparent gradient of “silenced” EphA4, which results from the ephrin-A 
gradient in the retina, complements the gradient of expression of EphA3 in the retina.
The above observations have lead to the hypothesis that graded repulsion by tectal 
ephrin-As sorts the more sensitive temporal axons, which express higher levels of 
“available” EphA receptors, to areas of low ephrin expression, and less sensitive 
nasal RGC axons to the posterior tectum. However graded repulsion alone cannot 
account for the observed phenotype in loss of function ephrin mutants. Knocking out 
ephrin-A2 and/or ephrin-A5 in the SC does result in the termination zones of 
temporal RGC axons being shifted in the posterior direction, which agrees with the 
idea that increasing ephrin-A levels in the posterior colliculus normally act as a 
repulsive signal (Feldheim et al., 2000; Frisen et al., 1998). However, in the absence 
of both ephrin-A2 and -A5 many axons project to the appropriate position and RGC 
axons terminate over the entire SC surface, rather than all being at the posterior pole 
in the absence of any repellent molecules (Feldheim et al., 2000). A model of graded 
repulsion together with axon competition has been suggested to explain these results.
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Normally temporal axons are repelled from the posterior tectum because of their high 
sensitivity for ephrin-A, and therefore terminate in the anterior tectum. Nasal axons 
can navigate into the posterior tectum where competition for an attractive or 
permissive factor is less. In the absence of ephrin-A the competition between axons 
results in the retinotopic map filling the entire SC (Feldheim et al., 2000). A 
computer model that incorporates competition between axons for target sites 
correctly predicts the topographic maps generated experimentally by genetic 
manipulation of both Eph receptors and ephrins in the retinotectai system (Honda, 
2003).
I.3.I.2.I. Guidance of the primary RGC axon.
As described above the termination zone of a RGC axon is formed by the preferential 
extension of interstitial branches at the correct anterioposterior position once the 
primary axon has overshot, and recently evidence has begun to accumulate 
suggesting that EphA receptor-ephrin-A interaction restricts axonal branching to the 
correct A-P level (Yates et al., 2001) (see section 1.3.1.2.2). Early studies 
investigating the role of EphA-ephrin-A interaction during retinotopic mapping 
concentrated on the position of RGC termination zones in the tectum, but did not 
distinguish between the role of EphA-ephrin-A interaction in guidance of the primary 
axon from subsequent effects on axon branching. The in vitro experiments described 
above together with recent in vivo evidence demonstrate that EphA-ephrin-A 
interaction effects the guidance of the primary axon by differential repulsion.
Although all axons overshoot their ultimate target position along the anterior- 
posterior axis, there is some retinotopic specificity in the initial targeting of RGC 
axons, since temporal RGC axons initially terminate in more anterior positions in the 
tectum than nasal RGC axons (Nakamura and O'Leary, 1989; Yates et al., 2001). It 
seems likely that the primary RGC axons are guided within the tectum by EphA- 
mediated repulsion since temporal RGC axons in vivo change their trajectory to 
avoid ectopic patches of abnormally high ephrin-A2 expression in the anterior tectum 
(Nakamoto et al., 1996). In addition temporal axons that over-express ephrin-A2 or 
ephrin-A5, and are therefore less sensitive to ephrin-A stimulation (see above), 
initially extend further along the A-P axis than wild type temporal RGC axons 
(Dutting et al., 1999; Homberger et al., 1999).
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More recently the technique of chromophore-assisted laser inactivation (CALI) has 
revealed a role for tectal ephrin-A5 in the repulsion of RGC primary axons (Sakurai 
et al., 2002). The principal of CALI is that irradiation of a chromophore-labelled 
antibody leads to specific local inactivation of the targeted protein to which the 
antibody is bound (Beermann and Jay, 1994). Inactivation of ephrin-A5 in specific 
areas within the posterior tectum leads to nasal RGC axons that would normally 
terminate in the irradiated region overextending into more posterior areas (Sakurai et 
al., 2002). Taken together the above is evidence for a role of EphA-ephrin-A 
interaction in the guidance of RGC axons in vivo by a mechanism of graded 
repulsion.
I.3.I.2.2. Restriction of interstitial branches.
The bias for RGC axons to initiate and extend branches at the appropriate 
anterioposterior level within the tectum is mirrored in vitro, as temporal RGC axons 
extend branches on stripes of anterior rather than posterior tectal membrane (Yates et 
al., 2001). This preference is abolished by addition of soluble EphA3, suggesting that 
tectal ephrin-As normally act to inhibit RGC axon branching (Yates et al., 2001). 
Inactivation of ephrin-A5 in specific regions of the tectum by CALI has revealed a 
major role of EphA-ephrin-A interaction in restricting RGC axons to the correct 
anterioposterior position in vivo. Removal of ephrin-A5 in the posterior tectum 
results in axons that would normally project to the irradiated area branching at 
positions posterior to the correct termination zone suggesting that branch elongation 
is normally restricted by tectal ephrin-A5 (Sakurai et al., 2002).
If RGC axons are prevented from branching in too posterior a position by high levels 
of ephrin-A expression, an additional signal must exist that prevents axon branching 
in the anterior tectum where ephrin-A expression is low (Yates et al., 2001). It has 
been suggested that one possibility is that ephrin-A reverse signalling is responsible 
for inhibiting axonal branching in the anterior tectum (Yates et al., 2001), since nasal 
RGCs express high levels of ephrin-A2 and ephrin-A5 (Connor et al., 1998; 
Hornberger et al., 1999; Marcus et al., 1996) and EphA3 is present at high levels in 
the anterior tectum (Cheng et al., 1995; Connor et al., 1998; Monschau et al., 1997). 
However, it has recently been shown that EphA3-induced reverse signalling by both 
ephrin-A2 and ephrin-A5 leads to increased adhesion (Huai and Drescher, 2001). 
Interstitial branches initially appear as filopodial-like structures, and since adhesion
24
to the substrate is necessary for filopodial stability (Vamum-Finney and Reichardt, 
1994), it would be predicted that high levels of ephrin-A reverse signalling in the 
anterior tectum would act to promote the stabilisation of newly formed branches by 
increasing adhesion. It is therefore unlikely that ephrin-A reverse signalling restricts 
RGC axons from branching in inappropriately anterior positions.
I.3.I.3. Retinotopic mapping along the lateral-medial axis.
Ventral RGCs expressing high levels of EphB2 project to the medial tectum, where 
there is a high expression of ephrin-B 1, and dorsal RGCs, expressing lower levels of 
EphB2 terminate in the lateral tectum (Fig 1.4A) suggesting an attractive interaction 
between EphB2 and ephrin-B 1 (Braisted et al., 1997).
In the mammalian and avian systems RGCs from a specific dorso-ventral position in 
the retina enter the optic tectum or superior colliculus over a broad lateral-medial 
range and extend interstitial branches towards their appropriate termination zone 
(Hindges et al., 2002; Simon and O'Leary, 1992b). RGCs that are medial to their 
termination zones preferentially extend interstitial branches laterally, down the 
ephrin-B 1 gradient, whereas RGCs that are lateral to their termination zone 
preferentially extend interstitial branches medially, up the ephrin-B 1 gradient (Fig 
1.4B). In EphB2/B3 knockout mice branches always grow laterally down the ephrin- 
B1 gradient, regardless of whether the axon is lateral or medial to its termination 
zone (Fig 1.4.C), suggesting that they have lost the ability to respond to an attractive 
signal from the higher levels of ephrin-B 1 in the medial SC (Hindges et al., 2002). 
The ephrin-B 1-induced attractive signal is mediated by EphB forward signalling, 
since dominant negative EphB2 expression results in similar defects (Hindges et al.,
2002). However, if ephrin-B 1-induced attraction is the only signal governing the 
direction of interstitial branch extension in the wild-type animal, EphB2-EphB3 
knockouts should show interstitial branches extending randomly (Hindges et al., 
2002; McLaughlin et al., 2003). Instead the EphB2/EphB3 phenotype, in which all 
branches grow laterally, suggests that a repulsive signal acts to guide branches 
laterally in the knockout mice (Hindges et al., 2002; McLaughlin et al., 2003). 
Ectopic expression of ephrin-B 1 in patches, superimposed on the wild-type ephrin- 
B1 gradient in the chick tectum, results in regions of ectopically high but still graded 
ephrin-B 1 expression (Fig 1.4D) (McLaughlin et al., 2003). Within
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Fig 1.4. EphB-ephrin-B interaction controls retinotectal mapping 
along the lateral-medial axis.
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A. There is an increasing D to V gradient of EphB receptors in the retina and a 
corresponding increasing L to M gradient of ephrin-B 1 in the OT/SC. RGCs 
arising from the dorsal (D) retina project to the lateral (L) optic tectum/superior 
colliculus (OT/SC), whereas ventral RGC axons terminate in the medial (M) 
OT/SC. B. In the wild-type visual system RGC axons arising from the same 
position in the retina enter the OT/SC over a broad L-M range. RGC axons 
medial to their correct target zone (TZ) grow laterally, down the ephrin-B 1 
gradient, and RGC axons lateral to their TZ grow medially, up the ephrin-B 1 
gradient. C . In EphB2 B 3/ knockout mice all RGC axons extend branches 
laterally, regardless of their L-M position (* indicates appropriate TZ). D. RGC 
axons lateral to their TZ extend branches laterally in areas of ectopically high 
ephrin-B 1 expression (* indicates appropriate TZ).
these patches all interstitial branches extend down the ephrin-B 1 gradient, regardless 
of whether they are lateral or medial to their termination zone (Fig 1.4D) 
(McLaughlin et al., 2003). The above data support a model in which high levels of 
ephrin-B 1 are repulsive to interstitial branches, and therefore axons medial to their 
termination zone (in a position of inappropriately high ephrin-B 1 expression) 
preferentially extend branches down the ephrin-B 1 gradient. In this model lower 
levels of ephrin-B 1 are attractive and therefore branches from axons lateral to their 
correct termination zone preferentially extend branches medially, up the ephrin-B 1 
gradient (McLaughlin et al., 2003).
It is possible that different EphB receptors mediate the attractive and repulsive 
responses to ephrin-B 1 in the OT/SC (McLaughlin et al., 2003). EphB2/B3 null RGC 
axons are still directed down the ephrin-B 1 gradient, suggesting they still respond to 
ephrin-B 1 as a repulsive cue (Hindges et al., 2002). EphBl, which is uniformly 
expressed across the retina, has been shown to recruit different signalling complexes 
to EphB2 when stimulated with ephrin-B 1, and this may underlie a differential 
response of wild-type and EphB2/EphB3 null RGC axons to the ephrin-B 1 gradient 
in the superior colliculus (McLaughlin et al., 2003; Stein et al., 1998b). Clustering of 
ephrin-B 1 into dimers has been shown to cause different responses and recruitment 
of alternate signalling complexes compared with ephrin-B 1 tetramers (Huynh-Do et 
al., 1999; Stein et al., 1998b). Increasingly high order clusters of ephrin-Bl in vitro 
may mimic the increasing ephrin-B 1 gradient in the OT/SC, and therefore contribute 
to the switch in response of RGCs from attraction to repulsion (McLaughlin et al.,
2003).
1.3.2. Topographic mapping of the Hippocamposeptal projection.
Countergradients of EphA and ephrin-A expression are thought to underlie 
topographic specificity of neuronal connections other than the retinotectal projection. 
For example at the time when hippocampal axons are reaching their target positions 
in the septum, a low medial to high lateral gradient of ephrin-A5 expression is seen 
within the septum (Zhang et al., 1996a). Axons arising from the medial 
hippocampus, which expresses multiple EphA receptors (Gao et al., 1996; Yue et al., 
2002; Zhang et al., 1996a), project to the medial septum whereas the lateral 
hippocampus, which displays weak EphA expression, innervates the lateral septum.
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In vitro ephrin-A5 has selective inhibitory effects on the outgrowth of medial, but not 
lateral hippocampal axons (Brownlee et al., 2000) and expression of a dominant 
negative EphA5 allows projections from medial hippocampal axons to invade the 
more lateral septum, from which they are normally excluded (Yue et al., 2002).
Interestingly the pattern of hippocampal projections observed in animals expressing 
dominant negative EphA5 suggests that inter-axon competition may play a role in 
topographic targeting in the Hippocamposeptal system (Yue et al., 2002), as is 
thought to occur in the retinotectal system. It is also intriguing that, while inhibitory 
effects on neurites in vitro are seen after a fixed time (Brownlee et al., 2000), careful 
analysis of axons demonstrates that short (<24 hour) exposure to ephrin-A5 increases 
hippocampal axon length, and axon retraction and fragmentation occur only after 
prolonged exposure (Gao et al., 1999), suggesting that ephrin-A5 might have 
bifunctional effects on these axons.
1.3.3. Topographic mapping of the Vomeronasal Projection.
In terrestrial vertebrates the vomeronasal organ is primarily responsible for detecting 
pheromones. Vomeronasal axons travel along the septum and across the surface of 
the main olfactory bulb to terminate in their target, the accessory olfactory bulb. The 
axons reaching the accessory olfactory bulb are segregated according to their origin 
in the vomeronasal organ, and basal vomeronasal axons innervate the posterior 
accessory olfactory bulb, while apical axons project to the anterior accessory 
olfactory bulb.
EphA-ephrin-A interaction has again been implicated in the formation of this 
topographic map, but in this case vomeronasal axons appear to be guided by 
attractive, reverse signals mediated by ephrin-As. Ephrin-A5 is more highly 
expressed in apical than basal vomeronasal neurons, and EphA6 is present at high 
levels in the anterior accessory olfactory bulb (Knoll and Drescher, 2002). In mice 
lacking ephrin-A5, apical vomeronasal axons project to both the anterior and 
posterior accessory olfactory bulb, suggesting that they have lost the ability to 
respond to a graded signal. Since vomeronasal axons preferentially grow on EphA 
substrates in vitro, it is likely that the accessory olfactory bulb signal is normally 
attractive (Knoll and Drescher, 2002).
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1.3.4. Non-graded ephrin-Eph expression.
In many regions of the nervous system Eph receptor-ephrin interaction appears to 
influence axon trajectories by limiting growth to particular Eph receptor/ephrin 
territories, or along Eph-ephrin boundaries. For example, ephrin expression at the 
midline appears to be very important for the correct guidance of both ascending and 
descending axon tracts, and within the brain, regional ephrin expression restricts the 
path taken by certain axons.
I.3.4.I. Guidance of Corticospinal tract axons.
Mice that are null for EphA4 or ephrin-B3 are grossly normal, but suffer from a very 
specific neurological defect in that they are incapable of unilateral movements. Most 
noticeably EphA4 and ephrin-B3 knockout mice walk with a hopping gait as both 
forepaws move together, as do both hind paws (Dottori et al., 1998; Kullander et al., 
2001a; Yokoyama et al., 2001). Retrograde and anterograde labelling of CNS 
neurons in these mice reveal that they have a defective projection of the corticospinal 
tract, which is the major descending pathway that controls voluntary movement. In 
normal animals all the corticospinal axons cross the midline in the medulla and 
project to the contralateral spinal grey matter. In the mutant mice corticospinal axons 
are able to re-cross the midline leading to bilateral innervation of the spinal cord 
(Dottori et al., 1998; Kullander et al., 2001a; Yokoyama et al., 2001).
Ephrin-B3 is expressed along the midline of the developing embryo (Gale et al., 
1996a; Imondi et al., 2000; Kullander et al., 2001a; Kullander et al., 2001b; 
Yokoyama et al., 2001) where it appears to act as a repulsive barrier for the EphA4 
expressing corticospinal axons (Kullander et al., 2001b; Yokoyama et al., 2001). In 
vitro neurons from the cortical region in which the corticospinal tract originates 
collapse in response to ephrin-B 3 and within the medulla ephrin-B3 expression is 
limited to the dorsal region, whereas the tracts cross the midline ventrally (Kullander 
et al., 2001a). Since mice expressing a truncated EphA4 still exhibit the hopping gait, 
forward signalling through EphA receptors seems to be required for axons to respect 
the ephrin-B3 midline barrier and not re-cross the midline (Kullander et al., 2001b).
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I.3.4.2. Guidance of Commissural Spinal Interneurons.
In vertebrates, intemeurons in the dorsal spinal cord initially send axons ventrally to 
the floor plate, before crossing the midline and projecting longitudinally. In part, 
guidance of these commissural axons ventrally is mediated by Netrin secreted from 
the ventral floorplate, which acts as an attractive cue to the commissural axons 
(Fazeli et al., 1997; Serafini et al., 1996), but this raises the question of how the 
axons overcome the attractive floorplate signal in order to continue their trajectory in 
the contralateral spinal cord.
Ephrin-B 1 and ephrin-B 3 are expressed in the floor plate of the mouse and the chick 
throughout the time of commissural axon pathfinding (Flenniken et al., 1996; Gale et 
al., 1996a; Imondi et al., 2000; Imondi and Kaprielian, 2001) and these ligands cause 
growth cone collapse of mice and chick commissural axons in vitro (Imondi et al., 
2000; Imondi and Kaprielian, 2001). Interestingly it has been shown that in both 
mice and chick EphB receptors are only expressed on sections of commissural axons 
that have crossed the midline (Imondi et al., 2000; Imondi and Kaprielian, 2001), 
which presumably allows the axons to enter the ipsilateral floor plate before being 
restricted to the contralateral spinal cord.
This observation reveals parallels with axon guidance at the midline in Drosophila. 
Roundabout (Robo), which is the receptor for the midline axon repellent Slit, is only 
expressed on commissural axons once they have crossed the midline (Kidd et al., 
1998a). Loss of the Robo gene results in commissural axons re-crossing the midline 
many times (Kidd et al., 1998a). Although disruption of ephrin-B-EphB interaction 
does not lead to re-crossing of commissural axons in the mouse (Imondi and 
Kaprielian, 2001), it has recently been shown that mammalian commissural axons 
also become sensitive to slit after they have crossed the midline (Zou et al., 2000), 
suggesting the these repulsive guidance cues may act together to constrain 
commissural projections. Genetic evidence shows that the dynamic regulation of 
Robo expression is under the control of Commissureless, which is also expressed at 
the midline (Kidd et al., 1998b). How EphB expression is regulated in commissural 
axons remains to be investigated.
Careful analysis of the trajectory taken by commissural axons once they have crossed 
the midline reveals that the majority of axons turn rostrally and grow longitudinally 
while being gradually deflected dorsally. These axons then make a final rostral turn
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at the border of a region of ephrin-B expression dorsal to their path (Imondi and 
Kaprielian, 2001). Disruption of ephrin-B-EphB interaction with soluble EphB-Fc 
prevents commissural axons from making their final rostral turn, and instead they 
grow into the ephrin-B expressing region (Imondi and Kaprielian, 2001).
1.3.4.3. Guidance of spinal motor axons.
Motor axons arising from the medial lateral motor column [LMC(m)], which do not 
express EphA4 innervate the ephrin-A5-positive ventral limb, whereas EphA4- 
expressing LMC [LMC(l)] axons project to the dorsal hind limb, which does not 
express ephrin-A5 (Eberhart et al., 2000; Eberhart et al., 2004; Ohta et al., 1996) (Fig 
1.5A). Ectopic expression of ephrin-A5 in the dorsal hind limb results in LMC(l) 
axons stalling at the base of the limb (Fig 1.5A), but in EphA4 knock-out mice these 
axons project with the LMC(m) axons into the ephrin-A5-positive ventral limb (Fig 
1.5B), suggesting that EphA4 expression on LMC(l) axons mediates a repulsive 
response to ephrin-A5 in vivo (Eberhart et al., 2004; Helmbacher et al., 2000). In 
support of this hypothesis ectopic EphA4 expression in LMC(m) axons results in 
their avoiding the ephrin-A5-positive ventral limb, and instead the axons innervate 
the dorsal limb (Fig 1.5B) (Eberhart et al., 2000).
In contrast to the behaviour of LMC(l) axons, EphA4-expressing motor axons 
originating in the medial portion of the medial motor column (MMC(m)} specifically 
project through the anterior half somite, which is| ephrin-A5 -positive. Expression of 
dominant-negative EphA4 in these axons, or ectopic expression of ephrin-A5 in the 
posterior half somite, causes aberrant projection into the posterior somite (Eberhart et 
al., 2004), which suggests that ephrin-A5 is normally attractive to MMC(m) axons. 
The different responses of EphA4-expressing LMC(l) and MMC(m) axons to ephrin- 
A5 are conserved in vitro. LMC(l) neurons extend very few neurites on an ephrin-A5 
substrate, whereas MMC(m) axons exhibit extensive neurite growth on ephrin-A5 
compared to control (Eberhart et al., 2004). These results, suggesting that ephrin-A5 
may act as a bifunctional guidance cue for motor axons, complement previous work 
that suggests hippocampal axons show both attractive and repulsive responses to 
ephrin-A5 (Gao et al., 1999; Brownlee et al., 2000; see section 1.3.2), and that 
ephrin-B 1 has both attractive and repulsive guidance effects on RGC axons
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Figure 1.5. EphA receptors and ephrin-As control the guidance of 
spinal motor neurons.
A B
D
LMC(l)
LMC(m)
Wild-lype v Ectopic EphA4/' Ectopic
ephrin-A5 EphA4
A. In wild-type animals EphA4-expressing axons (red) arising in the lateral part of 
the lateral motor column [LMC(l)j project to the dorsal (D) limb, which does not 
express ephrin-A5, but EphA4-negative axons (black) from the medial LMC 
fLMC(m)] innervate ephrin-A5-positive (green) territory in the ventral (V) limb. 
Ectopic ephrin-A5 expression in the D limb causes LMC(l) axons to stall at the 
base of the limb. B. LMC(I) axons in an EphA4 knockout animal project with the 
LMC(m) axons into ephrin-A5-positive territory in the V limb, and ectopic 
expression of EphA4 in the LMC(m) causes these axons to avoid the ephrin-A5- 
positive territory, and project along with the LMC(l) axons into the D limb. NT = 
neural tube
(McLaughlin et al., 2003; see section 1.3.1.2) and neural crest cells (Santiago and 
Erickson, 2002; see section 1.4.2.2).
1.4. Eph Receptors and ephrins in morphogenesis.
Correct development of a multicellular organism requires co-ordinated cell 
movements, which in turn require synchronised changes in cellular cytoskeleton and 
adhesion machinery. Eph receptor-ephrin interaction is essential for many of the 
tissue patterning and morphogenesis events that give rise to a structured embryo.
1.4.1. Development of the vascular system.
Formation of the vascular system during embryogenesis comprises two distinct 
processes, vasculogenesis and angiogenesis. During vasculogenesis the dispersed 
populations of vascular endothelial cell (EC) precursors, which will eventually line
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the blood vessels, differentiate and proliferate to form an initial network called the 
primary capillary plexus (Risau and Flamme, 1995). During angiogenesis the 
existing vessels of the primary capillary plexus are remodelled into a mature network 
via sprouting of new vessels and splitting, branching and pruning of existing vessels 
(Risau, 1997). Since co-ordinated changes in migration and adhesion of ECs are 
required for angiogenic remodelling it is unsurprising that Eph receptor-ephrin 
signalling has been shown to be critical for angiogenesis.
Ephrin-A 1 expression is induced by vascular endothelial growth factor (VEGF) 
stimulation and, like VEGF, has been shown to have angiogenic properties. Ephrin- 
A1 stimulation induces human umbilical vein endothelial cells (HUVECS) to form 
capillary-like structures in vitro, and implantation of an ephrin-A 1-Fc-coated pellet 
into the rat cornea induces vessel sprouting (Cheng et al., 2002a; Daniel et al., 1996; 
Ogawa et al., 2000; Pandey et al., 1995b). Despite the observation that ephrin-As are 
expressed at sites of vascular development in the mouse (Flenniken et al., 1996; 
McBride and Ruiz, 1998), no vascular defects have been reported in animals lacking 
a variety of EphA receptors or ephrin-As (Chen et al., 1996; Dottori et al., 1998; 
Feldheim et al., 2000; Frisen et al., 1998). EphB-ephrin-B signalling has also been 
implicated in angiogenic processes in vitro. Ephrin-B 1 can induce capillary-like 
assembly of ECs (Stein et al., 1998b), and ephrin-B2 can stimulate vessel sprouting 
in a corneal assay (Maekawa et al., 2003). Unlike ephrin-As however, there is a large 
body of evidence demonstrating that ephrin-B-EphB receptor signalling is essential 
for normal angiogenesis.
I.4.I.I. EphB4-ephrin-B2 expression during vascular development.
EphB4 and | its ligand, ephrin-B2, show a striking reciprocal expression pattern in the 
developing vasculature, in that ephrin-B2 is expressed exclusively on arteries and 
EphB4 is preferentially expressed on veins (Adams et al., 1999; Adams et al., 2001; 
Gerety et al., 1999; Gerety and Anderson, 2002; Wang et al., 1998)
Inactivation of either ephrin-B2 or EphB4 in mice leads to the identical phenotype of 
embryonic lethality following the failure of the primary plexus to remodel and veins 
and arteries to intercalate (Adams et al., 1999; Adams et al., 2001; Gerety et al., 
1999; Gerety and Anderson, 2002; Wang et al., 1998). The defects are specific to 
angiogenesis since the major trunk vessels, formed by vasculogenesis, appear normal
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in animals lacking ephrin-B2 or EphB4 (Adams et al., 1999; Gerety et al., 1999; 
Wang et al., 1998). Interestingly in the ephrin-B2 or EphB4 knockout, defects are 
seen in both arteries and veins (Adams et al., 1999; Gerety et al., 1999; Gerety and 
Anderson, 2002; Wang et al., 1998), suggesting that bi-directional signalling 
between the EphB4- and ephrin-B2- expressing cells is necessary for angiogenesis. 
This idea is supported by the report that knock-in of an ephrin-B2 construct that 
lacks the intracellular domain does not rescue the vascular defects seen in ephrin-B 2 
null mice (Adams et al., 1999). In vitro sprouting of ECs is stimulated by addition of 
both ephrin-B2-Fc and EphB4-Fc, demonstrating that both forward and reverse 
signalling can lead to cellular changes associated with angiogenesis in vivo (Adams 
et al., 1999; Adams et al., 2001).
It should be noted that, in addition to EphB4, EphB3 is also expressed on embryonic 
veins in the mouse (Adams et al., 1999). However, several lines of evidence suggest 
that EphB4 is primarily responsible for correct angiogenesis. EphB3 knock-out mice 
show no vascular defects (Adams et al., 1999) and while a double knock-out of 
EphB3/EphB2 results in vascular defects, the phenotype is, intriguingly, less severe 
than in ephrin-B2 or EphB4 knock-outs, with lower penetrance (Adams et al., 1999). 
Ephrin-B2 is the only known ligand for EphB4, and although ephrin-B 1 appears to 
be co-expressed with ephrin-B2 on arteries, over-expression of ephrin-B 1 cannot 
rescue ephrin-B2 vascular defects (Wang et al., 1998).
I.4.I.2. EphB4-ephrin-B2 signalling at the venous-arterial boundary.
Despite the crucial role of EphB4 and ephrin-B2 during angiogenesis little is known 
about the consequences of the complimentary expression pattern of this receptor- 
ligand pair at a cellular level. One possible role of complimentary ephrin-B2-EphB4 
expression in the developing vascular system is to keep the venous and arterial cells 
separate, analogous to the role of Eph receptor-ephrin signalling in restricting cell 
intermingling in the hindbrain (see section 1.4.3.1). Endothelial cell lines expressing 
EphB4 or ephrin-B2 will segregate when mixed (Fuller et al., 2003) suggesting that 
Eph receptor-ephrin interaction results in a repulsive signal preventing intermingling 
of arterial and venous cells. Forward signalling through EphB4 is sufficient for this 
segregation to occur (Fuller et al., 2003). Since truncated ephrin-B2, which would 
still be capable of initiating forward signalling through EphB4, cannot rescue the
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vascular defects seen in ephrin-B2 knockout mice (Adams et al., 1999), it seems 
unlikely that segregation of venous and arterial cell populations is sufficient to allow 
normal angiogenesis.
The function of EphB4 forward signalling in EC migration and angiogenic sprouting 
is not clear. Soluble ephrin-B2-Fc addition, or contact with ephrin-B2 expressing 
cells has been shown to promote migration of endothelial cells and increase capillary 
sprouting (Adams et al., 2001; Steinle et al., 2002; Zhang et al., 2001). However 
soluble ephrin-B2-Fc has also been reported to inhibit endothelial cell migration and 
sprouting (Fuller et al., 2003). Interpretation of these results is further complicated by 
the failure to address whether the experimental cell types used express Eph receptors 
other than EphB4. Interestingly two studies using cells that express EphB4 alone 
both demonstrate that EphB4 forward signalling inhibits adhesion, migration and 
sprouting of endothelial cells (Fuller et al., 2003; Hamada et al.» 2003).
Contradictory reports have also been published regarding the effects of stimulating 
ephrin-B2 reverse signalling in endothelial cells. Soluble EphB4-Fc has been shown 
to stimulate sprouting and migration of arterial endothelial cells, but contact with 
EphB4 expressing cells inhibits the formation of capillary-like structures by 
embryonic endothelial cells (Adams et al., 1999; Fuller et al., 2003; Zhang et al., 
2001).
1.4.1.3 Sites of neovascularization in the adult.
Recently it has been shown that the reciprocal pattern of ephrin-B2 expression in 
arteries and EphB4 expression in veins persists in the adult (Gale et al., 2001; Shin et 
al., 2001). In addition ephrin-B2 is expressed on newly sprouted vessels during 
wound healing in the adult, and during maturation of the corpus luteum in the adult 
ovary (Gale et al., 2001; Shin et al., 2001).
The role of Eph receptor-ephrin signalling in the formation of new blood vessels may 
explain the link between Eph receptors and ephrins, and tumourogenesis (Cheng et 
al., 2002a). Ephrin-B2 is seen on new blood vessels stimulated by tumourogenesis, 
and blocking Eph receptor activity has been shown to inhibit tumour vasculogenesis 
(Brantley et al., 2002; Cheng et al., 2002b)
35
I.4.I.4. Cross-talk with other mediators of vascular development.
In addition to ephrins, VEGFs and angiopoietins are growth factor families critical 
for angiogenesis. Mesenchymal cells surrounding the embryonic vessels express 
angiopoietin-1 (Ang-1), and ECs themselves express the receptor for Ang-1, Tie-2. It 
has been shown that Tie-2 can directly phosphorylate ephrin-B 1, which is expressed 
on endothelial cells in both veins and arteries (Adams et al 1999), and this may 
regulate ephrin-B 1 signalling. Functionally, ephrin-Eph receptor signalling may 
interact with other angiogenic signals, since soluble EphA2 can inhibit VEGF- 
stimulated endothelial cell migration in vitro, and neovasculogenesis in vivo (Cheng 
et al 2002).
1.4.2. Somitogenesis and trunk neural crest migration.
A basic feature of all vertebrate embryos is segmentation along the longitudinal body 
axis. The most striking regions of segmentation are the hindbrain and the paraxial 
mesoderm, which in turn underlie the development of a segmented nervous system. 
Eph receptor-ephrin interaction has been shown to play a major role in the induction 
and maintenance of a segmented body pattern in the embryo.
I.4.2.I. Somitogenesis.
Somites are transient embryonic structures that arise from the segmentation of the 
paraxial mesoderm into paired blocks. Somites organise the segmental pattern of die 
peripheral nervous system by restricting the migration of neural crest cells (section 
1.4.2.2) and motor axons (section 1.3.4.3), and then give rise to the vertebrae and 
ribs, the skeletal musculature of the back and limbs and the dorsal dermis. At the 
onset of somitogenesis the presomitic mesoderm (PSM) begins to express genes in a 
segmental pattern, and the presumptive somitic tissue is specified as having anterior 
or posterior identity. The juxtaposition of anterior and posterior PSM leads to the 
formation of a morphologically distinct intersomitic furrow, and the cells undergo a 
mesenchymal to epithelial transformation (Maroto and Pourquie, 2001). The genetic 
factors that underlie the early segmental patterning of PSM are well known (Maroto 
and Pourquie, 2001; Pourquie, 2001), and Eph receptor-ephrin signalling has been 
shown to play a role in the morphological changes and epithelialisation that occurs 
during somitogenesis.
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In the zebrafish EphA4 is expressed in the anterior half of the presumptive and newly 
formed somite, and there is reciprocal expression of two of its ligands in the posterior 
half of the presumptive somite (Durbin et al., 1998). Disruption of endogenous 
EphA4-ephrin signalling, by expression of dominant negative EphA4, interferes with 
somitogenesis by preventing the formation of intersomitic furrows (Durbin et al.,
1998). By contrast, transplantation of EphA4-expressing cells into zebrafish mutants 
that lack somites leads to formation of morphologically distinct intersomitic 
boundaries between EphA4 expressing- and wild-type cells (Barrios et al., 2003). 
EphA4-ephrin signalling is necessary for the changes in cell morphology and 
adhesion that underlie epithelialisation during zebrafish somitogenesis (Barrios et al., 
2003), and EphA4 expression in the chick PSM correlates with epithelial-like cell 
morphology (Schmidt et al., 2001).
I.4.2.2. Trunk neural crest migration.
Trunk neural crest cells delaminate from the neural tube and migrate in one of two 
spatially and temporally distinct pathways (Fig 1.6). Early migrating neural crest 
cells (NCCs) migrate ventrally from the neural tube through the anterior half of the 
somitic sclerotome (pathway 1 in Fig 1.6). These NCCs will become the sensory and 
sympathetic neurons of the peripheral nervous system, and the restriction of their 
migration through the anterior somites underlies the segmental arrangement of dorsal 
root and sympathetic ganglia in the adult animal. The posterior half of the 
sclerotome and overlying dermomyotome, from which the early NCC are excluded, 
express ephrin-B ligands (predominantly ephrin-B 1 in avians and ephrin-B2 in 
rodents) (Koblar et al., 2000; Krull et al., 1997; Wang and Anderson, 1997) and the 
first wave of NCCs express EphB receptors (EphB3 in avians, EphB2 in rodents) 
(Krull et al., 1997; Wang and Anderson, 1997).
Addition of soluble ephrin-B 1-Fc to whole-trunk explants in vitro, which will bind to 
the EphB receptors expressed on NCCs and prevent interaction with endogenous 
ephrin-B ligands, perturbs the in situ migration pattern of early NCCs (Koblar et al., 
2000; Krull et al., 1997; Santiago and Erickson, 2002). Disrupting EphB-ephrin-B 
interaction in this way results in early NCCs migrating through both anterior and 
posterior halves of the somite, and straying into the overlying dermomyotome 
(Koblar et al., 2000; Krull et al., 1997; Santiago and Erickson, 2002). Early NCCs in
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Figure 1.6. Trunk NCCs migrate from the neural tube along two
distinct pathways during development.
Pathway 1. Early NCCs delaminate from the neural tube (NT; grey) and migrate 
ventrally through the anterior (A) half of the adjacent somite (green). NCCs are 
excluded from entering the posterior (P) half somite (blue) and NCCs initially 
adjacent to a posterior half somite migrate longitudinally until they are able to 
navigate through permissive anterior somitic tissue. Pathway 2. Later migrating 
melanoblasts travel dorsol ate rally through the overlying dermomyotome (purple).
vitro  avoid growing on immobilised ephrin-B 1 or ephrin-B2 (Krull et al., 1997; 
Wang and Anderson, 1997) suggesting that ephrin-B ligands are responsible for a 
repulsive signal that excludes EphB expressing early NCCs from the posterior 
sclerotome and dermomyotome.
Approximately 18 hours after the early NCCs begin to migrate from the neural tube, 
a second wave of NCCs, destined to become melanocytes, migrates dorsolaterally 
from the neural tube through the dermom yotom e (path 2 in Fig 1.7). These 
m elanoblasts express EphB receptors, and ephrin-B expression persists in the 
dermomyotome along their migratory pathway at the time of melanoblast migration 
(Santiago and Erickson, 2002). Disruption of EphB-ephrin-B interaction in vivo just
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prior to the second wave of NCC migration prevents the melanoblasts from entering 
the dermomyotome, which suggests loss of an attractive or permissive signal. Indeed 
whereas chemotaxis of early NCCs in vitro is inhibited by the presence of ephrin-B 1- 
Fc in a chemotaxis chamber, melanoblast chemotaxis is increased in response to 
ephrin-B 1-Fc (Santiago and Erickson, 2002).
1.4.3 Rhombomere development and cranial neural crest migration.
I.4.3.I. Rhombomere formation.
During embryogenesis the developing hindbrain becomes segmented into repeating 
morphological compartments called rhombomeres. These compartments are not only 
morphologically discrete, but also have distinct genetic identity with sharp 
boundaries of gene expression corresponding to morphological boundaries (Lumsden 
and Krumlauf, 1996). The segmental pattern of cranial nerves is determined by the 
hindbrain organisation since cranial NCCs arising from particular rhombomeres 
migrate along specific pathways to the branchial arches where they contribute to 
specific ganglia (see section 1.4.3.2). Once the rhombomeres have formed there is a 
restriction of cell intermingling between neighbouring segments, although cells from 
different even numbered rhombomeres can mix, as can cells from odd numbered 
rhombomeres (Guthrie et al., 1993). A distinct morphological boundary will always 
form between cells of even origin and cells of odd origin (Guthrie -and Lumsden, 
1991).
There is complimentary expression of Eph receptors and ephrins on adjacent 
rhombomeres. Rhombomeres r3 and r5 express high levels of EphA4, EphB2 and 
EphB3, whereas the rhombomeres either side, r2, r4 and r6, express the ephrin-B 
ligands for these receptors (Becker et al., 1994; Bergemann et al., 1995; Flenniken et 
al., 1996; Gale et al., 1996a; Henkemeyer et al., 1994; Nieto et al., 1992) and Eph 
receptor-ephrin interaction at the rhombomere boundaries maintains the discrete 
compartments by restricting cell intermingling.
Mellitzer and colleagues have demonstrated restriction of cell intermingling by Eph 
receptors and ephrins appropriate to the hindbrain using a “fishball” assay. Mixing 
two cell populations from zebrafish animal caps each injected with a fluorescent 
tracer results in significant intermingling of the two populations, but this
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intermingling is restricted by the expression of EphA4 or EphB2 in one population 
and ephrin-B2 in the adjacent population (Mellitzer et al., 1999). A morphological 
boundary is seen between the cell populations, and, as in the hindbrain, this boundary 
corresponds to a region of reduced gap junction communication, thought to prevent 
the spread of regional identity signals between rhombomeres in vivo (Mellitzer et al.,
1999). In the fishball assay bi-directional signalling is necessary for the restriction of 
cell intermingling since juxtaposition of truncated ephrin-B2 with full length EphB2, 
or vice versa, does not prevent cell mixing. Unidirectional signalling by either the 
Eph receptor or the ephrin is sufficient to prevent communication via gap junctions 
(Mellitzer et al., 1999).
Injection of dominant negative EphA4 into one cell of a 2 cell stage zebrafish or 
Xenopus embryo leads to disruption of the ordered rhombomeres and the presence of 
ectopic cells with r3/r5 identity within even numbered rhombomeres (Xu et al.,
1995). Since ectopic ephrin-B2-positive cells sort to the boundaries of r3 and r5, but 
remain throughout even numbered rhombomeres it would appear that Eph receptors 
control the restriction of cell intermingling between odd and even fated rhombomeric 
cells, as opposed to influencing cell fate switching (Xu et al., 1999). This idea is 
supported by time-lapse microscopy of the movement of ectopic ephrin-B2 positive 
cells in the hindbrain. Although cells expressing truncated ephrin-B2 behave the 
same way as those expressing full length ephrin-B2, there is a contribution of ephrin- 
B reverse signalling to cell sorting, as truncated EphA4 expressed in a mosaic pattern 
leads to these cells being sorted to the edges of inappropriate (ephrin-B expressing) 
rhombomeres.
1.4.3.2.Cranial neural crest migration.
The NCCs of the hindbrain migrate into the branchial arches along specific pathways 
according to their rhombomeric origin, where they give rise to the facial cartilage 
and the bones and muscles of the neck as well as the cranial nerve ganglia. In chick, 
mouse and Xenopus NCCs from r2 migrate to the 1st branchial arch, NCCs from r4 
will populate the 2nd branchial arch and NCCs from r6 migrate to the 3rd and 4th 
branchial arches. NCCs arising from r3 and r5 do not migrate through their adjacent 
mesoderm but join the streams migrating either side of them (Kulesa et al., 2004) 
(Fig 1.7). These migratory streams of NCCs remain separate. Despite subtle
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Figure 1.7. Cranial NCCs migrate from rhombomeres to the
branchial arches along distinct pathways during development.
b a l ba2 ba3/4
Cranial neural crest cells (NCCs) migrate in separate stream s from specific 
rhombomeres (r) to populate the branchial arches (ba). In chick and mouse cranial 
NCCs from r2 populate b a l, r4 gives rise to NCCs that populate ba2 and r6 NCCs 
invade ba3 and ba4. In Xenopus r6 NCCs populate ba4 and ba5. NCCs from r3 
and r5 migrate with the adjacent rostral or caudal stream.
differences in the migratory pathway, destination and receptor-ligand expression of 
NCCs between species, studies in mice and Xenopus demonstrate a role for repulsive 
signals mediated by Eph receptor and ephrins in the guidance of cranial NCCs.
Complementary expression of Eph receptors and ephrins in neighbouring populations 
of cranial NCCs restricts intermingling between adjacent but differently fated NCC 
migratory streams. For example, in Xenopus, ephrin-B2 is expressed in the 2nd 
stream and EphA4 and E phB l (both of which are receptors for ephrin-B2) are 
expressed in the 3rd stream (Smith et al., 1997). Dominant-negative versions of either
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receptor causes Eph receptor-expressing crest normally destined for the 3rd arch to 
migrate aberrantly along with the more anterior stream of ephrin-B2-positive NCCs. 
This suggests that directional repulsive signalling between Eph receptor and ephrin 
expressing NCCs normally keeps the migrating streams separate (Smith et al., 1997). 
EphA-ephrin-A signalling also has a role in maintaining separate streams. In 
Xenopus NCCs destined for the 3rd branchial arch express EphA2. Introduction of 
dominant negative EphA2 allows intermingling of the 3rd and 4th branchial arch 
streams (Helbling et al., 1998).
Eph receptors and their respective ligands are expressed along the presumptive 
pathways taken by migrating cranial NCCs, and within the arches themselves, and in 
addition to restricting intermingling between migratory streams, Eph receptor-ephrin 
interaction prevents NCCs from invading inappropriate territory. In addition to a 
failure of NCCs to migrate in defined streams in ephrin-B2 knockout mice, NCCs 
invade territory that, in a wild-type animal would be ephrin-B2-positive, and thus 
from which they would normally be excluded. This repulsive exclusion is mediated 
by Eph receptor forward signalling since a knock in of ephrin-B2 without it’s 
cytoplasmic tail rescues the defects in NCC migration (Adams et al., 2001). It is also 
possible that Eph-ephrin signals are involved in patterning the branchial arches 
themselves as ephrin-B2 knockout mice have defective 2nd branchial arches (Adams 
et al., 2001).
1.5. Eph receptor signalling.
The biological functions of Eph receptors and ephrins described above all involve 
cell movements and/or changes in cell shape, which depend on co-ordinated changes 
in the organisation of the cell cytoskeleton and cellular adhesion. In molecular terms 
the intracellular signalling cascades induced by activation of Eph receptors 
ultimately influence the actin cytoskeleton and cell-matrix adhesions, to influence 
cell morphology and motility in a variety of in vitro systems.
1.5.1. Eph Receptor signalling to the actin cytoskeleton.
Activation of endogenous Eph receptors in a variety of cell types leads to 
reorganisation of filamentous actin (F-actin). These F-actin rearrangements induced 
by Eph receptor activation include the formation of contractile bundles of actin
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filaments, known as stress fibres, and the retraction of cell processes (Lawrenson et 
al., 2002; Miao et al., 2003; Ogita et al., 2003) as well as protrusive actin structures 
such as membrane ruffles and filopodia (Nagashima et al., 2002; Penzes et al., 2003). 
As discussed in section 1.3, activation of neuronal EphA receptors cause growth 
cone collapse in a variety of neuronal cell types, a process that also involves 
regulation of the actin cytoskeleton (Meima et al., 1997a; Meima et al., 1997b).
Eph receptor-mediated control of actin rearrangements can occur through members 
of the Rho family of monomeric GTPases. The Rho GTPases cycle between an 
inactive, GDP-bound conformation, and an active GTP-bound conformation in which 
they bind to effector molecules and transduce intracellular signals. GTPase exchange 
factors (GEFs) act to increase the level of GTP-bound, active Rho family member by 
binding the inactive form of the GTPase and catalysing the exchange of GDP for 
GTP (Nobes and Hall, 1994; Quilliam et al., 1995). Conversely GTPase activating 
proteins (GAPs) catalyse the hydrolysis of bound GTP to GDP, attenuating 
signalling through the GTPase (Lamarche and Hall, 1994). The inactive, GDP-bound 
GTPase can be stabilised by binding to guanine nucleotide dissociation inhibitors 
(GDIs) (Olofsson, 1999). Regulation of GTPase activity is involved in many of the 
biologically relevant responses to Eph receptor activation such as the repulsive 
response of neuronal growth cones, the morphology of dendritic spines and changes 
in vascular smooth muscle cell contractility (Irie and Yamaguchi, 2002; Jumey et al., 
2002; Ogita et al., 2003; Penzes et al., 2003; Wahl et al., 2000). In addition recent 
evidence suggests that Eph receptors interact with members of the Ableson (Abl) 
family of non-receptor tyrosine kinases (Yu et al., 2001), which have also been 
implicated in the organisation of the actin cytoskeleton in neural and non-neural 
tissues (Van Etten, 1999)
I.5.I.I. Rho Family GTPases; regulators of the actin cytoskeleton.
Despite the accumulating evidence that Rho family GTPases influence multiple 
intracellular signalling pathways, these proteins are best known for their pivotal role 
in regulating the actin cytoskeleton (Etienne-Manneville and Hall, 2002). Classic 
experiments in fibroblasts have revealed that of the three members that exemplify the 
Rho GTPase family, Racl activity results in localised actin polymerisation at the cell 
periphery resulting in the formation of lamella, activation of Cdc42 stimulates
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filopodial formation, and Rho A regulates cell contractility by inducing the formation 
of actomyosin cables known as stress fibres (Nobes and Hall, 1995; Ridley et al., 
1992; Ridley, 1999). Similarly injection of mutant Rho family GTPases into -> 
neuronal cells reveals that Cdc42 activation leads to increased filopodial formation 
and Rac-dependent lamella at the growth cone, whereas RhoA activity results in 
growth cone collapse and neurite retraction (Kozma et al., 1997)?^
The relevant cellular effector of RhoA during neurite retraction is likely to be Rho 
kinase (ROCK), since expression of a constitutively active form of ROCK is 
sufficient to cause neurite retraction in neuroblastoma cells in vitro (Amano et al.,
1998). ROCK binds to, and is activated by, RhoA-GTP (Leung et al., 1995; Matsui et 
al., 1996) and active ROCK can phosphorylate the regulatory light chain of myosin 
II (myosin light chain, MLC), increasing myosin ATPase activity (Amano et al.,
1996). In addition to this direct increase in MLC phosphorylation, active ROCK 
phosphorylates and inhibits myosin light chain phosphatase (Kimura et al., 1996) 
which would otherwise remove ROCK-phosphorylated residues on MLC. 
Phosphorylation of MLC leads to the assembly of contractile actin-myosin bundles 
known as stress fibres (Citi and Kendrick-Jones, 1987). In this way Rho activation 
leads to an increase in cell contractility via ROCK (Riento and Ridley, 2003). Rho- 
and ROCK-induced neurite retraction probably acts via increased actomyosin 
contraction, since a mutant version of MLC, which alone increases the activation of 
myosin ATPase, promotes neurite retraction in vitro (Amano et al., 1998).
Given that Racl and Cdc42 activation gives rise to the protrusive actin structures of 
lamella and filopodia respectively it is plausible to expect there to be a link between 
the activity of these GTPases and actin polymerisation machinery. Actin related 
proteins Arp2 and Arp3, and the WASP/WAVE family of actin nucleation factors 
define an actin assembly pathway that can be influenced by both Rac and Cdc42 
(Higgs and Pollard, 2001). The Arp2/3 complex binds the side of an existing actin 
filament and nucleates polymerisation of an actin side branch (Amann and Pollard, 
2001; Blanchoin et al., 2000). Members of the WASP/WAVE family of proteins bind 
the Arp2/3 complex and stabilise an active Arp2/3 conformation to promote 
nucleation (Amann and Pollard, 2001; Higgs and Pollard, 2001). Active Cdc42 can 
bind the regulatory domain of WASP, disrupting an inhibitory intramolecular 
interaction and allowing WASP to activate the Arp2/3 complex (Rohatgi et al.,
Fig 1.8. Regulation of actin dynamics in the growth cone by Rho 
family GTPases.
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GTPase-mediated signalling pathways are regulated by GEFs (Guanine 
nucleotide exchange factors), which increase the level o f active, GTP-bound 
GTPase, and GAPs (GTPase activating proteins), which catalyse the hydrolysis 
o f GTP for GDP. The GTPases Cdc42 and Rac promote actin polymerisation via 
the WASP/WAVE family o f actin nucleation factors and the Arp2/3 complex to 
stimulate the formation o f filopodia (Cdc42) and lamellae (Rac). Cdc42 and Rac 
also share a common effector in PAK, which inhibits the activity o f myosin light 
chain kinase (MLCK) to reduce actomyosin contractility, and activate LIM 
kinase (LIMK) to inhibit the actin depolymerisation factor cofilin, thus 
stabilising actin filaments. Rho acts via its effector ROCK to directly 
phosphorylate the regulatory light chain o f myosin, and also inhibit myosin light 
chain phosphatase, thereby increasing contractility, leading to growth cone 
collapse and axon retraction. ROCK can also activate LIMK.
44-i
1999). Racl can stimulate actin polymerisation by activating the Arp2/3 complex via 
WAVE2 (Takenawa and Miki, 2001), possibly by inducing the relocalisation of a 
protein complex including WAVE2 within the cell (Steffen et al., 2004).
Racl and Cdc42 have a common effector in p21-activated kinase (PAK) 
(Aspenstrom, 1999). Rac and Cdc42 activation leads to an increase in PAK activity, 
which in turn regulates the activity of other cellular kinases involved in actin 
rearrangement. PAK phosphorylation of LIM kinase increases fits activity towards 
the actin depolymerising factor cofilin (Dan et al., 2001). Since cofilin is negatively 
regulated by phosphorylation, PAK activation of LIM kinase ultimately leads to the 
stabilisation of actin filaments. In addition, PAK-mediated phosphorylation of 
myosin light chain kinase (MLCK) reduces it’s ability to phosphorylate myosin, and 
hence PAK activity can reduce actomyosin based contraction (Wirth et al., 2003). In 
this way Cdc42 and Rac activation promote protrusive actin structures by stimulation 
of actin polymerisation and stabilising existing actin filaments, and antagonise the 
actomyosin contraction that underlies Rho-mediated changes in the actin 
cytoskeleton.
I * See Fig. 1.8
I.5.I.2. Eph receptor regulation of Rho GTPases.
Given that Rac and Cdc42 activity stimulates protrusive actin structures, while Rho 
activity increases cell contractility, an overall model might predict that the repulsive 
responses induced by Eph receptor-ephrin interaction during development, for 
example in axon and neural crest guidance, might act through the Rho pathway 
rather than Rac and Cdc42. Activation of endogenous Eph receptors has been shown 
to increase the level of RhoA-GTP in a number of non-neuronal cell types, without a 
corresponding change in the activity of Racl or Cdc42 (Lawrenson et al., 2002; Miao 
et al., 2003; Ogita et al., 2003; Sharfe et al., 2002). Rho activity is important for the 
cellular response to ephrin stimulation, since blocking ephrin-induced increase in 
Rho activity prevents ephrin-induced retraction of melanoma cell line processes, and 
the formation of stress fibres in smooth muscle cells (Lawrenson et al., 2002; Ogita 
et al., 2003). Ephrin-A stimulation of RGCs in culture also stimulates RhoA activity, 
and inhibiting Rho activity with C3 toxin prevents ephrin-A-induced growth cone 
collapse (Wahl et al., 2000; see section 1.5.3).
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Eph receptor-mediated increases in RhoA activity have been shown to involve the 
activity of Rho GEFs, which play an important role in mediating biologically 
relevant responses to Eph receptor activation. For example the Rho GEF Ephexin 
mediates ephrin-A-induced RGC growth cone collapse in vitro (Shamah et al., 2001; 
see section 1.5.3) and the structurally related VSMRhoGEF (vascular smooth muscle 
Rho GEF) regulates Rho dependent contractile actin structures in smooth muscle 
cells (Ogita et al., 2003).
Vascular smooth muscle cell contractility is important for the maintenance of normal 
blood circulation, and this contractility is regulated by the RhoA-ROCK-myosinll 
pathway described in section 1.5.1.1 (Somlyo and Somlyo, 2000). The in vivo 
expression pattern of VSMRhoGEF in smooth muscle of many organs matches that 
of EphA4, and co-expression of EphA4 and VSMRhoGEF in smooth muscle cells 
leads to the specific activation of RhoA (Ogita et al., 2003). Reducing VSMRhoGEF 
expression by RNAi prevents ephrin-A-induced Rho activation and associated 
increase in contractile stress fibres in these cells (Ogita et al., 2003). Although the 
result of EphA4 activation on VSMRhoGEF activity was not investigated, these 
observations suggest that Eph-receptor-mediated phosphorylation of VSMRhoGEF 
increases Rho activity and hence regulates vascular smooth muscle cell contractility. 
This is interesting given that ephrin-Eph receptor interaction is required for normal 
development of vascular smooth muscle (Zhang et al., 2001), and suggests that Eph 
receptor signalling in vascular smooth muscle cells may act not only to regulate cell 
behaviour during development, but also during the normal physiological function in 
the adult.
In addition to the above evidence that Eph receptors can activate Rho via GEFs, there 
is also evidence that Eph receptor signalling can act via Rac and Cdc42 to induce 
rearrangements of the actin cytoskeleton that result in the protrusion of actin-rich 
structures. For example the formation of dendritic spines involves remodelling of 
filopodial protrusions into longer actin structures, a process that involves direct 
regulation of actin polymerisation (Halpain, 2000). Over-expression of EphB2 in 
hippocampal neurons, or stimulation of these neurons with ephrin-B 1, induces the 
formation of dendritic spines (Ethell et al., 2001; Penzes et al., 2003), and recent 
investigations have revealed a role for both Cdc42 and Rac activity in this process,
46
mediated by the Rho family GEFs Intersectin and Kalirin respectively (Ethell et al., 
2001; Irie and Yamaguchi, 2002; Penzes et al., 2001; Penzes et al., 2003).
Stimulation of primary hippocampal neurons with ephrin-B 1 results in increased 
levels of active Cdc42, and this is the result of a functional interaction between 
EphB2 and the Cdc42-specific GEF Intersectin (Irie and Yamaguchi, 2002). 
Endogenous neuronal EphB2 interacts with Intersectin, and co-expression of the two 
proteins increases Intersectin GEF activity towards Cdc42 (Irie and Yamaguchi, 
2002). Expression of a kinase-dead EphB2, or a truncated form of Intersectin lacking 
the GEF domain, blocks the formation of dendritic spines that normally appear on 
primary hippocampal neurons after a few weeks in culture (Ethell et al., 2001; Irie 
and Yamaguchi, 2002), suggesting that EphB receptor activation normally acts via 
Intersectin and Cdc42 to initiate and remodel dendritic spines during development.
A second Rho family GEF that has been implicated in ephrin-mediated changes in 
dendritic spine morphology is Kalirin, a member of the Trio family of GEFs. Over­
expression of Kalirin in hippocampal neurons results in an increase in size and 
number of dendritic spines, qualitatively similar to the effect of ephrin-B 1 
stimulation of hippocampal neurons in vitro (Penzes et al., 2001; Penzes et al., 2003). 
The changes in spine morphology are both Eph kinase- and Rac-dependent (Penzes 
et al., 2003), but although Kalirin exhibits in vitro GEF activity for Rac, and Kalirin 
GEF activity is required for ephrin-B 1-induced changes in dendritic spine- 
morphology, EphB2 activation does not change Kalirin’s GEF activity towards Rac 
(Penzes et al., 2000; Penzes et al., 2003). In agreement with this observation no 
increase in Rac activity is seen in hippocampal neurons in response to ephrin-B 1 
stimulation (Ethell et al., 2001). Instead, activation of EphB2 receptors on dendritic 
spines leads to a redistribution of endogenous Kalirin to synaptic clusters (Penzes et 
al., 2003). This adds an extra level of subtlety to the capacity of Eph receptors to 
induce highly localised changes in the actin cytoskeleton via modulation of the Rho 
GTPases. As well as activating GEF activity in a spatially discrete region, at or near 
the site of Eph receptor activation, Eph receptor activation could increase the 
concentration of previously active GEF to a very precise location, for example the 
dendritic spine.
Overall the experiments described above provide evidence that Eph receptor 
signalling can induce physiologically relevant changes in the actin cytoskeleton via
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Rho family GTPases and their GEFs, and that the cellular responses invoked by Eph- 
receptor activation can be both repulsive/retractive, via activation of Rho, or 
attractive/protrusive via Rac or Cdc42 activity. It should be noted however that the 
Rac/Cdc42 attraction and Rho repulsion pattern is not without notable exceptions. 
Rac activity is required to mediate cell-cell separation events during EphB-mediated 
repulsive responses, and is also necessary for EphA-mediated axon repulsion (Jumey 
et al., 2002; Marston et al., 2003). It is likely that since Eph receptor-ephrin 
interaction mediates such a complex array of morphogenic processes in vivo, Eph 
receptor activity regulates many intracellular signalling intermediates, including 
members of the Rho family, in a tightly controlled and co-ordinated manner.
I.5.I.3. Eph receptor signalling and Abl family kinases.
Members of the Abl family of non-receptor tyrosine kinases have been implicated in 
rearrangement of the actin cytoskeleton in response to signals mediated by many cell 
surface receptors (Hernandez et al., 2004; Woodring et al., 2003) as well as the 
control of axon guidance during development (Lanier and Gertler, 2000; Moresco 
and Koleske, 2003). Biochemical interactions between Abl and EphB2 have been 
reported, and these interactions are conserved between EphB2 and the Abl 
homologue, Arg (Abl related gene) (Yu et al., 2001). EphB2 association with the 
SH2 domain of Abl and Arg kinases depends on Eph kinase activity, and 
phosphorylation of the two conserved tyrosine residues in the Eph receptor 
juxtamembrane region (Yu et al., 2001). Co-expression of full length EphB2 results 
in phosphorylation of Abl and Arg, and this is also dependent on Eph kinase activity, 
although it is not clear whether Abl and Arg are directly phosphorylated by Eph 
kinases (Yu et al., 2001). Stimulation of cells expressing endogenous EphB2 with 
ephrin-Bl leads to a transient decrease in Abl kinase activity (Yu et al., 2001), but 
despite the intriguing possibility that Eph receptors may phosphorylate and regulate 
Abl kinase in response to physiological signals, no functional role for Abl activity 
during Eph receptor-mediated cell behaviour has been shown to date.
1.5.2. Eph receptor signalling and adhesion.
Cell attachment to the extracellular matrix (ECM) is mediated by integrins, which are 
transmembrane heterodimers that link the ECM to the cytoskeleton. Engagement of 
integrins by ECM proteins results in the recruitment of structural and signalling
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proteins at sites of cell-matrix adhesion, and ECM activation of integrin signalling 
induces changes in cytoskeletal organisation; so called “outside-in signalling” 
(Humphries, 2000). Integrin-mediated adhesion can be influenced by intracellular 
signals, which either induce a conformational change in the integrin heterodimers, 
regulating their affinity for ligands, or regulate integrin clustering, changing their 
avidity (Hughes and Pfaff, 1998). This “inside-out” signalling is not well understood 
but there is evidence that the intracellular signalling pathways stimulated by Eph 
receptor activation may modulate integrin-mediated adhesion.
Activation of the small GTPase R-Ras increases cell adhesion to ECM proteins by 
directly regulating integrin affinity and avidity, and inhibition of R-Ras prevents 
cells from maintaining integrin-mediated attachment (Kinashi et al., 2000; Kwong et 
al., 2003; Zhang et al., 1996b). The reported ability of EphB receptors to modulate 
R-Ras activity correlates with EphB-dependent changes in cell-matrix adhesion. 
EphB2 activation, which results in loss of cell-matrix adhesion in epithelial cells, 
leads to the phosphorylation of R-Ras effector domain, preventing effector binding 
(Zou et al., 1999) and thus inhibiting downstream signalling. Expression of a non- 
phosphorylatable mutant of R-Ras prevents EphB2-mediated loss of attachment, 
suggesting that EphB2 activity acts to reduce cell matrix adhesion by 
phosphorylating R-Ras (Zou et al., 1999). The R-Ras/EphB2 interaction may depend 
on the adaptor SHEP1, which associates with EphB2 in an activity dependent 
manner, and also binds R-Ras (Dodelet et al., 1999).
In contrast to EphB2, other studies have shown that EphBl activation increases 
integrin-mediated adhesion in a variety of cell types (Becker et al., 2000; Huynh-Do 
et al., 1999; Stein et al., 1998b). EphBl activation induces the formation of a protein 
complex that includes RasGAP and phosphorylated p62DOK, a protein which, when 
phosphorylated, can bind to and inactivate RasGAP (Becker et al., 2000; Kashige et 
al., 2000). Since RasGAP can downregulate R-Ras (Rey et al., 1994) and R-Ras 
activity can be correlated with an increased cell-matrix adhesion (Kinashi et al., 
2000; Kwong et al., 2003; Zhang et al., 1996b) it is therefore possible that EphBl- 
mediated phosphorylation of p62DOK inhibits RasGAP, and the resulting increase in 
R-Ras activity leads to increased cell-matrix adhesion. It is interesting to note 
however that activation of EphB2, which as discussed above can increase adhesion, 
can also lead to phosphorylation of p62DOK (Becker et al., 2000). This suggests that
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differential regulation of R-Ras by p62DOK phosphorylation cannot be the only 
mechanism underlying the opposing effects of EphBl and EphB2 on integrin- 
mediated adhesion.
During inside-out signalling, phosphorylation of focal adhesion kinase (FAK) 
correlates with increased cell-matrix adhesion, and is thought to be required for R- 
Ras-induced increases in adhesion (Kwong et a l, 2003; Pichard et al., 2001). 
Dephosphorylation of FAK following EphA2 activation correlates with ephrin-Al - 
induced loss of integrin-mediated adhesion (Miao et al., 2000). The Phosphatase 
SHP2 is recruited to EphA2 following stimulation with ephrin-Al, and expression of 
a dominant negative SHP2 leads to elevated levels of phosphorylated (Miao et al.,
2000). Dominant negative SH2 also inhibits ephrin-Al-induced loss of adhesion, 
suggesting that EphA2-mediated activation of SHP2 normally reduces adhesion by 
the dephosphorylation of FAK (Miao et al., 2000).
Recently it has been shown that PI3 kinase may be involved in phosphorylation o f 
FAK during the regulation of cell adhesion by R-Ras (Kwong et a l, 2003). 
Interestingly EphA8 mediated increases in cell adhesion depend on PI3 kinase 
activity, providing an additional link between Eph receptor signalling and regulation 
of FAK-mediated cell-matrix adhesions (Gu and Park, 2001).
Overall the experimental data suggests that Eph receptors have the potential to 
activate R-Ras via p62DOK-mediated inhibition of RasGAP, increasing integrin-
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mediated attachment through FAK and possibly PI3 kinase. Alternatively Eph 
receptor activation could directly phosphorylate R-Ras and inhibit a pathway that 
leads to FAK phosphorylation, and/or recruit SHP2 to dephosphorylate FAK, 
reducing integrin-mediated adhesion. The capacity of Eph receptors to both increase 
and decrease a signalling pathway is not restricted to R-Ras however. Unlike R-Ras, 
the closely related H-Ras signals through the MEK/ERK pathway, and there are 
reports of Eph receptor activation both positively and negatively regulating MEK and 
ERK (Elowe et al., 2001; Miao et al., 2001; Pratt and Kinch, 2002; Pratt and Kinch, 
2003; Vindis et al., 2003; Zisch et al., 2000). H-Ras can modulate integrin adhesions 
via MEK/ERK (Hughes et al., 1997) and there is evidence that EphB-mediated 
regulation of the MEK/ERK pathway plays a role in ephrin-B-induced cell migration 
(Vindis et al., 2003) and neurite retraction (Elowe et al., 2001; see section 1.5.3), but 
to date there is no direct evidence that the MEK/ERK pathway mediates these 
cellular effects via changes in cell-matrix adhesion (Vindis et al., 2003).
To date Eph receptor-dependent activation or repression of R-Ras signalling is the 
only factor that correlates with Eph receptor-mediated increase or decrease in cell- 
matrix adhesion. There does not appear to be a correlation between the adhesion 
effects and the subclass of Eph receptor that is active, or the method of ligand 
presentation (soluble vs. substrate bound). It is interesting to note that the majority 
of experiments performed to determine the effect of Eph receptor signalling on cell 
adhesion have utilised cell lines expressing abnormally high levels of Eph receptors, 
either as a consequence of transfection during an experimental protocol, or 
transformation prior to immortalisation. In either case the intracellular machinery 
recruited by active Eph receptors under normal physiological conditions might be 
absent or abnormally regulated. It would be interesting to address the effect of Eph 
receptor activation on adhesion of a cell type which endogenously expresses Eph 
receptor, and to which changes in adhesion are physiologically relevant, for example 
during neural crest migration or repulsive axon guidance.
I.5.2.I. Eph receptor signalling and Src family kinases.
The Src family of non-receptor tyrosine kinases can be activated by many different 
classes of cellular receptor, including growth factor, chemokine and adhesion 
receptors, and are involved in many biological activities, including regulation of the
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actin cytoskeleton and cell matrix adhesions (Frame et al., 2002; Thomas and 
Brugge, 1997). Of particular interest in terms of Eph receptor signalling is the 
evidence that Src kinase activity is necessary for cell motility, namely that fibroblasts 
deficient in Src family kinases show impaired migration in vitro (Fincham and 
Frame, 1998; Hall et al., 1996; Klinghoffer et al., 1999), and recently Src kinase 
activity has been implicated in mediating cell migration induced by Eph receptor 
activation (Steinle et al., 2002; Vindis et al.* 2003).
Several Eph receptors, including EphBl and EphB2, have been shown to interact 
with Src, and EphA3, EphA4, EphA8, and EphB3 can associate with the closely 
related kinase Fyn (Choi and Park, 1999; Ellis et al., 1996; Hock et al., 1998a; 
Prevost et al., 2002). In all cases investigated the interaction with Eph receptor 
depends on the SH2 domain of the Src family member in question, and the 
observation that substitution of the juxtamembrane tyrosine residues with 
phenylalanine abrogates Src or Fyn binding has been interpreted as evidence that Src 
and Fyn bind specifically to the phosphorylated juxtamembrane region. As 
mentioned in section 1.2.3 recent evidence that these residues mediate an 
autoinhibitory interaction suggests that such results must be interpreted with care, 
since phenylalanine substitutions will result in a receptor that is permanently in an 
inactive conformation and may therefore have reduced accessibility to many binding 
sites. However the motifs surrounding the juxtamembrane tyrosines correspond to 
high affinity Src binding sites (Ellis et al., 1996; Songyang et al., 1993), which 
supports the idea that the Src kinases bind in this region. Importantly activation of 
Eph receptors has been shown to increase the activity of Src and/or Fyn as assayed 
by an increased level of autophosphorylation (Sharfe et al., 2003; Steinle et al., 2002; 
Takasu et al., 2002; Vindis et al., 2003).
As discussed in section 1.4.1 EphB4-ephrin-B2 interaction is crucial for remodelling 
of the primary vascular plexus during embryogenesis, and directed cell movements 
underlie this in vivo remodelling and the in vitro sprouting angiogenesis induced in 
endothelial cells in culture following EphB4 stimulation (Adams et al., 1999; Adams 
et al., 2001; Gerety et al., 1999; Gerety and Anderson, 2002; Wang et al., 1998). 
Primary human microvascular endothelial cells, which endogenously express EphB4, 
show a positive chemotactic response to ephrin-B2, and this response is blocked by 
inhibiting Src kinase activity (Steinle et al., 2002). Similarly ephrin-B2 stimulation
52
of a cell line that endogenously expresses EphBl leads to a Src-dependent 
chemotactic response (Vindis et al., 2003). In both cell types Src becomes 
phosphorylated on tyrosine 416, which is indicative of increased Src kinase activity 
(Kmiecik et al., 1988; Steinle et al., 2002; Vindis et al., 2003).
EphBl- and EphB2-mediated migration of these cells is also dependent on the 
activities of MEK and PI3 kinase respectively, and Src activity is required for the 
activation of both these pathways downstream of Eph receptor activation (Steinle et 
al., 2002; Vindis et al., 2003). It is interesting that both MEK and PI3 kinase are 
potentially involved in ephrin-mediated changes in cell-matrix adhesion, as discussed 
above. Given the accumulating evidence that Src regulates the turnover of cell- 
matrix adhesions, and that Src’s role in disassembling adhesions is required for 
normal cellular migration (Carragher et al., 2001; Fincham and Frame, 1998; Hall et 
al., 1996; Klinghoffer et al., 1999; Webb et al., 2004) it is possible that Eph receptor- 
mediated increases in Src activity might contribute to ephrin-induced changes in 
adhesion, and hence allow successful migration in response to ephrin. Addition of a 
MEK inhibitor, or expression of a dominant negative MEK prevents Src-mediated 
disassembly of cell-matrix adhesions (Carragher et al., 2003). Since MEK has been 
implicated in Eph receptor-mediated changes in adhesion, and ephrin-induced 
growth cone collapse (see section 1.5.3) it is possible that Src activity plays a 
functional role downstream of Eph receptor signalling during axon guidance. It has 
been reported that ephrin-B2-mediated increase in cell adhesion is not| affected I by 
inhibiting Src activity (Vindis et al., 2003). However as discussed above Eph 
receptor activation can either increase or decrease cell-matrix adhesion, and Src 
activity is thought to regulate cell adhesion by specifically disassembling adhesion 
complexes (Carragher et al., 2001; Fincham et al., 1995; Fincham and Frame, 1998; 
Webb et al., 2004). It is therefore possible that Src activity is required during Eph 
receptor-induced loss of adhesion, for example during growth cone collapse.
1.5.3. Eph Receptor signalling and axon guidance.
As discussed in section 1.3 the ephrins act as repulsive guidance cues for many 
classes of axon in vivo. Stimulation of these neurons with soluble ephrin in vitro 
results in loss of the F-actin-rich lamella and filopodia of the growth cone, which 
reflects ephrin-induced rearrangements of the actin cytoskeleton (Cheng et al., 2003;
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Fournier et al., 2000; Jumey et al., 2002; Meima et al., 1997a; Meima et al., 1997b; 
Menzel et al., 2001; Monschau et al., 1997; Shamah et al., 2001; Wahl et al., 2000). 
Early experiments showed that disrupting the actin cytoskeleton prevents axons 
responding to repulsive guidance cues (Bentley and Toroian-Raymond, 1986), and 
more recently it has been shown that integrin-mediated cell adhesions are rapidly 
disassembled in response to repulsive axon guidance cues (Barberis et al., 2004; 
Serini et al., 2003). In agreement with the idea that repulsive axon guidance cues co- 
ordinately regulate the actin cytoskeleton and cell-matrix adhesion, many of the Eph 
receptor signalling intermediates discussed above have a role in ephrin-induced 
growth cone collapse.
As discussed in section 1.5.1, modulation of Rho GTPase activity is a major 
mechanism whereby Eph receptor activation can influence the actin cytoskeleton. 
Stimulation of RGCs in culture with ephrin-A5-Fc leads to an increase in the levels 
of active Rho in the cells, and this increase is necessary for ephrin-induced growth 
cone collapse, since inhibition of Rho activity with C3 transferase significantly 
reduces the proportion of RGC growth cones that collapse in response to ephrin-A5 
stimulation (Wahl et al., 2000). Inhibition of the Rho effector ROCK also inhibits 
ephrin-induced growth cone collapse (Wahl et al., 2000). EphA4, one of the Eph 
receptors endogenously expressed by RGCs in vitro and in vivo, has been found to 
associate with Ephexin, a GEF that has preferential activity for Rho over Cdc42 and 
Rac (Monschau et al., 1997; Shamah et al., 2001). The repulsive response of RGCs 
to ephrin requires Ephexin exchange activity, since expression of a dominant 
negative Ephexin reduces the ephrin-A5-induced collapse (Shamah et al., 2001). 
Together these results suggest Eph receptor activation leads to Ephexin-mediated 
increase in Rho activity, and growth cone collapse via ROCK.
In addition to modulation of the Rho pathway, stimulation of RGCs with ephrin-A2 
and ephrin-A5 has been shown to reduce the levels of active Rac (Jumey et al., 2002; 
Wahl et al., 2000). Whereas ephrin-induced increase in Rho activity correlates well 
with the observation that activation of Rho is sufficient to cause neurite retraction 
(Kozma et al., 1997) the functional significance of the reduction of Rac activity in 
response to ephrin is not clear, since inhibition of Rac activity alone does not cause 
RGC growth cone collapse, and expression of a constitutively active Rac does not 
inhibit ephrin-induced growth cone collapse (Jumey et al., 2002). The activities of
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* See Fig. 1.9
Fig 1.9. EphA and EphB receptor-mediated signalling pathways 
induce growth cone collapse and axon retraction.
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EphA receptors constitutively associate with the GEF Ephexin, and when EphA 
receptors become activated, Ephexin increases the levels of active Rho, while 
decreasing the levels of active Rac. EphA-mediated growth cone collapse and 
axon retraction occurs through activation Rho, and it’s effector ROCK, which 
increase actomyosin-based contractility. EphB receptor activation induces 
growth cone collapse and axon retraction via RasGAP-mediated inhibition of the 
Ras-MEK pathway. The mechanism by which this occurs is unclear, although 
there is evidence that the Ras-MEK pathway may antagonise Rho-ROCK 
signalling in non-neuronal cells. Despite the transient decrease in Rac activation 
that follows EphA activation, Rac activity is required for ephrin-A-induced 
growth cone collapse and axon retraction, possibly for the internalisation of 
growth cone membrane.
Rho and Rac/Cdc42 have been suggested to be mutually antagonistic during growth 
cone responses to repulsive cues, including ephrins, and the simultaneous activation 
of Rho and inhibition of Rac following ephrin stimulation of RGCs might shift the 
balance away from Rac/Cdc42 actin filament assembly, and favour collapse 
(Giniger, 2002; Hirose et al., 1998; Kozma et al., 1997; Wahl et al., 2000). 
Expression of Ephexin in fibroblasts results in a mixed phenotype of Rho-, Rac- and 
Cdc42-dependent structures, namely stress fibres, lamellae and filopodial extension 
respectively (Shamah et al., 2001). Upon co-transfection of EphA4 and Ephexin 
however, the majority of cells exhibit Rho-like phenotypes at the expense of Rac- 
and Cdc42-like phenotypes, which might suggest that EphA receptor activity 
potentiates Ephexin GEF activity towards Rho, while reducing GEF activity towards 
Rac and Cdc42, although this was not tested directly (Shamah et al., 2001).
Stimulation of RGCs in culture with soluble ephrin-A5 and ephrin-A2 leads to an 
increase in endocytosis, assayed by uptake of fluorescent dextran from the bathing 
medium, and this ephrin-mediated endocytosis is dependent on Rac activity 
(Fournier et al., 2000; Jumey et al., 2002). Recent work has shown that Rac 
dependent trans-endocytosis of EphB-ephrin-B complexes is necessary for separation 
of cells following receptor-ligand interaction at sites of cell-cell contact (Marston et 
al., 2003, Zimmer et al., 2003). This mechanism is thought to allow repulsive 
responses and cell-cell separation following an initial high affinity binding of Eph 
receptor and ligand (Marston et al., 2003). An alternative, Rac-independent, 
mechanism has been shown to mediate the separation of an EphA-expressing axon 
from an ephrin-A-expressing cell (Hattori et al., 2000). Eph A3 binding stimulates 
proteolysis of ephrin-A2 by the metalloprotease ADAM 10, and expression of a non- 
cleavable ephrin-A2 prevents axon withdrawal following contact with ephrin-A2 
expressing cell (Hattori et al., 2000). Given that growth cone collapse is not inhibited 
by lack of ephrin-A2 cleavage (Hattori et al., 2000), it is possible that Rac-dependent 
endocytosis contributes to the loss of growth cone structures via internalisation of 
membrane (Jumey et al., 2002) and that this explains the necessity for Rac activity 
during ephrin-A-induced growth cone collapse.
In addition to effects on the Rho GTPases there is evidence that Eph receptors might 
influence axon guidance decisions via the Ras-MEK-ERK kinase pathway. Ephrin- 
Bl-Fc stimulation of a neuronal cell line stably expressing EphB2 triggers the loss of
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growth cone-like structures and neurite retraction, and induces a reduction in the 
phosphorylation levels of both ERK and MEK (Elowe et al., 2001). The responses 
are likely mediated by RasGAP activity, since expression of dominant negative 
RasGAP inhibits ephrin-Bl-induced suppression of the MAP kinase pathway and 
constitutively active Ras blocks ephrin-Bl-induced growth cone collapse and axon 
retraction (Elowe et al., 2001). Taken together this evidence suggests that ephrin-B- 
induced axon guidance may be mediated by activation of RasGAP and subsequent 
decrease in Ras and MEK/ERK activity. One common way in which tyrosine kinase 
receptors modulate Ras activity is via the adaptor Grb2 complexed with the Ras 
exchange factor SOS, which together activate the Ras-MEK-ERK pathway 
(Downward, 1996). No association is seen between EphB2 and Grb2 in neuronal cell 
lines used above, which correlates with EphB2-induced reduction in ERK/MEK 
phosphorylation (Elowe et al., 2001). Interestingly, ablating the RasGAP binding 
domain of EphB 2 and simultaneously introducing a Grb2 binding site leads to 
upregulation of the MAP kinase pathway and abolishes neurite retraction following 
ephrin-Bl-Fc stimulation (Tong et al., 2003). Given that EphBl activation can 
activate ERK via recruitment of Grb2 in some cell types (Vindis et al., 2003) it 
would be interesting to determine whether the potential upregulation of Ras activity 
via Grb2 and SOS might underlie the attractive responses seen in some axons 
following EphB activation (Hindges et al., 2002; Mann et al., 2003).
The mechanism whereby Eph-mediated reduction in the Ras-MAP kinase pathway 
leads to growth cone collapse is not clear. Reduction in MEK/ERK activity correlates 
with increased integrin-mediated adhesion, rather than the reduction in adhesion 
which would be assumed to accompany growth cone collapse and axon retraction 
(Barberis et al., 2004; Hughes et al., 1997; Serini et al., 2003). Dominant negative 
H-Ras has been shown to reduce integrin-mediated adhesion in some cell types, but 
this is independent of the MEK/ERK pathway (Shibayama et al., 1999). However, 
stress fibre formation induced by active Rho or ROCK is compromised in cells 
expressing constitutively active Ras, and this effect is ameliorated by inhibition of 
MEK activity (Sahai et al., 2001). In addition a function-blocking anti-Ras antibody 
prevents neurite retraction in response to LPA (Leblanc et al., 1998). These results 
suggest that activation of the Ras-MEK-ERK pathway inhibits ROCK activity and 
provide an alternative mechanism by which Eph receptor signalling, via reduction of
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the MAP kinase pathway, could stimulate ROCK-mediated growth cone collapse and 
axon retraction|(See Fig. 1.9).
I.5.3.I. Modulation of Eph receptor-mediated growth cone collapse.
During recent years a great deal of interest has been stimulated by the observation 
that intracellular levels of cyclic nucleotides can modulate the response of Xenopus 
neurons to axonal guidance cues. For example the attractive response of an axon to 
Netrin can be switched to repulsion by reducing intracellular levels of cAMP in the 
neuron (Song and Poo, 2001). Although initial studies suggested that guidance cues 
can be placed into one of two groups depending on whether they are sensitive to 
levels of cAMP or cGMP, recent evidence suggests that the ratio of cAMP to cGMP 
can modulate the response to a single cue (Nishiyama et al., 2003; Song and Poo,
2001)
Xenopus RGCs collapse in response to ephrin-Bl-Fc stimulation, and this repulsive 
response is reduced by inhibiting PKG activity, suggesting that EphB-induced 
growth cone collapse is mediated by high intracellular levels of cGMP (Mann et al.,
2003). The collapse assay used in this study cannot address whether modulating 
cGMP levels can switch the repulsive response to ephrin-Bl to an attractive 
response. However use of the growth cone turning assay has revealed a role for ECM 
proteins in modulating the neuronal response to ephrin. When exposed to a gradient 
of soluble ephrin-A5 a subpopulation of Xenopus RGC axons growing on fibronectin 
turn away from the ephrin-A5 source, whereas neurons growing on laminin exhibit 
an attractive response, turning towards the source (Weinl et al., 2003). These 
observations highlight the incredible complexity that must underlie the integration of 
intracellular signalling pathways during axon guidance. Not only do Eph receptors 
have the potential to influence cytoskeletal dynamics and integrin mediated adhesion, 
but these signals are also influenced by intracellular signals mediated by many other 
classes of receptor.
1.6. Src family kinases.
Members of the Src family of non-receptor tyrosine kinases are key components of 
signal transduction pathways for a wide range of cellular processes including cell 
growth, migration and differentiation, which all require co-ordinated changes in the
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cellular adhesion and cytoskeletal machinery. For example an increase in Src activity 
and phosphorylation of Src substrates occurs in response to the activation of growth 
factor receptors, and Src is important for transducing signals initiated by these 
receptor tyrosine kinases to downstream targets, including components of the actin 
cytoskeletal machinery (Abram and Courtneidge, 2000; Thomas and Brugge, 1997). 
Of the 10 mammalian members of the Src family, Src Fyn and Yes are ubiquitously 
expressed, while Lck and Lyn have been detected in neurons as well as haemopoietic 
cells (Thomas and Brugge, 1997).
1.6.1. Src family signalling to the cytoskeleton.
The GTPase activating protein pl90RhoGAP has preferential GAP activity for Rho A 
in vitro (Ridley et al., 1993) and is a major substrate for phosphorylation by c-Src 
both in vitro and in vivo (Brouns et al., 2001; Roof et al., 1998). In fibroblasts EGF 
receptor activation leads to Src kinase-dependent disassembly of stress fibres 
accompanied by redistribution of pl90RhoGAP (Chang et al., 1995). Expression of 
the isolated GAP domain of pl90RhoGAP in fibroblasts induces loss of constitutive 
stress fibres, and prevents RhoA-induced stress fibre assembly (Haskell et al., 2001; 
Ridley et al., 1993). The middle domain of pl90RhoGAP appears to negatively 
regulate pl90RhoGAP activity, and the major Src phosphorylation site in 
pl90RhoGAP is situated in the middle domain (Haskell et al., 2001; Roof et al., 
1998). Overexpression of Src prevents the negative effects of the middle domain, 
reconstituting the loss of stress fibres, suggesting that Src phosphorylation of 
pl90RhoGAP at this site may increase pl90RhoGAP activity5(Haskell et al., 2001). 
It should be noted however that Src-mediated phosphorylation of pl90RhoGAP has 
no effect pl90RhoGAP in vitro, and mutation of the Src phosphorylation site leads to 
only a minor reduction in GAP activity (Haskell et al., 2001).
Despite these in vitro findings, there is a clear correlation between increased 
pl90RhoGAP phosphorylation and decrease in RhoA activity (Arthur et al., 2000), 
and Src activity may negatively regulate pl90RhoGAP phosphorylation via the low 
molecular weight protein tyrosine phosphatase (LMW-PTP). PDGF stimulation of 
fibroblasts leads to the Src-dependent phosphorylation of two LMW-PTP tyrosine 
residues that are known to positively regulate it’s phosphatase activity, and an 
associated reduction in the phosphorylation of pl90RhoGAP (Bucciantini et al.,
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Fig 1.10 Signalling by Src family kinases
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Src family kinases are regulated by the activation of various plasma membrane 
receptors, such as Integrins, EGF receptors and Eph receptors. Selected Src family 
substrates are shown (as indicated by (P), to denote phosphorylation by kinases), 
together with the cellular responses mediated by these Src-dependent signalling 
pathways.
Fig 1.11. Signalling by Abl family kinases.
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Abl family kinases are regulated by the activation of various plasma membrane 
receptors, such as Integrins, PDGF receptor and Eph receptors. Selected Abl family 
substrates are shown (as indicated by (5), to denote phosphorylation by Abl kinases), 
together with the effect of this phosphorylation, and the cellular responses mediated 
by these Abl-dependent pathways. Biochemical interactions are shown in blue, 
genetic interactions in green.
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1998; Chiarugi et al., 2000; Cirri et al., 1998; Rigacci et al., 1996). Together with the 
observation that a mutant of LMW-PTP that is not phosphorylatable by Src prevents 
PDGF-induced pl90RhoGAP dephosphorylation, these data suggest that Src- 
stimulated LMW-PTP activity leads to dephosphorylation of pl90RhoGAP 
(Chiarugi et al., 2000). It is not clear which site on pl90RhoGAP is 
dephosphorylated by LMW-PTP, but Y1105 in its middle domain, the site of direct 
Src phosphorylation, appears to be the major phosphorylation site in vivo (Roof et 
al., 1998). Overall the experimental evidence suggests that Src activity has the 
potential to either increase or decrease phosphorylation of pl90RhoGAP in response 
to receptor tyrosine kinase activation, and that this may activate or inhibit Rho 
activity to mediate changes in the actin cytoskeleton.
The regulation of actin dynamics by Src and pl90RhoGAP is further complicated by 
the observation that Src-mediated phosphorylation of pl90RhoGAP increases the 
association of pl90RhoGAP with pl20RasGAP (Roof et al., 1998). The association 
between these two enzymes has no effq'** on pl90RhoGAP activity, but reduces 
pl20RasGAP activity (Haskell et al., 2001; Roof et al., 1998). As mentioned in 
section 1.5.3 Ras activity antagonises Rho-ROCK-mediated stress fibre formation 
and prevents LPA-induced neurite retraction (Leblanc et al., 1998; Sahai et al.,
2001). It is therefore possible that in addition to regulating pl90RhoGAP activity,
Src activation can modulate Rho-dependent rearrangements of the actin cytoskeleton,
for example during axon guidance, via indirect changes in RasGAP activityj(See Fig. 1.10).
1.6.2. Src family regulation of adhesion.
Src kinase activity plays a crucial role in regulating the turnover of cell-matrix 
adhesions during cellular migration by mediating degradation of proteins within the 
adhesion complex (Fincham and Frame, 1998; Frame et al., 2002; Webb et al.,
2004). Fibroblasts deficient for Src, or all three ubiquitous Src family kinases, have 
much larger adhesion complexes than wild-type cells (Dumenil et al., 2000; Volberg 
et al., 2001). In addition Src-deficient fibroblasts exhibit stronger integrin- 
cytoskeletal links in response to vitronectin (Felsenfeld et al., 1999; Galbraith et al.,
2002), suggesting that in wild-type cells Src acts to negatively regulate the strength 
of some cell-matrix adhesions.
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The role of Src in regulating adhesion turnover has recently been directly addressed 
by examining the kinetics of the formation and disassembly of newly formed 
adhesions at the leading edge of migrating cells (Webb et al., 2004). Cells lacking 
Src Yes and Fyn assemble adhesions normally, but show a much reduced rate of 
adhesion disassembly (Webb et al., 2004). A series of experiments using a 
temperature-sensitive mutant of v-Src, the transforming product of Rous sarcoma 
virus that has constitutive kinase activity, has revealed a mechanism whereby Src 
activity regulates adhesion turnover by cleavage of FAK, which in turn results in the 
disassembly of the adhesion complex (Carragher et al., 2001; Carragher et al., 2003; 
Fincham et al., 1995). Inhibition of the calcium-dependent protease calpain prevents 
v-Src-induced FAK degradation and adhesion disassembly (Carragher et al., 2001; 
Carragher et al., 2002). A kinase-inactive mutant of v-Src does not lead to the 
degradation of FAK (Fincham and Frame, 1998), which may reflect the fact that v- 
Src activity increases calpain synthesis (Carragher et al., 2002). These observations 
provide strong evidence that v-Src activity induces the disassembly of adhesion 
complexes via increased calpain-mediated FAK proteolysis.
v-Src is similar to normal cellular Src in structure, except it lacks the regulatory c- 
terminal portion, but it is not clear that v-Src activity simply represents the behaviour 
of active cellular Src (c-Src). Fibroblasts deficient in c-Src, Yes and Fyn, or lacking 
c-Src kinase activity, do not disassemble cell-matrix adhesions normally (Webb et 
al., 2004), but to date there is no evidence that the c-Src kinases induce proteolysis of 
FAK. Interestingly in neurons Fyn activity enhances the proteolysis of NMDA 
receptor subunits by calpain (Rong et al., 2001), suggesting that in non-transformed 
cells, Src family kinases may have the potential to disassemble cell-matrix adhesions 
via calpain-mediated proteolysis.
1.6.3. Src family kinases in axon guidance.
Src and Fyn are highly expressed in the nervous system during development, and are 
enriched in developing axon tracts and neuronal growth cones in vivo (Bare et al., 
1993; Bixby and Jhabvala, 1993; Cotton and Brugge, 1983; Fults et al., 1985; 
Maness et al., 1988). Given the ability of Src family kinases to regulate both cell- 
matrix adhesion and the actin cytoskeleton it seems likely that the kinase activity of 
these proteins may be involved in axon guidance.
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Fyn has recently been shown to have a role in the cellular response to repulsive axon 
guidance cue Semaphorin3A (Sema3A). Sema3A is a diffusible axon guidance cue 
which acts to guide dorsal root ganglion (DRG) axons by repulsion, and induces 
collapse of DRG growth cones in vitro (Luo et al., 1995; Nakamura et al., 2000). 
Recently it has been reported that primary DRG neurons from Fyn homozygous null 
mice show reduced growth cone collapse in response to Sema3A in vitro (Sasaki et 
al., 2002). Both wild-type and constitutively active Fyn and c-Src lead to an increase 
in phosphorylation of the intracellular tail of the Semaphorin3A receptor Plexin-A2 
(Sasaki et al., 2002), and v-Src expression has been shown to increase 
phosphorylation of the RCM, the mammalian homologue of UNC5 family of 
receptors known to mediate repulsive responses to the axon guidance cue Netrin 
(Tong et al., 2001). v-Src also and potentiates Netrin-induced RCM phosphorylation 
(Tong et al., 2001). Since phosphorylation is such a widespread mechanism both for 
regulating receptor function and for transducing intracellular signals, this data 
presents a model whereby Src family kinase activity may act to transduce or 
modulate repulsive axon guidance signals induced by activation of Semaphorin and 
Netrin receptors.
1.7. Abl family kinases.
Members of the Abl family of non receptor tyrosine kinases, including Drosophila 
Abl (D-abl), C. elegans and vertebrate c-Abl (cellular Abl) and vertebrate Arg (abl 
related gene) proteins, transduce information from growth factor, axon guidance and 
adhesion receptors to regulate changes in cell morphology and motility (Hernandez 
et al., 2004; Moresco and Koleske, 2003). Regulation of cytoskeletal dynamics is 
thought to underlie the role of Abl kinase activity in axon guidance (Bateman and 
Van Vactor, 2001; Lanier and Gertler, 2000) and therefore of the many potential Abl 
interacting proteins and/or substrates identified by genetic and biochemical 
techniques (Hernandez et al., 2004; Woodring et al., 2003) I will focus on those that 
have a role in regulation of the actin cytoskeleton and/or axon guidance.
1.7.1. Abl kinases and the actin cytoskeleton.
During development of Drosophila many dosage-sensitive modifiers of D-abl mutant 
phenotypes are known regulators of the actin cytoskeleton, for example the actin-
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binding proteins chickadee/profilin and enabled (Ena), and the Rho-family GEF Trio 
(Gertler et al., 1990; Gertler et al„ 1995; Liebl et al., 2000; Wills et al., 1999)*Abl 
may act via these proteins to control cytoskeletal dynamics during development. For 
example during neuronal morphogenesis Abl/Arg null embryos exhibit buckling of
these embryos (Koleske et al., 1998). Vertebrate Abl is also instrumental in 
mediating cytoskeletal rearrangement, for example following integrin engagement, 
which increases Abl kinase activity (Lewis et al., 1996; Woodring et al., 2001; 
Woodring et al., 2002). Increased Abl kinase activity correlates with formation of 
filopodia not only in adherent cells, but also in detached cells, suggesting that 
extracellular signals other than integrin engagement may mediate cytoskeletal 
rearrangements via Abl activity (Woodring et al., 2002). In agreement with this idea 
PDGF treatment of cells causes an increase in Abl kinase activity, and Abl- 
dependent membrane ruffling (Plattner et al., 1999). An elegant study by Ting and 
colleagues, using a fluorescent resonance energy transfer (FRET) indicates that 
active Abl localises to these PDGF-stimulated ruffles, suggesting a local regulation 
of actin structure by Abl kinase activity (Ting et al., 2001).
Abl family kinases may regulate actin rearrangement via direct actin binding, since 
the ability of Arg-GFP to direct the formation of F-actin structures in fibroblasts 
depend on Arg’s F-actin binding domain (Wang et al., 2001). Both Abl and Arg can 
bundle actin filaments in vitro, and while Arg-dependent bundling requires only the 
presence of F-actin binding domains (Van Etten et al., 1994; Wang et al., 2001), the 
G-actin binding domain of Abl co-operates with the F-actin binding domain to 
bundle actin in vitro (Van Etten et al., 1994). Fragments of Arg lacking the kinase 
domain are still capable of bundling actin in vitro and inducing the formation of 
actin-rich structures in vivo (Wang et al., 2001), but Abl kinase activity is necessary 
for cytoskeletal rearrangement in other systems in response to RTK activation 
(Plattner et al., 1999), which suggests that Abl family kinases have additional roles in 
regulating cytoskeletal dynamics, other than actin bundling, likely involving 
interaction with and/or phosphorylation of substrates.
One major family of proteins known to link signalling pathways to actin dynamics is 
the Ena/VASP family, which consists of the product of the Drosophila enabled gene 
(Ena) and the vertebrate homologues Mena (Mammalian Enabled. VASP
the neural tube, which may result from the disordered F-actin bundles observed in
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(vasodilator stimulated phosphoprotein) and EVL (Ena-VASP like) (Gertler et al., 
1996). Ena and Mena are substrates for D-Abl and Abl respectively in vitro and in 
vitro (Comer et al., 1998; Gertler et al., 1996; Tani et al., 2003) and genetic and 
biochemical evidence suggests that Abl kinases inhibit the function of Ena/VASP 
proteins by phosphorylation (Comer et al., 1998; Gertler et al., 1990; Gertler et al., 
1995). Expression of the neural-specific isoform of Mena results in actin-rich 
membrane protrusions (Gertler et al., 1996), and VASP has an important role 
directing actin filament assembly during Listeria motility (Chakraborty et al., 1995) 
supporting an in vivo role for these proteins in actin dynamics.
Ena and VASP can directly bind G- and F-actin and promote actin filament 
nucleation in vitro, although the conditions under which this occurs are not 
physiological (Harbeck et al., 2000; Huttelmaier et al., 1999; Lambrechts et al., 
2000). To date it is not clear how these properties contribute to Ena/VASP family 
function in vivo, since clustering of endogenous Ena/VASP proteins with peptide 
binding partners in living cells fails to nucleate or recruit actin filaments (Bear et al., 
2000; Lasa et al., 1997; Pistor et al., 1994; Skoble et al., 2001). Instead sequestering 
Mena at the leading edge has a dramatic effect on the geometry and length of 
lamellipodial actin filaments (Bear et al., 2002). This is due to the ability of Mena to 
bind to uncapped actin filaments, preventing, or delaying their capping, and thus 
allowing actin filaments to increase in length (Bear et al., 2002).
Another potential link between Ena/VASP family proteins and the actin cytoskeleton 
is their ability to bind the actin binding protein profilin, both in vitro and in living 
cells (Gertler et al., 1996; Reinhard et al., 1995). Profilin promotes the formation of 
ATP-actin, and actin bound to profilin (profilactin) is preferentially added to the free 
barbed ends of actin filaments (Pollard and Borisy, 2003). Profilin binding sites of 
Ena/VASP proteins are situated within the central proline-rich domain (Ahem- 
Djamali et al., 1999; Gertler et al., 1996; Reinhard et al., 1995). The c-Abl 
phosphorylation site in Mena, and five out of six of the D-abl phosphorylation sites 
of Ena are also located in this proline-rich region (Comer et al., 1998; Tani et al.,
2003). The functional consequences of Abl-mediated phosphorylation on 
Mena/profilin binding are unknown, but phosphorylation of Ena by D-abl results in 
disruption of Ena association with SH3-containing proteins that normally bind the 
proline-rich region (Comer et al., 1998). Interestingly mice heterozygous for both
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profilin and Mena show a far more severe phenotype than loss of Mena alone, 
suggesting that Mena/profilin interactions might also be important in vertebrates 
(Lanier et al., 1999). In addition mutations in the Drosophila profilin gene chickadee 
give rise to a very similar phenotype to that seen in D-abl'' mutants, and D-abl and 
chickadee show dosage sensitive genetic interactions (Wills et al., 1999). Taken 
together these observations suggest that Abl-mediated phosphorylation of Ena/VASP 
family proteins may influence the actin cytoskeleton via profilin, and that these 
interactions are likely to be important in vivo.
Abl and Arg have also been shown to phosphorylate the SH2/SH3 domain containing 
adaptor protein Crk, and this phosphorylation event leads to an intramolecular 
interaction between the phosphotyrosine residue and the SH2 domain, preventing 
Crk interaction with some of it’s effectors (Escalante et al., 2000; Feller et al., 1994; 
Wang et al., 1996). Abl-dependent Crk phosphorylation correlates with a decrease in 
Crk association with CAS, whereas loss or inhibition of Abl kinase activity increases 
Crk-CAS coupling (Kain and Klemke, 2001). Crk binds the Rac GEF DOCK 180 via 
it’s SH3 domain (Matsuda et al., 1996), and co-expression of Crk and CAS promotes 
DOCK180-mediated increase in Rac activity and associated actin rearrangements 
(Kiyokawa et al., 1998). Although the effect of uncoupling Crk-CAS on DOCK180 
and Rac activity was not investigated in this study, it is possible that Abl 
phosphorylation of Crk, and the resulting uncoupling of the Crk-CAS complex, 
might antagonise DOCK180-mediated Rac activation and subsequently have 
modulatory effects on the actin cytoskeleton (See Fig. I l l ) ,
1.7.2. Abl kinases in axon guidance.
Expression of constitutively active Abl in neurons in culture leads to the formation of 
filopodia along the length of the axon, and increases axon outgrowth, providing 
evidence that Abl activity can modulate the neuronal cytoskeleton (Woodring et al., 
2002; Zukerberg et al., 2000). Abl and Arg are expressed in many regions of the 
mammalian brain, and in the growth cones of primary mammalian neurons in vitro, 
but genetic manipulations have failed to reveal any axon guidance defects in the 
absence of mammalian Abl and Arg. Viable double heterozygous knockout animals 
show no gross neuronal defects, and double homozygous knockouts die from defects 
in neural tube closure (Koleske et al., 1998).
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Much of the evidence that implicates Abl kinases im axon guidance comes from 
genetic studies in Drosophila. Axons in the embryonic CNS of Drosophila are 
organised into two major groups; longitudinal pathways that extend along the 
anterior-posterior axis, and commissural axons that project across the midline. The 
midline glia secrete the chemorepellent Slit, and the Slit receptor Robo is highly 
expressed on the longitudinal axons, preventing them from crossing the midline, and 
the commissural axons only after they have crossed the midline, preventing them for 
re-crossing (Guthrie, 2001; Van Vactor and Flanagan, 1999). D-abl homozygous 
loss-of-function mutants exhibit aberrant midline crossing of longitudinal axons in 
the developing Drosophila CNS (Hsouna et al., 2003; Wills et al., 1999; Wills et al.,
2002). The CNS scaffold in these animals resembles that observed in heterozygous 
Slit or Robo mutants (Hsouna et al., 2003) suggesting that D-abl co-operates with a 
repulsive axon guidance cue at the midline. Consistent with this idea, heterozygous 
mutations in Robo and Slit enhance the Abl mutant phenotype, and the low 
frequency of aberrant axon crossings in animals heterozygous for Slit is increased 20 
fold with an additional D-abl loss-of-function mutation (Hsouna et al., 2003; Wills et 
al., 2002). Robo heterozygous loss of function mutations show a higher frequency of 
midline errors than slit, especially if multiple Robo receptors are reduced in dose, but 
these loss of function phenotypes are also enhanced by Abl loss of function (Wills et 
al., 2002). Overexpression of wild-type or a hyperactive mutant of Robo can 
suppress the aberrant axon crossings seen in Abl loss of function mutants (Hsouna et
t i *al., 2003). Since a kinase dead mutant of D-abl cannot rescue the D-abl phenotype it 
seems likely that Abl kinase activity is necessary for the co-operative role of D-abl in 
mediating repulsive axon guidance at the midline following Slit-Robo interaction 
(Wills et al., 2002).
Although to date there is no evidence that Abl kinase is involved in axon guidance in 
vertebrates, Slit appears to function in guidance of callosal axons at the mouse 
midline, a process which requires the Abl substrate Mena (Bagri et al., 2002; Lanier 
et al., 1999), and this suggests that the role of Abl in mediating repulsive axon 
guidance signals may be conserved in mammals.
*(in which the lysine residue within the ATP-binding domain of the Abl kinase
domain has been replaced with asparagine, eliminating Abl tyrosine kinase activity)
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1.7.2.1. Ena/VASP family proteins in axon guidance.
Ena was first identified as a suppressor of the CNS defects in D-abl mutants (Gertler 
et al., 1990). Mutations in Ena have also been shown to suppress the motor neuron 
bypass phenotype and increased longitudinal axon crossing seen in D-Abl loss of 
function mutants (Wills et al., 1999; Wills et al., 2002), suggesting that Ena function 
antagonises Abl activity during axon guidance in Drosophila. There is also evidence 
that vertebrate Ena/VASP proteins play a role in axon guidance. Mice deficient for 
Mena have a defective corpus callosum, since cortical axons, having projected 
normally to the midline, fail to cross (Lanier et al., 1999). Although genetic studies 
are clearly useful for identifying potential signalling mediators, the results do not 
give rise to a unifying model for the role of Abl and Ena/VASP families in axon 
guidance, since genetic studies have also implicated Ena in mediating attractive 
guidance cues (Gitai et al., 2003; Yu et al., 2002). Biochemical interactions and in 
vitro assays might help to elucidate the role of Ena/VASP proteins and Abl kinase 
during axon repulsion, for example mediated by Eph receptors, which have been 
shown to interact with Abl (Yu et al., 2001).
1.7.2.2. Cdk5 and axon guidance.
The cyclin-dependent kinase Cdk5 is expressed in post mitotic neurons, and plays a 
major role in the positioning of certain neuronal sub-populations during cortical 
development (Ohshima and Mikoshiba, 2002). Recent evidence has implicated Cdk5 
in the repulsive neuronal response to both Sema3A and ephrin-A5 (Cheng et al., 
2003; Sasaki et al., 2002). Cdk5 is phosphorylated by c-Abl in vitro, and expression 
of activated c-Abl results in increased cellular levels of phosphorylated Cdk5 
(Zukerberg et al., 2000). It is likely that the adaptor cables is important for Abl- 
induced Cdk5 activity, c-Abl and Cdk5 do not associate in the absence of cables, and 
the presence of cables potentiates Abl-mediated phosphorylation of Cdk5 (Zukerberg 
et al., 2000).
Abl, cables and Cdk5 form a trimolecular complex in vitro, and colocalise in the 
growth cone of neurons grown in culture (Zukerberg et al., 2000), which is the region 
in which dynamic actin rearrangements occur in during the response to ephrin-A 
stimulation (Meima et al., 1997a; Meima et al., 1997b). Importantly phosphorylation 
by Abl increases the kinase activity of Cdk5 (Sasaki et al., 2002; Zukerberg et al.,
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2000), and recent data suggests that Cdk5 activity may mediate the repulsive 
response of RGCs to ephrin-A5, since pharmacological inhibition of Cdk5 in 
temporal RGCs inhibits ephrin-A5-induced growth cone collapse (Cheng et al.,
2003). Although no functional interaction between Eph receptors and Cdk5 has been 
demonstrated to date, it is possible that Eph receptor activation may lead to increased 
Cdk5 activity in these neurons, and that this contributes to ephrin-induced growth 
cone collapse. Given that Abl kinase phosphorylates and thus activates Cdk5, and 
that Eph receptors have been shown to interact with Abl (Yu et al., 2001; Zukerberg 
et al., 2000), the above observations raise the intriguing possibility that EphA 
receptors may mediate repulsive axonal responses via Abl kinase activity.
1.8. Aims of this thesis.
The main aim of this thesis is to identify signalling molecules that mediate ephrin-A- 
induced repulsion of RGCs. Although ephrin-As are membrane bound molecules in 
vivo (Gale et al., 1996b; Pandey et al., 1995b), previous studies have used soluble 
ephrins to identify signalling molecules that play a role in Eph receptor mediated 
signals. I have therefore developed a physiologically relevant co-culture assay, in 
which the response of an individual RGC growth cone to contact with an ephrin-A- 
expressing cell is followed dynamically. Previously, the Rho GEF Ephexin, Rho and 
the Rho effector ROCK have been implicated in the response of RGCs to soluble 
ephrin-A (Cheng et a l, 2003; Shamah et al., 2001; Wahl et al., 2000). I have used the 
co-culture assay to investigate the role of ROCK in the cellular response of RGCs to 
contact with an ephrin-A-expressing cell.
Inhibition of Rho, ROCK or Ephexin results only in partial inhibition of the RGC 
response to soluble ephrin-A (Cheng et al., 2003; Shamah et al., 2001; Wahl et al., 
2000), suggesting that other signalling intermediates play a role in mediating 
neuronal EphA-dependent signals. In order to test the hypothesis that non-receptor 
tyrosine kinases of the Src and Abl family are involved in neuronal EphA-mediated 
signalling pathways, I have investigated the effect of well-characterised 
pharmacological inhibitors of theses kinases on the dynamic RGC response to 
stimulation with ephrin-A, and present evidence that Abl family kinases mediate all 
aspects o f the RGC response to stimulation with ephrin-A.
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Chapter 2. Materials and Methods.
2.1. Media and solutions.
Unless otherwise stated all general laboratory chemicals are from Sigma.
2.1.1. Cell media.
RGC culture medium.
8% v/v Foetal bovine serum Gibco
2% v/v Chicken serum Sigma
1% v/v Penicillin/streptomycin Gibco
2mM L-Glutamine Gibco
in DMEM/F12-HAM Sigma
DRG culture medium.
10% Foetal bovine serum
0.2% w/v Na Bicarbonate
0.7% w/v Glucose
2mM L-Glutamine
1% v/v Penicillin/streptomycin
in L-15 medium Gibco
Cell line medium.
10% v/v Foetal bovine serum
1% v/v Penicillin/streptomycin 
in DMEM
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2.1.2 Cell fixation and coverslip mountant.
Cytoskeletal buffer.
lOmM MES pH6.1
125mM KC1 
3mM MgCl 
2mM EGTA 
10% w/v Sucrose
Mowial mountant.
25% v/v glycerol 
0.1M Tris-HCL ph8.5-8.8
10% w/v Mowial Calbiochem
2.1.3 Solutions for biochemistry 
TBS.
20mM Tris-HCL pH7.4 
150mM NaCl
RIPA buffer.
20mM Tris-HCL pH7.4
150mM NaCl 
1% v/v Triton X-100 
0.5% w/v Na deoxycholate 
0.1% w/vSDS 
10% v/v Glycerol 
5mM EDTA 
50mM NaF 
0.5mM NaVo3
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Complete Protease Inhibitor tablet (Roche)
lOO/zgrnl'1 PMSF
IP buffer.
20mM Tris-HCL pH7.4 
1% v/v NP-40 
10% v/v Glycerol 
50mM NaF 
0.5mM NaVo3
Complete Protease Inhibitor tablet 
lOO^gml1 PMSF
Running buffer.
25 mM Tris-HCL
192mM Glycine 
0.1% w/v SDS
Transfer buffer.
48mM Tris-HCL
39mM Glycine 
0.037% w/v SDS 
20 %v/v Methanol
2.2. Cell culture.
2.2.1. Coating of coverslips and tissue culture dishes.
13- or 22- mm diameter glass coverslips (BDH) were washed in concentrated Nitric 
acid in a 1L conical flask for 5 min, washed under running tap water for 10 min and 
then rinsed twice in distilled water. After a final wash in methanol the coverslips 
were transferred to a glass Petri dish and baked at 120°C for 4 hours. Coverslips were 
transferred under sterile conditions to a 9 cm plastic Petri dish containing 25 ml of
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lm gm l1 poly-L-lysine (pLL; Fluka). The dishes were sealed with Parafilm and the 
coverslips were incubated overnight at room temperature on an orbital shaker, the 
pLL was removed (and retained for re-use at 4°C for a maximum of 3 times) and the 
coverslips rinsed three times with distilled water. The coverslips were washed 
overnight with distilled water on a orbital shaker for 3 consecutive nights, with the 
water changed each morning. The coverslips were then dried overnight by balancing 
them on edge around the edge of a dry-.9-cm plastic Petri dish in a sterile tissue 
culture hood. Dry laminin-coated coverslips were stored in clean 9 cm plastic Petri 
dishes, sealed with Parafilm for up to 4 weeks. Prior to use, pLL-coated coverslips 
were placed in a dry clean 9 cm plastic Petri dish and 500\il of lOOp-gml'1 laminin 
(Sigma) in DMEM (Gibco) was added to each 22 mm coverslip (200p,l to each 13 
mm coverslip). A second pLL-coated coverslip was placed on top of each coverslip, 
sandwiching the laminin solution between the coverslip sandwiches were incubated 
overnight at 37°C and 5% C 02 in a humidified tissue culture incubator, then each 
coverslip was rinsed in sterile DMEM and placed, laminin-side up, into one well of a 
six-well (22 mm coverslips) or 4-well (13 mm coverslips) tissue culture dish (both 
Nunc). Approx. 100p,l of the appropriate growth medium was added to each 
coverslip while cells were prepared, to avoid the coverslips drying out.
For isolated RGCs (see section 2.1.3) 9 cm tissue culture dishes (Nunc) were 
incubated with 25 ml of lmgml'1 pLL solution overnight on an orbital shaker. Dishes 
were rinsed three times in sterile phosphate-buffered saline (PBS) and used 
immediately for laminin coating (see below) or left to dry overnight in a sterile tissue 
culture hood before being stored in sealed bags containing desiccating agent (Sigma). 
6 ml of lOOngml'1 laminin-DMEM was placed in each pLL-coated tissue culture 
dish, the dishes sealed with Parafilm and incubated at room temperature overnight on 
an orbital shaker. The laminin solution was removed and retained at 4oC for re-use 
(maximum three times) and the dishes were washed three times with sterile DMEM 
and then incubated with 10 ml RGC medium at 37°C and 5% C 0 2 in a humidified 
tissue culture incubator until the isolated RGCs (see section 2.1.3) were ready for 
plating.
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2.2.2. Retinal explants.
Fertile eggs were obtained from Henry Stewart and Co. (Fakenham, UK). Eggs were 
rinsed with 70% ethanol and E7 embryos were placed in a 9 cm tissue culture dish 
(Nunc) in RGC medium and sacrificed by decapitation using size 2 forceps. The 
eyeballs were removed by gently pinching them out with forceps (size 2) and placed 
in RGC medium on ice while not in use. Each eyeball was placed on a dry dish for 
removal of the mesenchyme and the pigment layer under a dissecting microscope 
(Zeiss), using size 5 forceps at a shallow angle to avoid tearing the retina. The 
eyeball was then transferred to a 9 cm dish containing RGC medium for removal of 
the vitreous body by inserting size 5 forceps into the lens hole and drawing out the 
vitreous humor between a second pair of open size 5 forceps. The nasal third of the 
retina was separated from the rest, which was discarded. A strip of black mixed- 
cellulose filter (HABP filter, Millipore) was placed in the dish and slid under the 
sheet of retina. The retina was gently unrolled with closed forceps and attached, RGC 
layer uppermost, to the filter by pressing the edge of the retina down with closed 
forceps. The flat-mounted retina was cut into 400 nm-wide strips using a Mcllwain 
tissue chopper (Mickle Laboratory Engineering Company Ltd). 20p,L of RGC 
medium was spread over the surface of the removable cutting disk and the flat- 
mounted retina was placed onto the disk with the nasal-temporal axis parallel to the 
blade. Approx. 50pi of RGC medium was added to the flat-mounted retina after the 
strips were cut to avoid the tissue drying out. Individual retinal strips were 
transferred to a six-well tissue culture dishes (Nunc) or 35 mm glass-bottomed dishes 
(World Precision Instruments), containing a 22 mm pLL/laminin coated coverslip in 
each well, using size 5 forceps to grip the end of the cellulose strip where there is no 
retinal tissue. The retinal strips were placed RGC layer down onto the coverslips. 
Typically two strips were placed on each 22 mm diameter coverslip, and anchored 
with small stainless-steel bars (approx. 1 0 x 1 x 1  mm in dimension). 2 ml of RGC 
medium was added to each well. The retinal explants were incubated for 20-26 hours 
in RGC medium at 37°C and 5% C 02 in a humidified tissue culture incubator.
2.2.3. Isolated RGC cultures.
This method of isolating RGCs is based on a protocol described by de Curtis (1991) 
and depends on the difference in density of these cells compared to other retinal
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cells. 10-20 E7 chick retinae were dissected as described in section 2.1.2, but instead 
of being flat-mounted on cellulose filters the retinae were incubated on ice in a 15 ml 
centrifuge tube (Falcon) in RGC medium. RGC medium was removed by aspiration 
and Retinae were washed twice with sterile PBS. Retinae were allowed to settle by 
gravity between and after washes. PBS was removed by aspiration and the retinae 
were incubated with 2.2% hyaluronidase (Sigma) in PBS (1 ml total volume) in a 
water bath for 5 min at 37°C. Retinae were spun in a  swinging rotor centrifuge at 
500g for 3 min, washed with sterile PBS and spun again at 500g for 3 min. All 
supernatant was removed and the retinae were then incubated in 0.1% trypsin and 
0.01% DNAase I type IV (both Sigma) in sterile PBS (total volume 5 ml) in a water 
bath for 8 min at 37°C, during which time the tube was inverted every 2 min. 5 ml of 
RGC medium was added to inhibit the trypsin, together with a further 0.01% 
DNAase I type IV, and the cells were spun at 500g for 3 min. Supernatant was 
removed and the cells were gently resuspended in 5 ml RGC medium, spun again 
and resuspended in 0.2% soybean trypsin inhibitor (Sigma) and 0.05% DNAase I 
type IV in RGC medium (2 ml total volume) at room temperature. The cells were 
triturated slowly (8 aspirations and expulsions lasting about 2 seconds each) using a 
fire polished pipette with a 1 ml bulb, and the cells were diluted with RGC medium 
to a total volume of 12 ml.
The Percoll (Amersham) gradient was prepared by mixing layers of decreasing 
density (Table 2.1) at room temperature in a 15 ml centrifuge tube (Falcon), and 
slowly pipetting each layer in the following order into a 50 ml centrifuge tube 
(Falcon).
The gradient was spun in a cooled, swinging rotor centrifuge for 30 min at 500g and 
5°C with minimum acceleration and deceleration. The higher of the two bands of 
isolated cells, which is enriched in RGCs (de Curtis et al., 1991), was collected with 
a fire polished pipette. RGC medium was added to a final volume of 10 ml and the 
cells were spun at 500g for 8 min, before being resuspended in 1 ml RGC medium 
and pre-plated on a 9 cm tissue culture dish at 37°C for 3-5 hours to remove any 
remaining non-neuronal cells. RGCs were removed from the dish by pipetting and 
spun at 500g for 3 min. Approx. 106 RGCs were plated onto a 9 cm laminin-coated 
tissue culture dish (see section 2.1.1). Isolated RGCs were grown in RGC medium at 
37°C and 5% C02 for 20-26 hours in a humidified tissue culture incubator.
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Table 2.1. Preparation of Percoll gradient.
Layer DMEM-F12 HAM Cell suspension Percoll
5 4 ml 0 ml 5.65 ml
4 2 ml 4 ml 3.8 ml
3 4 ml 4 ml 1.75 ml
2 4 ml 4 ml 0.842 ml
1 4 ml 0m l 0m l
2.2.4. DRG explants.
Fertile eggs were rinsed with 70% ethanol, and the E7 embryos placed in L-15 
medium (Gibco). E7 embryos were sacrificed by decapitation using size 2 forceps 
and eviscerated using size 5 forceps at a shallow angle to avoid damaging the tissue 
either side of the spinal cord. The limbs and tail were pinched off using size 5 
forceps and the torso transferred with forceps to a silicon-coated dish containing L- 
15 medium. The torso was placed dorsal side up and, viewed under a dissecting 
microscope, was pinned flat by inserting dissecting pins either side of the spinal cord. 
The torso was spilt longitudinally along the centre of the spinal cord with a 
microsurgical knife (World Precision Instruments) each half was unpinned and 
reoriented with the newly cut surface uppermost. After pinning the half-torso in 
position the spinal tissue and myelin were peeled away from each cut surface of the 
embryo using size 5 forceps, and the ganglia removed from the region between the 
limbs by pinching the nerve root between size 5 forceps. Each DRG was divided into 
two using size 5 forceps and placed onto the centre of a 13 mm pLL/laminin coated 
coverslip in a 4-well tissue culture dish (Nunc) in 600pl of DRG medium. Most of 
the medium was removed with a pipette to bring the DRG explant into contact with 
the coverslip and allow it to attach to the laminin. After approx. 30 min incubation at 
room temperature in minimal volume, DRG medium was gently added to each well 
to a final volume of 600pi, and the explants incubated for 20-26 hours at 37°C and 
5% C 0 2.
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2.2.5. Cell lines.
Swiss-3T3 fibroblasts.
Swiss 3T3 fibroblast cells were grown in cell line medium in 9 cm tissue culture 
dishes (Nunc). At 60-80% cell confluency the medium was removed by aspiration 
and the cells were washed twice with trypsin-EDTA (Gibco) and incubated with 
minimum volume of trypsin-EDTA in a humidified tissue culture incubator for 2 min 
at 37°C. 4 ml cell line medium was added to inhibit the trypsin and dislodge the cells, 
which were then transferred to a 15 ml centrifuge tube (Falcon) and spun in a 
swinging rotor centrifuge at 2000 rpm for 1 min. The medium was removed and the 
cells resuspended in 1 ml cell line medium. The cells were re-plated at dilutions 
between 1:4 and 1:10, in fresh cell line medium in a clean 9 cm tissue culture dish, or 
approximately 4000 Swiss-3T3 fibroblasts were plated on a 22 mm pLL/laminin 
coated coverslip with or without retinal explants, for use in the co-culture assay or 
for immunofluorescence studies respectively (see below). Swiss 3T3 fibroblasts were 
cultured in a humidified tissue culture incubator at 37°C and 5% C 0 2.
MDCK cells.
MDCK cells were grown in cell line medium in 9 cm tissue culture-dishes (Nunc). 
At 100% confluency the medium was removed by aspiration and the cells were 
washed twice with trypsin-EDTA (Gibco) and incubated with 2 ml trypsin-EDTA at 
room temperature for 10 min to disrupt cell-cell junctions, before being transferred to 
a humidified tissue culture incubator for 5 min at 37°C. 4 ml cell line medium was 
added to inhibit the trypsin and dislodge the cells, which were then transferred to a 
15 ml centrifuge tube (Falcon) and spun in a swinging rotor centrifuge at 2000 rpm 
for 1 min. The MDCK cells were resuspended and re-plated on 9 cm tissue culture 
dishes or pLL/laminin-coated coverslips as described above for Swiss-3T3 
fibroblasts. MDCK cells were cultured in a humidified tissue culture incubator at 
37°C and 5% C 02.
COS cells.
COS cells were grown in cell line medium in 9 cm tissue culture-dishes (Nunc). At 
80-90% confluency the medium was removed by aspiration and the cells were
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washed twice with trypsin-EDTA (Gibco) and incubated with 2 ml trypsin-EDTA in 
a humidified tissue culture incubator for 2 min at 37°C. 4 ml cell line medium was 
added to inhibit the trypsin and dislodge the cells, which were then transferred to a 
15 ml centrifuge tube (Falcon) and spun in a swinging rotor centrifuge at 2000 rpm 
for 1 min. The COS cells were resuspended in 1 ml of cell line medium and plated on 
9 cm tissue culture dishes at dilutions between 1:2 and 1:10, or into 6 well plates 
(Nunc) for transfection experiments (see below). COS cells were cultured in a 
humidified tissue culture incubator at 37°C and 5% C 02.
2.3. Microinjection and transfection techniques.
2.3.1. Expression plasmids
prk5-EphA4 was a gift from David Wilkinson (NIMR, London) and pCDM8-ephrin- 
A5 was a gift from Uwe Drescher (King’s College, London).
2.3.2 Microinjection.
Retinal-MDCK co-cultures were placed in RGC medium on the heated stage of an 
inverted microscope (Zeiss) and viewed with 5x and 32x phase contrast air 
objectives. The cells were maintained at 37°C and 5% C 0 2 throughout. A solution of 
0.06 mgml"1 DNA and 0.1 mgml'1 FITC-dextran (as an injection marker) in filtered 
PBS was loaded with microloader pipette tips (Eppendorf) into boro-silicate needles, 
pulled with a horizontal needle puller (Suter). The needle was inserted into the 
nucleus of MDCK cells surrounding the retinal explant using a micromanipulator 
(Eppendorf) and DNA was injected with a Transjector pump (Eppendorf). Co­
cultures were replaced in a humidified tissue culture incubator at 37°C and 5% C 02, 
for 3-4 hours to allow for expression. Injected MDCK cells in the proximity of 
growing RGC axons were identified by briefly scanning the co-culture for FITC- 
dextran-positive cells under a 5x objective, and the resulting interactions were 
analysed by phase time-lapse microscopy (see section 2.5.1).
2.3.3. Transfection of COS cells.
COS cells, at 50-60% confluency, growing in cell line medium in 6-well plates 
(Nunc) were transfected using GeneJuice (Merk Biosciences). For each well 3^1 of 
GeneJuice was mixed with lOOpl DMEM and incubated at room temperature for 5
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min before lp,g of DNA was added to the cells and the mixture incubated for a 
further 10 min. The DNA-GeneJuice complex was added drop-by-drop and mixed by 
gentle rocking. Cells were cultured for 24 hours in a humidified tissue culture 
incubator at 37°C and 5% C 02 prior to use in experiments.
2.4. Anti-phospho-Eph receptor antibody.
Anti-phospho-Eph receptor antibodies were raised in rabbit against the peptide 
sequence LRTYpVDPHTYpEDPTQ. This sequence is taken from the 
juxtamembrane region of EphA3, in which both of the juxtamembrane tyrosine 
residues, which are highly conserved throughout the Eph receptor family, are 
phosphorylated (Fox et al., 1995; Sajjadi and Pasquale, 1993; Shamah et al., 2001). 
Phosphorylation of these two tyrosine residues, which are major autophosphorylation 
sites in vitro and in vivo, is required for full Eph kinase activity (Binns et al., 2000; 
Choi and Park, 1999; Ellis et al., 1996; Kalo et al., 2001; Kalo and Pasquale, 1999; 
Wybenga-Groot et al., 2001; Zisch et al., 1998). In addition to recognising 
phosphorylated EphA3 (Shamah et al., 2001) this antibody recognises 
phosphorylated EphB2, EphB4, EphA4 and EphA7 (Marston et al., 2003; DJ 
Marston and CD Nobes, unpublished data). Unpublished work from the lab has also 
shown that this antibody does not recognise unphosphorylated Eph receptors, and 
that antibody binding can be inhibited by pre-incubation with the phospho-peptide 
antigen (DJ Marston, unpublished data).
It should be noted that the anti-phospho-specific Eph receptor antibody has not been 
affinity purified against the peptide substrate, and it is therefore formally possible 
that this antibody recognises phosphorylated tyrosine residues on proteins other than 
Eph receptors, or indeed phosphotyrosine residues within the Eph receptor sequence 
other than the juxtamembrane tyrosines. If this were the case, the staining pattern 
revealed when using this antibody for immunocytochemistry or Western blotting (see 
sections 2.5 and 2.9) might reflect tyrosine phosphorylation of other signalling 
molecules within RGCs or COS cells, in addition to phosphorylation of Eph 
receptors on the residues that correlate with increased Eph kinase activity.
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2.5. Immunocytochemistry.
Cell medium was removed by aspiration and cells were 5 fixed with 4% formaldehyde 
in cytoskeletal buffer (Symons and Mitchison, 19991) with or without 0.2% 
gluteraldehyde for 10 min at room temperature. Coverrslips were rinsed 3 times in 
PBS. In the case of retinal explants the fixed axons wvere cut close to the explant 
tissue using a microsurgical knife after fixation, and the eexplant removed to minimise 
autofluorescence. Coverslips were incubated with 0.2%) triton-X 100 for 5 min and 
then rinsed 3 times in PBS. 0.5 mgml"1 Na borohydrides was added for 10 min and 
cells were rinsed 3 times with PBS. The primary antibodly was added to the coverslip 
for 45-60 min at room temperature. Coverslips were rinssed 3 times in PBS and then 
washed over 15-30 min with a minimum of 3 changes off PBS. Secondary antibodies 
were added to the coverslip for 45 min at room temperaiture. F-actin was visualised 
with rhodamine-labelled phalloidin, included with the secondary antibody. 
Coverslips were incubated with secondary antibody and/cor phalloidin for 45 min, the 
coverslips were rinsed 3 times in PBS and then washted over 30-60 min with a 
minimum of 3 changes of PBS. Coverslips were rimsed in distilled water and 
mounted on Microscope slides with Mowial mountant containing phenylenediamine 
as an anti-fade agent. All dilutions were made in PBS.
In order to visualise ephrin-As on the surface of Swiss-33T3 fibroblasts and MDCK 
cell in culture, EphA5 (R & D Systems) at a concentiration of 4pgml'1 in RGC 
medium was incubated with a 5-fold excess of goat anti-hiuman IgG (Stratech) for 20 
min in a humidified tissue culture incubator at 37°C and 5%  CO2. Clustered EphA5- 
Fc was added to the bathing medium at a final concentrattion of lpgml"1 for 10 min 
prior to fixation as described above, and the EphA5-Fc visualised using FITC- 
labelled anti-goat antibody.
In order to visualise endogenous, phosphorylated Eph recteptors present on RGCs in 
culture, cells were fixed, permeablised and quenched as  described above. Anti- 
phospho-Eph receptor antibody (at a dilution of 1:300) was detected using a tyramide 
amplification system (Molecular Probes).
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Table 5.2. Com m ercially available antibodies used for 
immunocytochemistry.
Antibody Species Dilution Source
Ephrin-A5 Goat 1:250 R & D Systems
FITC anti-Goat Donkey 1:300 J a c k s o n  I m m u n o -  
Laboratories
FITC anti-Rabbit Donkey 1:300 J a c k s o n  I m m u n o -  
Laboratories
Rhodamine anti-Goat Donkey 1:300 Stratech
Rhodamine Phalloidin* 1:250 (neurons) 
1:500 (cell lines)
Sigma
tRhodamine Phalloidin was diluted to a stock concentration of SOpgmT1 in Methanol 
and stored at -20°C.
2.6. Cell imaging.
2.6.1 Phase time-lapse microscopy.
Retinal explants and co-cultures were placed in RGC medium in a 35 mm glass- 
bottomed dish (World Precision Instruments) on the heated stage of an inverted 
microscope (Zeiss) and viewed using 5x and 32x phase contrast air objectives. The 
cells were maintained at 37°C and 5% C 0 2 throughout. Time-lapse images were 
collected using the 32x objective with the addition of a 1.6x optivar lens, using an 
Orca ER camera (Hamamatsu) and Openlab software (Improvision). Movies of 
soluble ephrin-A5-Fc-induced RGC growth cone collapse were collected one frame 
every 10 seconds, with the exception of movie 4.5 (in the presence of Y27632) 
which was filmed at one frame every 12 seconds. RGC-fibroblast/MDCK 
interactions were filmed at one frame every 15 seconds with the exception of movies 
4.6 and 4.9 (RGC-fibroblast interactions in the presence of PP2 and PP3 
respectively) which were filmed at 1 frame every 20 seconds. During the period of 
recording poly(dimethylsiloxane) 200 mineral oil (Aldrich) was placed on top of the
79
medium to prevent evaporation. After recording the oil was removed with a pipette 
from the RGC-MDCK co-cultures that would be fixed and stained to check for 
ephrin-A5 expression.
2.6.2. Confocal microscopy.
Fluorescent images were obtained using an upright confocal microscope (Leica) 
using a 63x oil immersion objective. The images were processed using the Leica 
confocal software and PhotoShop (Adobe).
2.7. Cell assays.
2.7.1. Co-culture assay.
Swiss-3T3 fibroblasts or MDCK cells were trypsinised as described in section 2.1.3 
and added to coverslips on which retinal explants had previously been cultured for 
18-24 hours (Swiss-3T3 fibroblasts) or 10-16 hours (MDCK cells). Co-cultures were 
incubated for 2-4 hours (Swiss 3T3 fibroblasts) or 8-10 hours (MDCK cells) at 37°C 
and 5% C 0 2 in a humidified tissue culture incubator before being transferred to the 
heated stage of an inverted microscope (Zeiss). Co-cultures were viewed under a 32x 
objective to identify potential RGC-Fibroblast/MDCK cell interactions. Time-lapse 
phase microscopy recordings of cell-cell interactions were made as described in 
section 2.5.1. RGC responses to cell contact were quantified under two sets of strict 
criteria. Loss of lamella is defined as the complete loss of RGC growth cone lamella 
for more than 1 min. Axon retraction is defined as the phase-dark region in the 
central domain of the RGC growth cone, which is revealed as the axon terminal 
when the RGC lamella is lost, retracting beyond j its position at the point of initial 
cell contact. Initial contact is defined as contact between the lamella of the RGC 
growth cone and the lamella of the contacting cell. Withdrawal of the contacting cell 
is defined as the non-neuronal cell retracting more than 10pm from the point of 
contact with a RGC growth cone. Non-neuronal cells that were migrating prior to the 
interaction were not quantified for withdrawal. Interactions were recorded for a 
minimum of 25 min after initial contact, unless axon retraction had occurred before 
this time.
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To detect RGC Eph receptor phosphorylation induced by contact with a Swiss-3T3 
fibroblast, fibroblasts were added to retinal explants as described above and after 2-4 
hours the co-cultures were fixed and stained with fluorescent phalloidin and anti- 
phospho-Eph receptor, as described in section 2.4. Images of RGCs alone or in 
contact with a Swiss-3T3 fibroblast were captures by confocal microscopy (see 
section 2.5.2).
2.7.2. Soluble growth cone collapse assay.
Retinal or DRG explants were cultured as described in section 2.1. Soluble ephrin- 
A5-Fc (R & D Systems) was clustered in to higher order oligomers by incubation of 
ephrin-A5-Fc (4p,gml1) in RGC medium with a 5-fold excess of goat or rabbit anti­
human IgG (Stratech) for 20 min in a humidified tissue culture incubator at 37°C and 
5% C 0 2. Anti-human IgG was incubated in the same way, but in the absence of 
ephrin-A5-Fc as a control. Clustered ephrin-A5-Fc at a final concentration of lp,gmT 
\  or anti-IgG at a final concentration of Sugml'1, was added to the bathing medium 
of retinal explants, gently mixed by pipetting and the retinal explants were incubated 
with ephrin-A5-Fc at 37°C and 5% C 02 for 10 min in a humidified tissue culture 
incubator. Sema3A (R & D Systems) was added to the bathing medium of DRG 
explants at a final concentration of 1 or 5 ngml'1 and the DRG explants incubated at 
37°C and 5% C 0 2 for 10 min in a humidified tissue culture incubator. The explants 
were then fixed, stained with Rhodamine-labelled phalloidin and mounted on 
microscope slides as described above. RGC and DRG axons were viewed under an 
inverted fluorescence microscope (Axioscope) using a 63x oil immersion objective 
and were quantified under three strict sets of criteria with regards the morphology of 
their F-actin cytoskeleton. Full growth cone defines axons that have visible growth 
cone lamella. Loss of lamella defines axons that exhibit no visible growth cone 
lamella and have more than three F-actin positive filopodia or retraction fibres. Total 
collapse defines axons that have 3 or fewer filopodia/retraction fibres. More than 100 
axons were counted in each experiment, and at least three repeat experiments were 
performed.
RGC responses to soluble lpgml-1 clustered ephrin-A5-Fc recorded by phase time- 
lapse microscopy were quantified for loss of lamella and axon retraction as in the co­
81
culture assay, but times were ,measured from the addition of ephrin-A5-Fc to the 
bathing medium.
2.8. Pharmacological inhibitors.
Pharmacological inhibitors, or the equivalent volume of the appropriate carrier, were 
added to the bathing medium of retinal or DRG cultures at the concentrations and 
stated below. Y27632 was added 1 hour prior to the addition of soluble ephrin-A5- 
Fc, and 1-2 hours prior to RGC-fibroblast/MDCK interaction. PP2, PP3 and STI571 
were added to the bathing medium 20 min prior to addition of ephrin-A5-Fc or 
Sema3A, and 20-30 min prior to RGC-fibroblast/MDCK interaction. STI571 was 
added to the bathing medium of COS cells transfected with EphA4 for 2 hours prior 
to cell lysis (see below). Eph-A5-Fc dimers (R & D Systems) were added at a final 
concentration of lpgml'110-20 min prior to RGC-fibroblast/MDCK interaction.
Table 2.3 Pharmacological inhibitors
Inhibitor (Target) Final
Cone.
Carrier Reference (Source)
Y27632 (ROCK) lOpM H20 Ishizaki et al., 2000; Uehata et al., 1997. 
(Calbiochem)
PP2 (Src family kinases) lOpM DMSO Hanke et al., 1996. (CN Biosciences)
PP3 (negative control PP2) lOpM DMSO Traxler et al., 1996. (CN Biosciences)
STI571 (Abl family kinases) 10jiM DMSO Buchdunger et al., 1996; Drucker et al., 
1996. (Novartis)
2.9. Biochemical techniques
2.9.1. Cell lysis
Isolated RGCs treated with clustered ephrin-A5-Fc, or COS cells transfected with 
EphA4, were placed on ice, the medium aspirated off and the cells washed 4 times 
with cold Tris-buffered saline (TBS). After the final wash had been removed 200pi 
of cold RIPA buffer was added to each dish of cells. The lysed cells were collected at 
the edge of the dish using a cell scraper (Marathon) and passed 3 times through a
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23G microlance needle (H M & S). The lysed cells were transferred to a 1.5 ml 
centrifuge tube (Eppendorf) on ice and spun at 5°C and 13000 rpm for 5 min. The 
supernatant was transferred to a clean 1.5 ml centrifuge tube on ice and mixed with 
an equal volume of 2x Laemmli sample buffer (Sigma).
2.9.2. Immuno-precipitation.
COS cells transfected with EphA4 were placed on ice, the medium aspirated off and 
the cells washed 4 times with cold TBS. After the final wash had been removed 
lOOfxl of cold immuno-precipitation (IP) buffer was added to each well. The lysed 
cells were collected at the edge of the dish using a cell scraper and passed 3 times 
through a 23G microlance needle. The lysed cells were transferred to a 1.5 ml 
centrifuge tube on ice and spun at 5°C and 13000 rpm for 5 min. The supernatant was 
transferred to a clean 1.5 ml centrifuge tube on ice. 20pi was removed for analysis of 
proteins by western blot, added to an equal volume of 2x Laemmli sample buffer and 
incubated in a heat block at 95°C for 5 min. The remaining cell lysate was incubated 
overnight at 5°C with 2pl anti-Mena antibody (BD biosciences) or 2.5 pi anti-c-abl 
antibody (Merk Biosciences) on a rotating wheel.
Protein G agarose beads (Upstate Biotech) were washed 4 times by addition of IP 
buffer and spinning at 2000 rpm for 20 seconds), taking care to keep the volume 
constant. 50pl of equilibrated protein G agarose was added to each sample of 
immuno-precipitate and incubated for a further hour on a rotating wheel at 4°C. The 
protein G agarose was washed 4 times with IP buffer as above, and then all the 
supernatant was removed. 25 pi of 2x Laemmli sample buffer was added and the 
samples incubated at 95°C for 5 min. The samples were immediately analysed by 
western blotting.
2.9.3. SDS-PAGE and Western blotting.
10-15% SDS-polyacrylamide gels were poured by hand using the Bio-Rad Mini-Gel 
system (Bio-Rad) and 10-20pL of lysate or immuno-precipitated sample was loaded 
to each well. The samples were separated by SDS-PAGE at 150V for 90-120 min 
and transferred to PVDF membrane (Amersham) using the Protean 3 electrophoresis 
system (Bio-Rad). Transfer buffer was used cold, and protein transfer was carried out 
at 4°C overnight. The membranes were blocked in a 1% solution of Superblock
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(Pierce) in TBS-Tween (TBST) for 90 min at 4°C on an orbital shaker. Primary 
antibodies were diluted in 1% Superblock-TBST and membranes were incubated 
with primary antibody at room temperature for 30-45 min. The membranes were 
rinsed 3 times in TBST and then washed for 20-30 min with a minimum of 3 changes 
of TBST. Secondary antibodies were diluted in 0.1% Superblock-TBST and 
membranes incubated with secondary antibody for 30-40 min at room temperature. 
Membranes were rinsed and washed in TBST for 45-60 min, and the secondary 
antibodies visualised with SuperSignal West Pico chemiluminescent ECL substrate 
and CL-Xposure film (both Pierce).
Table 2.4. Antibodies used for Western blotting.
Antibody Source (Clone) Dilution Source
Phospho-Eph receptor Rabbit 1:10000
Alpha tubulin Rat (YL1/2) 1:2500 Serotec
Mena Mouse (21) 1:250 BD Biosciences
c-Abl Mouse (Ab-3) 1:50 Oncogene
Phospho-tyrosine Mouse (PT66) 1:1000 Sigma
HRP-anti-rabbit Goat 1:20000 Stratech
HRP-anti-rat Donkey 1:50000 Stratech
HRP-anti-mouse Goat 1:20000 Stratech
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Chapter 3. Contact-induced RGC 
repulsive responses mediated by EphA 
signalling.
3.1. Introduction.
During development of the visual system RGC axons project to positions in their 
midbrain target (the tectum in avians, amphibians and fish, the superior colliculus 
[SC] in mammals) in a spatially organised manner, to produce a topographic map. 
Specifically axons arising from RGCs in the temporal retina terminate in the anterior 
tectum, while nasal RGC axons project to the more posterior tectum/SC (Holt and 
Harris, 1993; Mey and Thanos, 1992). As discussed in section 1.3.1 there is to date a 
large body of evidence that the topographic mapping that occurs along the anterior- 
posterior axis during the development of the retinotectal projection is governed by an 
increasing anterior to posterior gradient of ephrin-As expressed in the tectum/SC, 
and that these ephrin-As guide RGCs, which express a corresponding high temporal 
to low nasal gradient of EphA receptors, by differential repulsion (Kullander and 
Klein, 2002; Wilkinson, 2001).
Traditionally axon | guidance l directed by repulsive guidance cues has been studied in 
vitro using the related phenomenon of growth cone collapse (Cox et al., 1990; Raper 
and Kapfhammer, 1990; Walter et al., 1990a). For example addition of a suspension 
of membranes isolated from the chick tectum to the bathing medium of RGCs in 
culture induces the loss of the F-actin-rich lamella and filopodia that comprise the 
growth cone, which is present at the tip of an extending axon (Cox et al., 1990). 
Since the cloning of ephrin-A5 and ephrin-A2 the growth cone collapse assay has 
been routinely used to describe the differential repulsive response of temporal and 
nasal RGC axons to ephrin-As, and to identify potential signalling intermediates 
involved in the RGC response to EphA receptor activation (Cheng et al., 2003; 
Jumey et al., 2002; Menzel et al., 2001; Monschau et al., 1997; Shamah et al., 2001; 
Wahl et al., 2000). The growth cone collapse assay used in these studies involves
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addition of chimeric proteins, comprising the extracellular receptor-binding domain 
of ephrin-A fused to the Fc fragment of human IgG or alkaline phosphatase in order 
that they are soluble, to the bathing medium of RGCs in vitro. Ephrin-As are 
membrane bound in vivo and therefore guide axons by contact repulsion rather than 
acting as soluble, diffusible guidance cues (Gale et al., 1996b; Orioli and Klein, 
1997; Pandey et al., 1995a; Tessier-Lavigne and Goodman, 1996; Wilkinson, 2001). 
A more physiologically relevant assay with which to study the RGC response to 
EphA receptor activation would therefore involve contact between a RGC growth 
cone and a cell that expresses endogenous levels of ephrin-A.
A series of elegant studies by Roger Davenport and his colleagues have described the 
response of RGCs to contact with isolated tectal cells, but these studies do not 
address whether the RGC response is due to EphA receptor signalling (Davenport et 
al., 1996; Davenport et al., 1998; Davenport et al., 1999; Thies and Davenport, 
2003). In order to develop a physiologically relevant assay with which to study the 
neuronal response to EphA receptor activation I have described the response of nasal 
RGCs in vitro to contact with individual Swiss-3T3 fibroblasts, which express 
endogenous levels of ephrin-A on their surface. In response to contact with an 
individual Swiss-3T3 fibroblast RGCs exhibit rapid loss of growth cone lamella 
followed by axon retraction. Contact with a Swiss-3T3 fibroblast induces activation 
of Eph receptors on the RGC growth cone, and disruption of the EphA-ephrin-A 
interaction prevents the contact-induced loss of RGC growth cone lamellatand axon 
retraction. Together with the observation that overexpression of ephrin-A5 in a cell 
type that does not endogenously express ephrin-A is sufficient to induce the RGC 
repulsive response, these data provide strong evidence that the robust and 
reproducible RGC response to contact with a Swiss-3T3 fibroblast described in this 
chapter is mediated by neuronal EphA signalling, which justifies the use of this co­
culture assay to investigate signalling intermediates involved in EphA signalling in 
RGCs.
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3.2. Results.
3.2.1. Swiss-3T3 fibroblasts endogenously express ephrin-A.
Roger Davenport and colleagues have previously described the response of 
individual RGCs to contact with individual primary tectal neurons that express 
ephrin-As (Davenport et al., 1996; Davenport et al., 1998; Davenport et al., 1999; 
Thies and Davenport, 2003). Given the steep ephrin-A expression gradient along the 
anterior-posterior axis of the tectum it is unlikely that, even within a sub-population 
of tectal cells, the level of ephrin-A expression is uniform (Cheng et al., 1995; 
Drescher et al., 1995; Monschau et al., 1997), and this could lead to a variable RGC 
response to contact with a tectal neuron. In addition tectal neurons in culture have 
very round cell bodies, making careful analysis of the behaviour of RGC growth 
cone filopodia and lamellaeat the sites of cell-cell contact difficult when viewed 
under phase time-lapse microscopy. In order to develop a reproducible assay with 
which to study the response of RGC growth cones to contact with an ephrin-A- 
expressing cell, I have screened a variety of cell lines for endogenous, uniform 
ephrin-A expression, and a flat, well-spread morphology.
Swiss-3T3 fibroblasts, when plated at low density on laminin and grown in RGC 
medium, are flat cells with large spread lamellae (Fig 3.1a) and therefore have 
suitable morphology to allow study of contact-induced responses in RGC growth 
cones. Cell surface ephrin-A expression can be detected by indirect 
immunofluorescence using a chimeric protein composed of the extracellular ligand- 
binding domain of EphA5, which has selective binding affinity for ephrin-As (Davis 
et al., 1994; Gale et al., 1996a; Gale et al., 1996b), fused to the Fc fragment of 
human IgG (EphA5-Fc ) (Davy et al., 1999; Krull et al., 1997; Marcus et al., 2000). 
EphA5-Fc, added to the bathing medium of live Swiss-3T3 fibroblasts in culture, can 
be visualised after fixation with a fluorescently-tagged secondary antibody, revealing 
clusters of ephrin-A evenly distributed across the entire surface of the fibroblast 
under conditions in which it can be co-cultured with RGCs (Fig 3.1b and green in 
3.1c). Ephrin-A distribution extends to the edge of the Swiss-3T3 lamella (Fig 3.1c), 
indicating that contact of a RGC growth cone with a Swiss-3T3 fibroblast should 
lead to activation of EphA receptors on the RGC growth cone regardless of the site 
of contact. It should be noted that EphA5-Fc does not detect ephrin-A on the surface
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Figure 3.1. Swiss-3T3 fibroblasts in culture express endogenous 
ephrin-A.
Under conditions in which they can be co-cultured with RGCs, Swiss-3T3 
fibroblasts are flat with spread lamellae, shown by fluorescent phalloidin staining (a 
and d). Detection of surface ephrin-As using EphA5-Fc, added to live Swiss-3T3 
fibroblasts (a-c), and a fluorescent secondary antibody (b, e, and green in c and 0  
reveals evenly distributed clusters of ephrin-A across the Swiss-3T3 fibroblast 
surface. Omitting EphA5-Fc (d-f) acts as a control for non-specific antibody 
staining. Scale bars = 20|im.
c and f  are merged images.
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of the Swiss-3T3 fibroblast unless it is clustered into oligomers with an anti-human 
antibody before being added to the bathing medium. This may account for the 
punctuate staining shown in Fig 3.1b and Fig 3.1c, and it is possible that under basal 
conditions ephrin-As are present in a more diffuse pattern on the surface of a Swiss- 
3T3 fibroblast in culture. Fig 3.Id-f are included to control for non-specific antibody 
binding.
I attempted to characterise the particular ephrin-A family members expressed by 
Swiss-3T3 fibroblasts using Western blot and by immunofluorescence. Unfortunately 
the commercially available antibodies raised against individual ephrin-A family 
members failed to produce a detectable signal by either method. It is not clear that 
identifying the particular ephrin-A members expressed by Swiss-3T3 fibroblasts will 
provide additional evidence that these cells are suitable with which to investigate the 
behaviour of RGCs, beyond the observation reported here that Swiss-3T3 fibroblasts 
show ephrin-As evenly distributed across their surface. It has been reported that the 
EphA receptors expressed on RGCs have up to a ten-fold difference in binding 
affinities for different members of the ephrin-A family, but these experiments were 
performed using soluble-A proteins, whose affinity for their receptor alone reflects 
whether binding will occur (Flanagan and Vanderhaeghen, 1998; Gale and 
Yancopoulos, 1997). This does not necessarily reflect the biological relevance of 
interaction at the cell-cell interface, where co-operative interactions between multiple 
Eph receptor-ephrin family members simultaneously may influence the binding 
between particular partners (Gale and Yancopoulos, 1997). For the same reason, 
experiments that report nasal RGCs in vitro show a repulsive response to ephrin-A5, 
but not ephrin-A2 or ephrin-A6 use only one ligand, and might not reflect the 
physiological situation (Menzel et al., 2001; Monschau et al., 1997). The uniform 
distribution pattern of ephrin-A across the surface of Swiss-3T3 fibroblasts (Fig 3.1) 
will allow detailed analysis of the dynamic RGC behaviour of a RGC at the site of 
contact with a cell that expresses endogenous levels of ephrin-A.
3.2.2. Contact with an ephrin-A-expressing Swiss-3T3 fibroblast
induces a rapid repulsive response in nasal RGCs.
In order to describe the dynamic response of a single RGC growth cone to contact 
with an ephrin-A-expressing Swiss-3T3 fibroblast, interactions between the two cell
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types were recorded by phase time-lapse microscopy. An example of the repulsive 
response induced in a RGC following contact with a Swiss-3T3 fibroblast is shown 
in Fig 3.2 (See also Movie 3.2 on the enclosed CD). The RGC growth cone is highly 
dynamic prior to contact with the ephrin-A-expressing fibroblast, and within 2 min of 
contact the RGC lamella begins to retract from the site of cell-cell contact (Fig 3.2, 
arrowheads, Movie 3.2). The RGC growth cone lamella is completely lost by 7 min 
after contact. Loss of RGC growth cone lamella is assessed under the strict criteria of 
complete absence of lamellaefor longer than 1 min (see section 2.7.1). The majority 
(76.7%) of RGCs completely lose growth cone lamellae.within 10 min of initial 
contact with an ephrin-A-expressing Swiss-3T3 fibroblast (Table 3.1). Of the RGCs 
that lose growth cone lamellaewithin the normal period of recording (25 min after 
contact), on average the lamella is completely lost by 5.9 ± 2.5 min (n=25).
After the RGC growth cone is completely lost the RGC axon begins to retract from 
the site of cell-cell contact (Fig 3.2). Axon retraction is defined as the phase-dark 
central zone of the growth cone, revealed as the axon terminal when the lamella is 
lost, retracting beyond it’s position at the time of initial contact (Fig 3.2 black 
arrows), and by these criteria 43.3% of RGC axons retract within 20 min of initial 
contact with a Swiss-3T3 fibroblast (Table 3.1). In the example shown in Fig 3.2 
axon retraction occurs at 10.5 min after contact and by 15 min the axon has retracted 
well beyond the point of initial contact. The RGC repulsive response to contact with 
an ephrin-A-expressing Swiss-3T3 fibroblast consists of a series of distinct events. In 
the majority (69.2%) of RGC-Swiss-3T3 fibroblast interactions the lamella is 
completely lost before the axon begins to retract, and on average axon retraction 
begins at 8.3 ± 4.8 min after initial contact (n=13).
As the growth cone lamella is lost following contact with a Swiss-3T3 fibroblast, the 
growth cone filopodia are revealed (Fig 3.2 white arrows). Most of these filopodia 
are pulled away as the axon retracts, leaving behind very few, fine retraction fibres. 
A negative correlation exists between the presence of growth cone filopodia, 
revealed as the lamella is lost, and axon retraction. Of the 10 RGCs that lose lamella 
but do not retract following contact with a Swiss-3T3 fibroblast, 9 retain more than 3 
filopodia after complete loss of growth cone lamellae-. In comparison, of the RGC 
growth cones that completely lose lamella before retracting (n=9) 8 leave behind 3 or 
fewer retraction fibres, which appear to have initially been growth cone filopodia, 1
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Figure 3.2. Contact with an ephrin-A-expressing fibroblast induces 
loss of RGC growth cone lamella and axon retraction.
Time-lapse stills showing that contact with a Swiss-3T3 fibroblast induces a rapid 
repulsive response in an individual nasal RGC axon. Following contact between the 
RGC growth cone lamella and the Swiss-3T3 fibroblast the growth cone lamella 
begins to collapse (arrowheads). As the growth cone lamella is lost, growth cone 
filopodia are revealed (white arrows). After the growth cone lamella is completely 
lost, the RGC axon begins to retract, and by 15 min after initial contact has retracted 
well beyond its position at the time of initial contact (black arrows). As the RGC axon 
retracts most of the growth cone filopodia are pulled away, leaving behind only a few, 
very Fine retraction fibres. Times shown are relative to initial contact. Scale bar = 
20|im.
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Table 3.1.
Cell type and treatm ent
(n)
RGCs showing loss of 
lamella within 10 min 
of contact.
RGCs showing axon 
retraction within 20 
min of contact.
Swiss 3T3 fibroblast (30) 76.7% 43.3%
Swiss 3T3 fibroblast + 
EphA5-Fc (16)
6.3% 0.0%
MDCK (15) 26.7% 6.7%
MDCKephrin-A5 (16) 87.5% 75%
MDCK mock (4) 25.0% 25.0%
Table 3.2.
Cell type and treatm ent (n) Contacting cells withdrawing >10pm 
within 10 min of contact with a RGC.
Swiss 3T3 fibroblast (21) 52.4%
Swiss 3T3 fibroblast +EphA5-Fc (11) 27.2%
MDCK (8) 50.0%
MDCK-ephrin-A5 (9) 0.0%
MDCK-mock (4) 33.3%
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minute after axon retraction begins, supporting the idea that filopodia are pulled 
away by the retracting axon. Phase time-lapse microscopy of RGC-Swiss-3T3 
fibroblast interactions therefore reveals that contact with an ephrin-A-expressing 
Swiss-3T3 fibroblast induces a repulsive response in the RGC, which consists of a 
sequence of distinct cellular events, each of which can be quantified.
Interestingly the Swiss-3T3 fibroblast also responds to contact with a RGC growth 
cone; withdrawing its lamella at the site of cell-cell contact (Fig 3.2). Approximately 
half (52.4%) of Swiss-3T3 fibroblasts withdraw further than 10pm from the site of 
initial cell-cell contact within 10 min (n=21, see Table 3.2), but this response does 
not appear to be the result of EphA-ephrin-A interaction (see below).
3.2.3. Blocking EphA-ephrin-A interaction prevents the RGC 
repulsive response to contact with an ephrin-A-expressing Swiss-3T3 
fibroblast.
It is clear that contact with an ephrin-A-expressing Swiss-3T3 fibroblast results in a 
robust and reproducible RGC response. To make use of the contact-induced RGC 
response as an assay with which to investigate signalling pathways downstream of 
EphA receptor activation, the loss of RGC growth cone lamellae and axon retraction 
must depend on Eph receptor-ephrin interaction. Soluble EphA5-Fc, presented as 
unclustered dimers, has previously been used to disrupt potential EphA-ephrin-A 
interactions in vitro, to demonstrate that the inhibitory response of mouse RGCs to 
ephrin-A-expressing tissue from the optic chiasm is mediated by EphA signalling 
(Marcus et al., 2000). In order to demonstrate that the RGC response to contact with 
a Swiss-3T3 fibroblast is due to Eph receptor-ephrin interaction, lp-gml'1 EphA5-Fc 
was added to the bathing medium of RGCs and Swiss-3T3 fibroblasts in co-culture 
10-20 min prior to cell-cell contact. EphA5 has a high affinity for all ephrin-As, but 
does not bind ephrin-Bs (Davis et al., 1994; Gale et al., 1996a; Gale et al., 1996b; 
Monschau et al., 1997). Soluble dimers of the extra-cellular binding domain of 
EphA5 retain the ability to bind ephrin-As (Monschau et al., 1997) but are not 
clustered into oligomers considered necessary to activate reverse signalling (Huai 
and Drescher, 2001). EphA5-Fc dimers added to the bathing medium will therefore 
bind to and mask ephrin-As on the surface of the Swiss-3T3 fibroblast, preventing 
their interaction with EphA receptors on the RGC growth cone.
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An example of the interaction between a RGC growth cone and a Swiss-3T3
* -
fibroblast in the presence of EphA5-Fc is shown in Fig 3.3. Following contact with 
the Swiss-3T3 fibroblast, the RGC growth cone lamella does not collapse. Instead 
the RGC growth cone continues to advance across the substrate, lamella intact, for 
more than 15 min after initial contact with the Swiss-3T3 fibroblast. Addition of 
EphA5 prior to cell-cell contact significantly reduces the percentage of RGCs that 
completely lose lamellae following contact with an ephrin-A-expressing Swiss-3T3 
fibroblast (6.3%, see Table 3.1) compared to control interactions (76.7%, p<0.0001, 
Fisher’s exact test for independence). In addition, the presence of EphA5-Fc 
completely abolishes the RGC axon retraction in response to contact with an ephrin- 
A expressing fibroblast. Of the 16 RGC-Swiss-3T3 interactions recorded in the 
presence of EphA5-Fc, none resulted in RGC axon retraction, compared to 43.3% of 
control interactions (p<0.002, Fisher’s exact test for independence, See Table 3.1). In 
contrast EphA5-Fc does not significantly reduce the percentage of Swiss-3T3 
fibroblasts that withdraw following contact with a RGC growth cone (p>0.2, Fisher’s 
exact test for independence, see Table 3.2), suggesting that the fibroblast response is 
not induced by EphA-ephrin-A interaction. Together the above data provide strong 
evidence that the loss of RGC lamellaeand axon retraction induced by contact with a 
Swiss-3T3 fibroblast are mediated by EphA-ephrin-A interaction.
It is formally possible that the RGC repulsive response following contact with a 
Swiss-3T3 fibroblast is due to reverse signalling through the ephrin-As expressed on 
RGCs in culture (Homberger et al., 1999). Swiss-3T3 fibroblasts in culture express 
low levels of EphA receptors (C.D. Nobes, unpublished observations) and therefore 
contact between a RGC growth cone and a Swiss-3T3 fibroblast may induce 
signalling through neuronal ephrin-As, rather than through EphA receptors. The 
observation that EphA5-Fc inhibits the RGC repulsive response does not distinguish 
between these possibilities. It has been reported that ephrin-A-mediated signalling in 
non-neuronal cells increases cell-matrix adhesion, and in primary neurons, induces 
neurite outgrowth (Davy et al., 1999; Davy and Robbins, 2000; Huai and Drescher, 
2001). Activation of ephrin-A-signalling in RGCs would therefore not be predicted 
to induce RGC growth cone collapse and axon retraction, but to address this issue 
directly I have stimulated RGCs in culture with soluble EphA5-Fc, clustered into 
oligomers in order to activate ephrin-A reverse signals. Fig 3.4 clearly demonstrates
♦(See also Movie 3.3 on the enclosed CD) 
^(See also Movie 3.4 on the enclosed CD)
Figure 3.3. Blocking EphA-ephrin-A interaction prevents the RGC 
repulsive response to contact with a Swiss-3T3 fibroblast.
Time-lapse stills showing that disruption of EphA-ephrin-A interaction, using soluble 
EphA5-Fc, prevents both the loss of RGC lamella and axon retraction induced by 
contact with a Swiss-3T3 fibroblast. EphA5-Fc (l|ig /m l) was added to the bathing 
medium of Swiss-3T3 fibroblasts and RGCs in co-culture 10-20 min prior to cell-cell 
contact. In the presence of EphA5-Fc the RGC growth cone continues to advance 
across the substrate, lamella intact, for more than 15 min after initial contact with the 
ephrin-A-expressing Swiss-3T3 fibroblast. Times shown are relative to initial contact. 
Scale bar = 20pm.
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Figure 3.4. Activation of ephrin-A signalling does not induce growth 
cone collapse or axon retraction.
Time-lapse stills showing that stimulation of ephrin-A signalling in RGCs, by 
addition of soluble clustered EphA5-Fc, does not induce loss of RGC lamella, or axon 
retraction. Following addition of clustered EphA5-Fc (lpg/m l) the RGC continues to 
advance across the substrate, lamella intact. Times shown are relative to addition of 
EphA5-Fc. Scale bar = 20pm.
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that stimulation with clustered EphA5-Fc does not induce RGC collapse and axon 
retraction. The RGC growth cone retains a full, spread lamella following addition of 
EphA5-Fc and the axon continues to advance across the substrate. Taken together the 
data described above provide strong evidence that the RGC repulsive response to 
contact with a Swiss-3T3 fibroblast is mediated by activation of neuronal EphA 
receptors following interaction with ephrin-As on the surface of a Swiss-3T3 
fibroblast.
3.2.4. Following contact with a Swiss-3T3 fibroblast, Eph receptors 
on the RGC growth cone become activated.
Eph receptors contain a highly conserved pair of tyrosine residues in the 
juxtamembrane region that are major sites of autophosphorylation, and 
phosphorylation at these sites is required for ligand-activated Eph kinase activity 
(Binns et al., 2000; Choi and Park, 1999; Ellis et al., 1996; Fox et al., 1995; Kalo and 
Pasquale, 1999; Sajjadi and Pasquale, 1993; Wybenga-Groot et al., 2001; Zisch et 
al., 1998). Mutation of these residues in EphA4, which is expressed by nasal RGCs 
in vitro and is required for the repulsive response of RGCs to substrate-bound ephrin- 
A5, prevents EphA4 kinase activity against an exogenous substrate in vitro (Binns et 
al., 2000; Monschau et al., 1997; Walkenhorst et al., 2000). An antibody raised 
against Eph receptors phosphorylated on these residues (see section 2.4) can 
therefore be used as a read-out of Eph receptor activity (Marston et al., 2003; 
Shamah et al., 2001). Fig 3.5 shows that contact with a Swiss-3T3 fibroblast induces 
activation of Eph receptors on the RGC growth cone, particularly in the central 
region of the growth cone (Fig 3.5a-c). The experiment shown in Fig 3.5 was not 
done in such a way as to allow exact timing of the RGC-Swiss-3T3 fibroblast 
interaction, and it is possible that at earlier time-points Eph receptor activity is 
concentrated at the growth cone periphery. Note the growth cone of a fasciculated 
axon does not show Eph receptor phosphorylation (Fig 3.5 a, b, arrows). 
Interestingly there is a high level of Eph receptor phosphorylation along the RGC 
axon (Fig 3.5), which may be a result of axon fasciculation. RGCs cultured in the 
absence of Swiss-3T3 fibroblasts (Fig 3.5d-f) do not show any Eph receptor 
phosphorylation on the growth cone, or along the portion of the axon that is not in 
contact with another axon (Fig 3.5e and green in f). Beyond the fasciculated growth
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Figure 3.5. Contact with a Swiss-3T3 fibroblasts induces activation 
of Eph receptors on the RGC growth cone.
e
RGCs, in the presence (a-c) or absence (d-f) of Swiss-3T3 fibroblasts, were fixed and 
stained with phalloidin (a and d, red in c and 0  and anti-phospho-Eph receptor (b 
and e, green in c and f). A RGC growth cone in contact with a Swiss-3T3 fibroblast 
stains positive for phosphorylated Eph receptor (b), whereas the growth cone of a 
fasciculated RGC does not (a, b, arrows). RGC growth cones in the absence of 
Swiss-3T3 fibroblasts do not display phospho-Eph receptor staining (d-f). Note that 
fasciculation of RGC axons correlates with Eph receptor phosphorylation (a-c, d-f 
beyond the fasciculated growth cone {d, arrow}). Scale bars = 20pm.
c and f  are merged images. It should be noted, as mentioned in section 2.4, the anti- 
phospho-Eph receptor antibody used was not affinity purified against the 
phosphopeptide, and therefore the staining pattern shown here may also reflect 
increased phosphorylation o f other proteins.
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cone (Fig 3.5d arrow) however, the RGC axons are positive for phospho-Eph 
receptor (Fig 3.5d-f). EphA4 is highly phosphorylated in the nasal retina in vivo, and 
this is thought to be the result of co-expression of ephrin-A ligands by nasal RGCs 
(Connor et al., 1998; Hornberger et al., 1999). This would explain the fact that 
fasciculated nasal RGCs express phosphorylated Eph receptors (Fig 3.5). 
Importantly, phosphorylation of Eph receptors on the RGC growth cone is only seen 
following contact with an ephrin-A-expressing Swiss-3T3 fibroblast (Fig 3.5), which 
provides further evidence that the repulsive RGC response induced by contact with 
these cells is mediated by Eph receptor activation.
3.2.5. MDCK cells do not express endogenous ephrin-A and induce a 
much-reduced RGC repulsive response.
The observation that blocking EphA-ephrin-A interaction prevents loss of RGC 
lamellae and axon retraction suggests that ephrin-A expression on the contacting cell 
is necessary for contact-induced loss of RGC lamellatand axon retraction. In order to 
test this hypothesis I have investigated the RGC response to contact with a cell type 
that does not endogenously express ephrin-As. Sub-confluent MDCK cells plated on 
laminin and grown in RGC medium have a similar actin morphology to sub­
confluent Swiss-3T3 fibroblasts, in that they are well spread with large lamellae (Fig 
3.6a, d). However under these conditions MDCK cells do not display detectable 
amounts of ephrin-A on their surface by indirect immunofluorescence using EphA5- 
Fc (Fig 3.6b, e, green in 3.6c, f). Recombinant rat ephrin-Al-Fc has previously been 
used to demonstrate that MDCK cells in culture endogenously express EphA 
receptors (Miao et al., 2003), ruling out the possibility that the recombinant rat 
EphA5-Fc used to detect surface ephrin-A in Fig 3.6 does not bind canine ephrin-A.
Fig 3.7 shows an example of the interaction between a RGC growth cone and an 
MDCK cell. Following contact with the MDCK cell the RGC growth cone does not 
lose lamella but begins to spread intact lamella along the edge of the MDCK cell. At 
later time-points (7, 10 and 15 min) after the initial contact the RGC growth cone 
lamella becomes spread over a large area, which is a prelude to this particular growth 
cone bifurcating as the axon branches (Movie 3.7). By 20 min after contact a smaller 
growth cone is present on the left-hand axon branch (Fig 3.7B arrow), while the 
right-hand branch has grown under the MDCK cell (Fig 3.7B arrowhead). The
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Figure 3.6. MDCK cells in culture do not express endogenous 
ephrin-A.
Under conditions in which they can be co-cultured with RGCs, MDCK cells are flat 
with spread lamellae, shown by fluorescent phalloidin staining (a and d, red in c and 
f). EphA5-Fc, added to live MDCK cells (a-c), and a fluorescent secondary antibody 
(b, e, and green in c and f) does not reveal any surface ephrin-A staining compared 
with the surface ephrin-A staining seen on Swiss-3T3 fibroblasts (Fig 3.1). Omitting 
EphA5-Fc (d-f) acts as a control for non-specific antibody staining. Scale bars = 
20pm.
c and f  are merged images.
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Figure 3.7. Contact with an MDCK cell does not induce loss of RGC
growth cone lamella or axon retraction.
min
A. Time-lapse stills showing that interaction with an MDCK cell, which does not 
express detectable levels of ephrin-A, does not induce loss of growth cone lamella or 
axon retraction in a contacting RGC. The RGC growth cone grows around the edge 
of the MDCK cell without losing its lamella for more than 15 min after contact. After 
the RGC growth cone has split, the right hand branch is not visible, as it has grown 
under the MDCK cell (B, arrowhead). The left hand axon branch has a growth cone 
that continues to grow along the edge of the MDCK cell (B, arrow), retaining its 
lamella for the entire period of filming (C, 25 min after initial contact). Times shown 
are relative to initial contact. Scale bars = 20pm.
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newly visible growth cone continues to advance along the edge of the MDCK cell, 
lamella intact, for the remainder of the recording (25 min after initial contact, Fig 
3.7C). Analysis of 15 RGC-MDCK interactions reveals that only 26.7% of RGC 
growth cones completely lose lamellasLwithin 10 min of contact with an MDCK cell 
(table 3.1) compared with 76.7% of RGCs contacting a Swiss-3T3 fibroblast 
(p<0.003, Fisher’s exact test for independence). In addition a very low percentage of 
RGC axons retract following contact with an MDCK cell (6.7%, see table 3.1) 
compared with a Swiss-3T3 fibroblast (43.3%, p<0.02, Fisher’s exact test for 
independence). This greatly reduced repulsive response correlates with lack of 
detectable ephrin-A expression and therefore the above data demonstrate that contact 
with a cell type that does not endogenously express ephrin-A results in a significantly 
reduced RGC repulsive response compared to contact with an ephrin-A-expressing 
cell.
3.2.6. Expression of ephrin-A5 in MDCK cells is sufficient to induce 
a RGC repulsive response.
Ephrin-A2 and ephrin-A5 appear to be the major members of the ephrin-A family 
that confer topographic specificity along the anterior-posterior axis in vivo (Feldheim 
et al., 2000; Frisen et al., 1998). Nasal RGCs in vitro are insensitive to ephrin-A2, 
but show repulsive responses to soluble and substrate-bound ephrin-A5 (Monschau 
et al., 1997; Nakamoto et al., 1996). In order to demonstrate that ephrin-A-expression 
in the contacting cell is sufficient to induce loss of RGC lamella and axon retraction I 
have microinjected MDCK cells with a mammalian expression vector encoding 
ephrin-A5 (MDCKephrin-A5 cells), along with FITC-dextran as an injection marker. 
Allowing 3-4 hours for expression of ephrin-A5, injected MDCK cells were selected 
for their proximity to an advancing RGC growth cone, and the resulting axon 
retraction was observed by time-lapse microscopy.
An example of the interaction between a RGC growth cone and an MDCKephrin-A5 
cell is shown in Fig 3.8. The RGC growth cone lamella begins to retract 2 min after 
initial contact with the MDCKephrin-A5 cell (Fig 3.8A arrowheads) and the lamella 
is completely lost by 5 min. Once the lamella is lost the RGC axon begins to retract 
and by 10 min after initial contact has retracted well beyond its position at the time 
of initial contact (Fig 3.8A black arrows). By 15 min the RGC axon has retracted
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Figure 3.8. Expression of ephrin-A5 in MCDK cells is sufficient to
induce loss of RGC growth cone lamella and axon retraction.
A. Time-lapse stills showing that contact with an ephrin-A5-expressing MDCK cell 
induces a rapid repulsive response in an individual nasal RGC axon. The growth 
cone lamella begins to collapse 2 min after initial contact with an MDCK cell 
(arrowheads), and is completely lost after 5 min. By 10 min the RGC axon has 
retracted well beyond its position at the time of initial contact (black arrows) and at 
15 min has retracted beyond the growth cone of a fasciculated axon (white arrows).
B. Final time-lapse still of Movie 3.8, showing a lower magnification view of the 
MDCK-ephrin-A5 cell shown in A. C. The cells were fixed and stained with anti- 
ephrin-A5 prior to permeablisation, to demonstrate that the MDCK-ephrin-A5 cell 
that induces the RGC response shown in A is injected with FITC dextran (green) and 
expresses surface ephrin-A5 (red). D. A non-injected MDCK cell on the same 
coverslip does not express surface ephrin-A5. Scale bars = 20|im.
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beyond the growth cone of a fasciculated RGC axon (Fig 3.8A white arrows). Fig 
3.8B shows the final still from Movie 3.8 at 16 min after initial contact. The cells 
were fixed within a few minutes of this final image, hence the images in Fig 3.8B 
and C are not precisely superimposible. The MDCK cell that induces rapid loss of 
RGC growth cone lamella and axon retraction (Fig 3.8A) expresses ephrin-A5 (red in 
Fig 3.8C). FITC-dextran was included as in injection marker (green in Fig 3.8C). Fig 
3.8D shows non-injected MDCK cells on the same coverslip to control for non­
specific antibody staining.
Analysis of 16 interactions between a RGC growth cone and an MDCKephrin-A5 
cell reveal that 87.5% of RGC growth cones completely lose lamella:within 10 min 
of contact (Table 3.1). This value is significantly higher than the percentage of RGCs 
that completely lose lamellaewithin 10 min of contact with a non-injected MDCK cell 
(p<0.001, Fisher’s exact test for independence), and is not significantly different 
from the percentage of RGC growth cones that lose lamellae in response to contact 
with a Swiss-3T3 fibroblast, which endogenously expresses ephrin-A (p>0.4, 
Fisher’s exact test for independence). The majority (75.0%) of RGC axons retract 
within 20 min of contact with an MDCKephrin-A5 cell (Table 3.1), significantly 
more than undergo axon retraction in response to a non-injected MDCK cell 
(p<0.0002, Fisher’s exact test for independence). Over-expression of ephrin-A in 
NIH3T3 fibroblasts has previously been shown to induce axon retraction in an 
identical percentage of nasal RGCs following contact in vitro (Davenport et al., 
1998).
Fig 3.9 demonstrates that injection of an MDCK cell with vector alone (mock- 
injected MDCK) does not affect the response of a RGC axon following contact with 
the injected cell. The RGC growth cone retains lamella for over 15 min after initial 
contact, and the RGC axon does not retract (Fig 3.9A). The final still from Movie 3.9 
is shown in Fig 3.9B. This movie was left to record for a long time; the final still was 
taken over an hour after initial contact and therefore the RGC axon has grown past 
the MDCK cell (Fig 3.9B). In order to demonstrate that the MDCK cell shown in Fig 
3.9A is injected, a fluorescence image showing FITC dextran is shown in Fig 3.9C. 
The percentage of RGCs that lose lamellaewithin 10 min of contact with a mock- 
injected MDCK cell (25.0%, see table 3.1) is not significantly different from the 
percentage of axons that lose lamella in response to a non-injected MDCK cell
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Figure 3.9. Contact with a mock-injected MDCK cell does not 
induce a RGC repulsive response.
+ 1 min
B
A. Time-lapse stills showing that contact with a mock-injected MDCK cell does not 
induce loss of RGC growth cone lamella or axon retraction. Following contact with 
a mock-injected MDCK cell the RGC growth cone continues to advance across the 
substrate, lamella intact. B. The final still from Movie 3.9, to correspond with the 
fluorescent image in C, demonstrating that the MDCK cell has been injected with 
FITC dextran. Scale bars = 20pm.
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(p>0.9, Fisher’s exact test for independence). Similarly mock injection has no effect 
on the percentage of RGC axons that retract in response to contact with an MDCK 
cell (see Table 3.1, p>0.3, Fisher’s exact test for independence). Taken together these 
data suggest that expression of ephrin-A5 on the surface on an MDCK is sufficient to 
induce a repulsive RGC response similar to that induced by contact with a fibroblast 
that endogenously expresses ephrin-As.
3.2.7. Soluble ephrin-A5-Fc causes loss of RGC jlamellae and axon 
retraction.
Many published studies have reported that ephrin-A5, presented in soluble form, 
triggers collapse of RGC growth cones, defined as the complete loss of the F-actin- 
rich lamella and filopodia that comprise the axonal growth cone (Cheng et al., 2003; 
Drescher et al., 1995; Monschau et al., 1997; Wahl et al., 2000; Weinl et al., 2003; 
Wong et al., 2004). Few of these reports describe the response of RGCs dynamically, 
and none address whether the loss of RGC lamella can occur separately from the loss 
of filopodia and axon retraction, as is seen in response to an endogenous ephrin-A- 
expressing cell. To extend the published results I have studied the response of RGCs 
to soluble ephrin-A5 in detail and dynamically, in particular to investigate the 
possibility that soluble ephrin-A5 triggers a series of temporally distinct events. 
Addition of ephrin-A5-Fc to the bathing medium of nasal RGCs in culture will also 
allow comparison of the RGC responses induced by soluble ephrin and those induced 
by contact with an ephrin-A-expressing cell.
EphA4, expressed on nasal RGC axons in culture, is required for the repulsive 
response of these axons to substrate-bound ephrin-A5 (Monschau et al., 1997; 
Walkenhorst et al., 2000). Ephrin-A5-Fc dimers fail to induce phosphorylation of 
EphA4 unless they are clustered in to higher order oligomers, and similarly ephrin- 
A5-Fc only inhibits outgrowth of EphA4-positive motor neurons when it is clustered 
(Ohta et al., 1997). Ephrin-A5-Fc was therefore clustered with an anti-human 
antibody (see section 2.7.2) before it was added to the bathing medium of nasal 
RGCs in culture at a final concentration of lp g m l1. Nasal RGCs in culture have a 
characteristic growth cone that consists of F-actin-rich filopodia (Fig 3.10a arrows) 
and a veil-like lamella (Fig 3.10a arrowheads). Stimulation of RGCs with clustered 
ephrin-A5-Fc for 10 min results in the complete loss of the growth cone lamella and
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Figure 3.10. Soluble ephrin-A5-Fc induces loss of RGC growth cone 
lamella and filopodia.
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Phalloidin staining shows that RGCs in culture, treated with anti-Fc as a control (a) 
have full growth cones with spread lamella (arrowheads) and filopodia (arrows). 
Stimulation with clustered ephrin-A5-Fc (lpg/m l) for 10 minutes triggers loss of 
growth cone lamella and filopodia (b). In order to quantify the response to soluble 
ephrin-A5-Fc, retinal explants were stimulated with clustered ephrin-A5-Fc 
(lpg/m l) for 10 min before being fixed, stained with phalloidin and categorised as 
having a full growth cone (for example see a), having completely lost lamella but 
retaining more than 3 filopodia (“Loss of lamella”, for example see c), or having lost 
lamella and having 3 or fewer filopodia/retraction fibres (“Total collapse”, for 
example see b). Quantification of the RGC response to soluble ephrin-A5 
demonstrates that the percentage of RGCs that exhibit total collapse in response to 
stimulation with ephrin-A5-Fc (lpg/m l) for 10 minutes is significantly higher than 
the percentage of totally collapsed control RGCs (d, * p < 0.001, student’s T-test for 
2-tailed data of unequal variance).
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filopodia (Fig 3.10b). In order to quantify the response of a large number of RGC 
axons to soluble ephrin-A5-Fc, retinal explants were fixed after 10 min stimulation 
with lpgm l'1 ephrin-A5-Fc, and stained with fluorescently labelled phalloidin in 
order to visualise the morphology of their actin cytoskeleton. RGCs classified as 
having a “full growth cone” show spread lamella and filopodia (for example Fig 
3.10a). In order to investigate whether stimulation with soluble ephrin-A5 can trigger 
loss of growth cone lamellae without subsequent loss of filopodia, as can occur in 
response to contact with an ephrin-A-expressing cell, RGC axons meeting the strict 
criteria of complete loss of lamellae.but having more than 3 filopodia are categorised 
as “loss of lamella” (for example Fig 3.10c). The final category, “total collapse”, is 
defined as complete loss of lamellae with 3 or fewer F-actin positive filopodia or 
retraction fibres at the end of the axon (for example Fig 3.10b). In the control 
situation the majority (79.0 ± 6.0%) of RGC axons have a full growth cone, but 
stimulation with ephrin-A5-Fc induces loss of both lamellaCand filopodia to cause 
total collapse in 80.9 ± 5.7% of the axons (Fig 3.10d). The percentage of RGC axons 
that exhibit total collapse in response to ephrin-A5-Fc is significantly higher than the 
percentage of control RGCs in this category (9.8% ± 2.7%, p<0.001 Student’s T-Test 
for 2-tailed data of unequal variance). There is a small percentage (11.8 ± 6.4%) of 
RGCs that lose only lam ella in response to stimulation with ephrin- A5-Fc (Fig 
3.10d), but this is not significantly higher than the percentage of control RGCs with 
this morphology (11.1 ± 4.9%, p>0.8 Student’s T-Test for 2-tailed data of unequal 
variance). This suggests that, unlike contact with an endogenous ephrin-A-expressing 
cell (see section 3.2.2), stimulation with soluble ephrin-A5-Fc does not cause loss of 
lamella independent of loss of filopodia.
Analysis of individual RGCs by time-lapse microscopy reveals that the response of a 
RGC to ephrin-A5-Fc is extremely rapid (Fig 3.11). The RGC growth cone lamella 
has already begun to collapse 2 min after addition of ephrin-A5-Fc (Fig 3.11 
arrowheads) and is completely lost by 2.5 min. After the lamella is completely lost 
the axon begins to retract (Fig 3.11). On average the lamella of an ephrin-A5 
stimulated RGC is completely lost by 2.47 ± 0.49 min (n=6). The axon retraction is 
slightly delayed, beginning on average 2.58 ± 0.57 min after ephrin addition. 
Examination of each individual RGC reveals that in the majority (83.3%) of cases 
the lamella has been lost completely before the axon begins to retract (n=6),
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Figure 3.11. Soluble ephrin- A5-Fc induces rapid loss of RGC growth
cone lamella, followed by axon retraction.
Time-lapse stills showing that stimulation with clustered ephrin-A5-Fc (lpg/m l) 
induces rapid loss of RGC growth cone lamella and filopodia, and axon retraction. 
Within 2 min of ephrin-A5 addition the growth cone lamella begins to collapse 
(arrowheads), and by 2.5 min the lamella is completely lost. After the RGC growth 
cone lamella is completely lost the axon begins to retract, and as it does most of the 
growth cone filopodia are dragged away, leaving behind only a few retraction fibres, 
which were initially filopodia (arrows). Scale bar = 20pm
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similar to the sequential response seen in RGC growth cones following contact with 
a Swiss-3T3 fibroblast.
It is more difficult to quantify the timing of filopodia loss in response to soluble 
ephrin-A5. Filopodia are largely hidden by the lamella of a growth cone prior to 
ephrin-A5-Fc addition (Fig 3.11) making it impossible to compare filopodial 
behaviour before and after ephrin stimulation. It is clear however that most of the 
RGC growth cone filopodia are dragged away as the axon retracts (Fig 3.11, Movie 
3.11). Similar to contact with an ephrin-A-expressing cell, a few retraction fibres, 
which appear to be filopodial in origin, remain as the axon retracts I (Fig 3.11, arrows). 
Axon retraction in response to soluble ephrin-A5-Fc occurs in all cases recorded by 
phase time-lapse microscopy (n=6), and in none of these cases do more than three 
retraction fibres remain after 90s of axon retraction. Although the strict criteria for 
assessing total collapse in fixed cultures does not formally address whether these 
axons have retracted, the above observations suggest that ephrin-A5-Fc-treated RGC 
axons that have 3 or fewer F-actin positive filopodia/retraction fibres (meeting the 
criteria for total collapse) are likely to have retracted.
In order to correlate the repulsive RGC response to ephrin-A5-Fc with neuronal Eph 
receptor activation, I have blotted RGC lysates with the antibody raised against Eph 
receptors phosphorylated at the juxtamembrane tyrosine residues. This antibody 
detects a major band at around llOkD, which correspond to full-length 
phosphorylated Eph receptors (Becker et al., 1995), as well as minor bands at around 
50kD (Fig 3.12A, see also Fig 4.10). These lower bands are likely to be degradation 
products, as they are induced with the same time course as the major band (Fig 3.12). 
Stimulation of isolated RGCs in culture with clustered ephrin-A5-Fc induces a rapid 
and sustained increase in Eph receptor phosphorylation (Fig 3.12A). RGC Eph 
receptors are substantially activated after 2 min of ephrin-A stimulation, at which 
time RGCs begin to lose their growth cone lamella (Fig 3.11). RGC lysates were also 
blotted with an anti-tubulin antibody to control for protein levels (Fig 3.12B).
3.3. Discussion.
In Chapter 3 I have described a robust and reproducible assay with which to 
investigate the response of an individual nasal RGC growth cone to contact with a 
single Swiss-3T3 fibroblast that expresses endogenous ephrin-A. The RGC response
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3.12. Stimulation of isolated RGCs with ephrin-A5-Fc 
rapid and sustained activation of Eph receptors.
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Isolated RGCs in culture were treated with anti-Fc as a control (C) or stimulated with 
clustered ephrin-A5-Fc (lpg/m l) for the time indicated. Cells were lysed with RIPA 
buffer and lysates were separated by SDS-PAGE and blotted with anti-phospho-Eph 
receptor antibody (A) to monitor receptor activation. Stimulation with ephrin-A5 
results in rapid and sustained increase in Eph receptor phosphorylation. Cell lysates 
were blotted with anti-tubulin antibody (B) as a control for protein levels.
It should be noted, as mentioned in section 2.4, the anti-phospho-Eph receptor 
antibody used was not affinity purified against the phosphopeptide, and therefore the 
bands shown here may also reflect increased phosphorylation o f other proteins.
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to contact with a Swiss-3T3 fibroblast consists of rapid loss of RGC growth cone 
lamella, which is often followed by axon retraction. Contact with a Swiss-3T3 
fibroblast induces activation of Eph receptors on the RGC growth cone, and 
disruption of the EphA-ephrin-A interaction prevents the contact-induced loss of 
RGC growth cone lam eteand axon retraction. Contact with a cell type that does not 
express ephrin-As results in a much-reduced incidence of lamellae loss and axon 
retraction, and overexpression of ephrin-A5 in this cell type is sufficient to induce 
the repulsive response. Together the data presented in this chapter demonstrate that 
RGC EphA signalling mediates a series of distinct cellular events induced by contact 
with a Swiss-3T3 fibroblast. The assay described in this chapter allows detailed 
analysis of nasal RGC behaviour in response to an individual endogenous ephrin-A- 
expressing cell, which is physiologically relevant since ephrin-As are membrane 
tethered in vivo. Therefore this novel assay, used in conjunction with the traditional 
soluble collapse assay, provides a powerful tool with which to identify signalling 
pathways that mediate the distinct events that comprise the repulsive response; loss 
of RGC lamella, and subsequent loss of filopodia and axon retraction.
3.3.1. Comparison with previous studies of contact-mediated RGC 
collapse.
The repulsive response of a nasal RGC to contact with a Swiss-3T3 fibroblast 
consists of a series of temporally distinct events. The RGC growth cone lamella 
rapidly collapses, and in many cases this is followed by axon retraction concomitant 
with loss of filopodia. Analysis of contact-induced RGC responses in this detail has 
not been described previously, as published studies do not separate these events 
(Davenport et al., 1996; Davenport et al., 1998; Davenport et al., 1999; Thies and 
Davenport, 2003). The nasal RGC response to contact with a Swiss-3T3 fibroblast 
described in this chapter can be compared to previous reports from Roger Davenport 
and colleagues describing the behaviour of temporal RGCs following contact with 
isolated tectal cells (Davenport et al., 1996; Davenport et al., 1998; Davenport et al., 
1999; Thies and Davenport, 2003). In these studies the authors report that contact 
with isolated chick tectal neurons induces around 80% of temporal RGC axons to 
retract while nasal RGCs are unresponsive (Davenport et al., 1996; Davenport et al., 
1999; Thies and Davenport, 2003). In this chapter I demonstrate that 43.3% of nasal
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RGC axons retract in response to contact with a Swiss-3T3 fibroblast. Temporal 
RGCs in culture express higher levels of EphA3 than nasal axons, and are more 
sensitive to ephrin-A2 and ephrin-A5, both of which are expressed by the tectal 
neurons that induce temporal RGC axon retraction (Davenport et al., 1996; 
Davenport et al., 1998; Monschau et al., 1997; Nakamoto et al., 1996). I could not 
determine which members of the ephrin-A family Swiss-3T3 fibroblasts express 
under co-culture conditions. It is possible that a combination of differential EphA 
receptor expression on nasal and temporal RGC axons, and a different complement 
of ephrin-As expressed on the contacting cell accounts for the differences in the 
frequency of axon retraction reported in this chapter and the published studies. 
However, it is important to note that the authors of the published studies have not 
addressed whether the repulsive RGC response they describe is mediated by Eph- 
ephrin interaction.
The repulsive axonal guidance cue RGM (repulsive guidance molecule), which is 
unrelated to the ephrins, is expressed in an increasing anterior to posterior gradient in 
the chick tectum (Monnier et al., 2002). RGM is expressed on isolated chick tectal 
neurons in vitro [B.K. Muller, unpublished observations reported in (Muller et al., 
1996)], and temporal but not nasal RGC axons in vitro are repelled by both soluble 
and substrate-bound RGM (Monnier et al., 2002; Muller et al., 1996). The repulsive 
response of temporal RGCs to contact with chick tectal neurons, described by Roger 
Davenport and colleagues, may therefore be the result of signalling pathways 
induced by RGM, instead of, or in addition to, ephrin-As. In this chapter I have 
demonstrated that addition of EphA5-Fc to the bathing medium of RGCs and Swiss- 
3T3 fibroblasts in co-culture, which will disrupt EphA-ephrin-A interaction at sites 
of cell-cell contact (Marcus et al., 2000), completely abolishes nasal RGC axon 
retraction in response to contact with a fibroblast. Together with the observation that 
MDCK cells induce very little axon retraction unless they over-express ephrin-A5, 
this provides strong evidence that nasal RGC axon retraction in response to Swiss- 
3T3 fibroblast, although occurring at a lower frequency than the temporal axon 
retraction induced by contact with a tectal neuron, is entirely mediated by this EphA- 
ephrin-A interaction. Given that contact-induced loss of RGC lamellatis similarly 
dependent on EphA-ephrin-A interaction, the RGC repulsive response to contact 
with a Swiss-3T3 fibroblast described in this chapter provides a robust, reproducible
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and physiologically relevant assay with which to study the signalling pathways that 
mediate the neuronal responses to ephrin-A stimulation.
3.3.2. The contact-induced responses in the ephrin-A expressing cell 
are not a result of EphA or ephrin-A signalling
Approximately half of RGC-Swiss-3T3 interactions result in withdrawal of the 
fibroblast at the site of cell-cell contact. There are several reasons why it is unlikely 
that reverse signalling through ephrin-A ligands expressed on the surface of the 
Swiss-3T3 fibroblast meditates this withdrawal response. Withdrawal of MDCK 
cells, which do not express ephrin-As, also occurs in around 50% of interactions with 
RGCs, and expression of ephrin-A5 does not increase the incidence of MDCK cell 
withdrawal, in fact it reduces the MDCK response (Table 3.2). Activation of ephrin- 
A signalling in fibroblasts promotes cellular protrusion (Davy and Robbins, 2000), 
suggesting that activation of ephrin-A-mediated signalling following contact with a 
RGC would not result in withdrawal of the contacting cell. RGCs in culture express 
ephrin-As (Homberger et al., 1999) and both Swiss-3T3 fibroblasts (C.D. Nobes 
unpublished data) and MDCK cells (Miao et al., 2003) in culture express endogenous 
EphA receptors, but addition of EphA5-Fc to the bathing medium does not 
significantly reduce the percentage of Swiss-3T3 fibroblasts that withdraw after 
contact with a RGC (Table 3.2). This suggests that neither ephrin-A- nor EphA- 
mediated signalling is responsible for the non-neuronal cell response, and therefore 
this response is not a suitable assay with which to investigate these signalling 
pathways.
3.3.3. Comparison between the RGC response to soluble and 
membrane-tethered ephrin-A.
Ephrin-As are membrane-tethered molecules in vivo (Gale et al., 1996b; Pandey et 
al, 1995a), and therefore the co-culture assay described in this chapter is a more 
physiologically relevant assay with which to study the RGC response to stimulation 
with ephrin-A than the traditional soluble collapse assay. However, the soluble 
collapse assay has an advantage in that it can be used to check for cell autonomy in 
the effect of pharmacological inhibitors. Overall the RGC response to soluble ephrin- 
A5-Fc is very similar to that induced by contact with a Swiss-3T3 fibroblast, and
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therefore the soluble collapse assay can be used in combination with the novel co­
culture assay described in this chapter to identify signalling molecules that mediate 
the various aspects of the RGC response to ephrin-A. The only significant difference 
between the RGC response to soluble ephrin-A5-Fc and contact with a Swiss-3T3 
fibroblast is that stimulation with soluble ephrin-A5-Fc induces loss of RGC growth 
cone lamellae, and axon retraction more rapidly. It is possible that this difference 
reflects a variation in the ligands that induce the repulsive response, because I could 
not determine which members of the ephrin-A family Swiss-3T3 fibroblasts express 
under co-culture conditions. Of the ephrin-A ligands tested to date however, only 
ephrin-A5 induces significant growth cone collapse of nasal RGCs in vitro (Menzel 
et al., 2001; Monschau et al., 1997), which might suggest that the complement of 
ephrin-As expressed by Swiss-3T3 fibroblasts in culture includes ephrin-A5.
It is possible that lp.gml'1 soluble ephrin-A5 is a higher effective concentration of 
ligand that that presented on the surface of a cell that expresses endogenous levels of 
ephrin-A, such as a Swiss-3T3 fibroblast. Chick RGCs in vivo express multiple 
EphA receptors, and to date expression of three of these has been demonstrated in 
vitro (Connor et al., 1998; Holash and Pasquale, 1995; Monschau et al., 1997). It is 
possible that a high concentration of ephrin-A5 may activate additional, lower 
affinity EphA receptor to those activated by endogenous levels of ephrin-A presented 
on the surface of a Swiss-3T3 fibroblast, and thus cause an amplified and more rapid 
response. However, MDCK-ephrin-A5 cells express much higher levels of ephrin-A 
expression than Swiss-3T3 fibroblasts, since surface ephrin-A5 is easily detected 
using an anti-ephrin-A5 antibody (Fig 3.9C). Contact with an MDCK-ephrin-A5 cell 
does not result in a significantly faster lamellae.collapse (p>0.3) or axon retraction 
(p>0.6) compared to contact with a Swiss-3T3 fibroblast, which suggests that 
differences in the effective ephrin-A concentration does not account for the 
difference in the latency of RGC response to soluble and membrane bound ephrin-A.
Stimulation of RGCs with ephrin-A2 and ephrin-A5 leads to increased fluid phase 
endocytosis with a time-course that matches ephrin-induced growth cone collapse 
(Fournier et al., 2000; Jurney et al., 2002). Blocking the activity of Rac, which 
prevents this ephrin-induced endocytosis, also inhibits ephrin-induced growth cone 
collapse, and the authors suggest that endocytosis is required for loss of growth cone 
structures during the neuronal response to repulsive axon guidance cues (Jumey et
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al., 2002). It has also been shown that following contact with an EphA-expressing 
axon ephrin-A2 is proteolytically cleaved from the surface of a transfected cell, and 
is internalised by the axon during subsequent axon retraction (Hattori et al., 2000). 
Cleavage of membrane-bound ephrin-A2 commences 10 min after EphA binding, 
and, although it must be noted that uptake of soluble ephrin-A was not measured in 
the published studies, fluid phase endocytosis was stimulated within 5 min of soluble 
ephrin-A addition (Hattori et al., 2000; Jumey et al., 2002). If endocytosis of ephrin- 
A is necessary to induce the loss of RGC growth cone lamella and axon retraction 
described in this chapter, the more rapid response to soluble versus membrane bound 
ephrin-A may reflect the fact that soluble ephrin-A can be internalised more quickly 
than membrane bound ephrin-A, which may need to be cleaved first. Soluble ephrin- 
A5 added to the bathing medium has the potential to simultaneously bind EphA 
receptors all over the growth cone, as well as available EphA receptors along the 
RGC axon shaft. Global EphA activation and/or ephrin-A internalisation at multiple 
sites simultaneously may contribute to the more rapid repulsive response to soluble 
ephrin-A-5.
The slightly slower response of RGCs to contact with a Swiss-3T3 fibroblast reveals 
distinct cellular events that are difficult to separate in response to soluble ephrin-A. 
Since ephrin-As are membrane bound in vivo, the cellular responses to endogenous 
ephrin-A on the surface of a Swiss-3T3 fibroblast are likely to reflect the 
physiological consequences of neuronal EphA receptor activation. In support of this 
idea, in vivo analysis of RGC behaviour at the optic chiasm, where repulsion by 
ephrin-As is thought to contribute to RGC axon guidance, reveals dynamic extension 
and retraction of filopodia and lamella, and periods of axon extension and retraction 
(Godement et al., 1994; Marcus et al., 2000). The novel RGC-Swiss-3T3 co-culture 
assay described in this chapter allows quantification of the various aspects of the 
RGC response to stimulation with ephrin-A and, used in conjunction with the soluble 
collapse assay, will provide a powerful tool with which to investigate the signalling 
pathways that mediate loss of growth cone lamellae and axon retraction during the 
RGC response to stimulation with ephrin-A.
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Chapter 4. The roles of ROCK and Src 
family kinases in ephrin-A-induced 
RGC repulsive responses.
4.1. Introduction.
Numerous signalling proteins and adaptor molecules that interact with Eph receptors 
in an activity-dependent manner have been identified (see section 1.5), but the signal 
transduction pathways downstream of Eph receptors remain far from fully 
characterised. In an effort to identify signals involved in the repulsive RGC response 
to membrane-bound ephrin-A, I have concentrated on two potential signalling 
intermediates previously implicated in axon guidance and Eph receptor signalling, 
the RhoA-associated kinase, ROCK, and members of the Src family of non receptor 
tyrosine kinases.
Rho family GTPases are major regulators of the actin cytoskeleton, and have 
important roles in axon guidance (Dickson, 2002). In particular Rho activity has been 
linked to repulsive axon guidance mediated by ephrin-A, since the level of active 
Rho in RGCs increases following stimulation with soluble ephrin-A5 (Wahl et al., 
2000). One possible mechanism for this increase is via the guanine exchange factor 
(GEF) Ephexin, which binds to EphA4 (Shamah et al., 2001). In vitro Ephexin 
catalyses RhoA guanine nucleotide exchange, and a dominant negative form of 
Ephexin, which cannot increase Rho activity, inhibits ephrin-A-induced collapse of 
rat RGC growth cones (Shamah et al., 2001).
ROCK, an effector of Rho, directly phosphorylates the regulatory light chain of 
myosin II (myosin light chain, MLC), and this leads to the assembly of contractile 
actin-myosin filaments (Amano et al., 1996; Citi and Kendrick-Jones, 1987). 
Expression of a constitutively active mutant of ROCK is sufficient to induce neurite 
retraction (Amano et al., 1998) and inhibiting the activity of Rho or ROCK in chick 
RGCs, with C3 toxin or the pharmacological inhibitor Y27632 respectively, has been 
shown to inhibit the growth cone collapse induced by soluble ephrin-A5 (Cheng et
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al., 2003; Wahl et al., 2000). Interestingly, expression of dominant negative Ephexin 
inhibits ephrin-A-induced growth cone collapse less than inhibition of Rho and Rock 
(Shamah et al., 2001; Wahl et al., 2000), suggesting that an additional mechanism 
may modulate the Rho-ROCK pathway in RGCs in response to ephrin-A.
Genetic manipulation in Drosophila has provided evidence that the Rho-ROCK- 
MLC pathway is involved in axon retraction in vivo, and that this pathway is 
negatively regulated by pl90RhoGAP (Billuart et al., 2001). Interestingly reducing 
Src expression suppresses the axon retraction phenotype seen in pl90RhoGAP 
mutants, suggesting that Src activity may positively regulate Rho dependent axon 
retraction in vivo (Billuart et al., 2001).
Src is enriched in the axon tracts and growth cone membrane fractions of RGCs in 
vivo, and both Src and Fyn are expressed in growth cones of chick RGCs in culture 
(Burden-Gulley and Lemmon, 1996; Maness et al., 1988; Sorge et al., 1984). EphA4, 
which is expressed by chick RGCs in vitro and is required for the repulsive response 
of nasal RGC axons to ephrin-A5 (Monschau et al., 1997; Walkenhorst et al., 2000), 
interacts with Fyn in vitro and in whole cells (Ellis et al., 1996; Prevost et al., 2002). 
Ephrin-stimulation of a variety of cell types, including primary neurons, in culture 
results in an increase in Src and Fyn activity (Sharfe et al., 2003; Steinle et al., 2002; 
Takasu et al., 2002; Vindis et al., 2003) and Src kinases have been functionally 
linked to Eph receptor signalling, since pharmacological inhibition of Src kinase 
activity inhibits ephrin-induced migration of endothelial cells (Steinle et al., 2002; 
Vindis et al., 2003).
RGC growth cone collapse in response to tectal membranes involves co-ordinated 
regulation of the actin cytoskeleton and cell-matrix adhesions (Cox et al., 1990), and 
recently it has been shown that ECM molecules can influence the RGC response to 
ephrin-A5 (Weinl et al., 2003). Since Src family kinases are known to play a role in 
the turnover of focal adhesions and mediating integrin signals (Carragher et al., 
2001; Cary et al., 1999; Fincham et al., 1995; Fincham and Frame, 1998; Webb et 
al., 2004), they are good candidates for mediating or regulating the repulsive RGC 
response to ephrin-A stimulation.
In an effort to characterise the signalling pathways downstream of EphA receptors I 
have used specific inhibitors of ROCK (Y27632) and Src family kinases (PP2), to
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investigate the role of these signalling molecules in the ephrin-induced RGC 
repulsive response. I have determined the effect of these inhibitors on the behaviour 
of RGC axons following contact with an ephrin-A-expressing Swiss 3T3 fibroblast, 
and after stimulation with soluble ephrin-A5, and demonstrate that while ROCK is 
involved in ephrin-A-induced axon retraction, it does not mediate ephrin-A-induced 
loss of lamella. By contrast it appears that Src family kinase activity is not required 
for ephrin-A-induced growth cone collapse and axon retraction.
4.2. Results.
4.2.1. The ROCK inhibitor Y27632 prevents RGC axon retraction, 
but not loss of| lamellae in response to contact with an ephrin-A- 
expressing cell.
To determine the role of ROCK activity in the repulsive response of RGCs to 
stimulation with membrane-bound ephrin-As I have investigated the effect of 
Y27632 on the behaviour of RGCs in response to contact with Swiss 3T3 fibroblasts, 
which endogenously express ephrin-As (see Chapter 3). Y27632 is a specific 
inhibitor of ROCK activity, with a similar IC50 for both ROCK isoforms (Ishizaki et 
al., 2000; Uehata et al., 1997). Treatment of RGCs with lOpM Y27632 for 1 hour 
results in complete inhibition of ROCK activity in these cells, assayed by 
phosphorylation levels of MLC (Wahl et al., 2000). Co-cultures of retinal explants 
and Swiss 3T3 fibroblasts were therefore incubated with lOpM Y27632 for 1-2 hours 
prior to cell-cell contact in order to address the role of ROCK during the repulsive 
RGC response to ephrin-A.
An example of the interaction between a RGC growth cone and an ephrin-A- 
expressing fibroblast following incubation with Y27632 is shown in Fig 4.1 and 
Movie 4.1. Following contact with the fibroblast the RGC growth cone continues to 
advance for several minutes before the lamella begins to retract (Fig 4.1 arrowheads). 
The growth cone lamella is completely lost by 10 min post-contact, and following 
loss of lamella the axon ceases to advance (Fig 4.1). Inhibition of ROCK does not 
inhibit the loss of RGC growth cone lamellae in response to contact with an ephrin-A-
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Figure 4.1 The ROCK inhibitor Y27632 prevents RGC axon retraction 
but not loss of growth cone lamella in response to contact with an 
ephrin-A-expressing fibroblast.
Time-lapse stills showing that Y27632 prevents RGC axon retraction, but not loss of 
lamella, in response to contact with an ephrin-A-expressing Swiss-3T3 fibroblast. 
Y27632 (lOpM) was added 1-2 hours prior to cell contact and times shown are 
relative to initial contact. Following contact with the fibroblast, the RGC growth cone 
continues to advance a short distance before the lamella begins to collapse at around 
5 minutes post-contact (see arrowheads). The RGC growth cone lamella is not 
completely lost until 10 minutes after contact, significantly delayed compared to 
control (see text). The RGC axon does not retract within 15 minutes of contact, and 
retains filopodia over this period (see arrows). Scale bar = 20pm.
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Table 4.1
Cell type and treatment RGCs showing loss of RGCs showing axon
(n) lamella within 20 min retraction within 20
of contact. min of contact.
Swiss 3T3 fibroblast (30) 83.3% 43.3%
Swiss 3T3 fibroblast + 93.3% 6.7%
Y27632 (15)
expressing fibroblast; 93.3% of Y27632-treated RGCs lose lamellae,within 20 min of 
contact with a Swiss-3T3 fibroblast, compared with 83.3% of control, untreated 
axons (see Table 4.1, p>0.8; Fisher’s exact test for independence). Treatment with 
Y27632 does however delay the RGC loss of lamellaein response to contact with an 
ephrin-A-expressing fibroblast. On average complete loss of Y27632-treated RGC 
lamellaeoccurs at 11.2 ± 4.6 min (n=15) compared with 5.9 ± 2.6 min for control 
RGCs (n=25, p<0.001; Student’s T-Test for 2-tailed data of unequal variance).
The Y27632-treated RGC axon shown in Fig 4.1 retains filopodia following lamella 
loss (Fig 4.1 arrows). As discussed in Chapter 3 the presence of filopodia following 
ephrin-A stimulation correlates with lack of axon retraction, and Fig 4.1 
demonstrates that Y27632 prevents RGC axon retraction within 15 min of contact 
with an ephrin-A-expressing fibroblast. Quantification of 15 RGC-fibroblast 
interactions in the presence of Y27632 reveals that only 6.7% of Y27632-treated 
axons retract within 20 min of contact with an ephrin-A-expressing fibroblast, 
compared with 43.3% of control axons (see Table 4.1, p<0.02; Fisher’s exact test for 
independence). Since the presence of Y27632 significantly delays ephrin-A-induced 
loss of RGC lamella, it is possible that axon retraction is similarly delayed. Not all 
RGC-fibroblast interactions in the presence of Y27632 were recorded for longer than 
20 min, but the interaction shown in Fig 4.2 is an example filmed over a greater 
period of time. Although the RGC lamella is completely lost 10 min after contact the 
axon does not retract up to 40 min after contact with the ephrin-A-expressing 
fibroblast, and retains filopodia over this time course (Fig 4.2 arrows). Of the 9 
Y27632-treated RGC-fibroblast interactions recorded beyond 20 min after initial
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Figure 4.2 The Y27632-dependent inhibition of axon retraction is not 
the result of a delayed RGC response to contact with an ephrin-A- 
expressing fibroblast.
Time-lapse stills showing that RGC axon retraction is not delayed following contact 
with an ephrin-expressing Swiss-3T3 fibroblast. Y27632 (10pM) was added 1-2 
hours prior to cell contact and times shown are relative to initial contact. RGC lamella 
loss is not complete until 10 minutes after contact, but the RGC axon does not retract 
within 40 minutes, and the RGC retains filopodia throughout the period of contact 
with the fibroblast cell (see arrows). Scale bar = 20pm.
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contact, 8 do not result in axon retraction within the duration of recording (30-45 min 
post contact), although all lose lamella within 12 min. Together these data 
demonstrate that inhibition of ROCK prevents axon retraction, and delays but does 
not prevent loss of RGC lamella in response to stimulation with membrane-tethered 
ephrin-A.
4.2.2. The ROCK inhibitor Y27632 prevents ephrin-A5-Fc-induced 
loss of RGC filopodia and axon retraction.
It has previously been reported that Y27632 significantly reduces the percentage of 
RGC axons that lose both lamellae and filopodia in response to soluble ephrin-A5 
(Cheng et al., 2003; Wahl et al., 2000). As described above, Y27632 specifically 
inhibits loss of filopodia, but not lamella^ in response to membrane tethered ephrin- 
A. In order to determine whether this effect of Y27632 is conserved in the response 
of RGC growth cones to stimulation with soluble ephrin-A5, and to confirm that the 
effects of Y27632 are RGC-autonomous, I have investigated the effect of Y27632 on 
the loss of RGC lamella or filopodia, or both, following addition of ephrin-A5-Fc.
Typical examples of the actin morphology of RGC growth cones treated with ephrin- 
A5-Fc and/or Y27632 are shown in Fig 4.3. Incubation with 10p,M Y27632 (Fig 
4.3b) has no effect on the actin morphology of RGC growth cones compared to 
control (Fig 4.3a); both have spread lamellae and filopodia. Stimulation of RGCs with 
ljxgmT1 ephrin-A5-Fc for 10 min induces the loss of growth cone lamellae,and 
filopodia (Fig 4.3c). Although the ephrin-A5-induced loss of lamella is not inhibited 
by Y27632 treatment, the growth cone retains filopodia (Fig 4.3d), and therefore, as 
discussed in Chapter 3, is unlikely to have retracted.
Quantification of the effect of ROCK inhibition on the response of RGCs to 
stimulation with soluble ephrin-A5 is shown in Fig 4.3e. Incubation with Y27632 
does not affect growth cone morphology, since the percentage of axons with a full 
growth cone is not significantly changed (71.5 ± 3.4% of Y27632-treated RGCs 
compared with 76.8 ± 6.0% of control, p>0.1; Student’s T-Test for 2-tailed data of 
unequal variance). As shown in Chapter 3, stimulation with ephrin-A5-Fc (lp g m l1) 
for 10 min induces total collapse (loss of growth cone lamellae and filopodia) in the 
majority (76.1 ± 4.2%) of RGC axons (Fig 4.3e). Pre-treatment of RGCs with 
Y27632 (10pM) for 20 min significantly rescues the percentage of axons that exhibit
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Figure 4.3 The ROCK inhibitor Y27632 does not prevent the loss of 
RGC growth cone lamellae in response to soluble ephrin-A5, but does 
prevent loss of growth cone filopodia.
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Y27632 inhibits ephrin-A5-Fc-induced loss of RGC filopodia but not loss of lamella. 
Phalloidin staining shows that RGCs treated with anti-Fc control have full growth 
cones with spread lamella and filopodia (a). Treatment with Y27632 (10pM) alone 
for 1 hour has no effect on the f-actin morphology of growth cones (b). Stimulation 
with clustered ephrin-A5-Fc ( ljug/ml) for 10 minutes triggers loss of growth cone 
lamella and filopodia (c). Y27632 prevents the loss of filopodia in response to 
ephrin-A5, but does not prevent the loss of lamella (d). Quantification of the effect 
of Y27632 on ephrin-A5-treated RGCs demonstrates that pre-treatment with 
Y27632 (lOpM 1 hour) significantly reduces the percentage of RGCs that lose both 
filopodia and lamella (Total collapse) in response to stimulation with ephrin-A5-Fc 
(l(lg/ml) for 10 minutes (e, * p < 0.0001, student’s T-test for 2-tailed data of unequal 
variance). The majority (58.7 ± 4.6%) of Y27632-treated RGCs lose lamella but not 
filopodia following stimulation with-A5.
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total collapse (28.5 ± 3.4%, p<0.0001; Student’s T-Test for 2-tailed data of unequal 
variance, see Fig 4.3e). Instead of having a full growth cone however, the majority 
(58.7 ± 4.7%) of Y27632-treated RGCs lose lamellatbut retain filopodia in response 
to ephrin-A5 stimulation (Fig 4.3e), a response seen in only 14.1 ± 3.0% of RGCs 
stimulated with ephrin-A5 alone (p<0.0001; Student’s T-Test for 2-tailed data of 
unequal variance). These data demonstrate that inhibiting ROCK activity prevents 
total collapse of RGC growth cones in response to stimulation with soluble ephrin- 
A5. They also provide strong evidence that Y27632 inhibits ephrin-A5-induced 
growth cone collapse by preventing loss of filopodia and axon retraction, but does 
not prevent ephrin-A5-induced loss of RGC lamellae.
In response to soluble ephrin-A5, RGCs lose lamellae-entirely before losing filopodia 
and retracting (Chapter 3). It is therefore possible that Y27632 delays the cellular 
response to ephrin-A5 stimulation, revealing an intermediate stage of ephrin-A5- 
induced collapse in Y27632-treated RGC axons. To address this issue I have 
investigated the effect of Y27632 on the response of RGCs to 30 min stimulation 
with ephrin-A5. Longer incubations with anti-Fc antibodies (as a control) have no 
effect on the actin morphology of untreated (Fig 4.4a) and Y27632-treated (Fig 4.4b) 
RGCs. The actin morphology of RGCs treated with ephrin-A5-Fc for 30 min is 
similar to 10 min stimulation, since the RGCs lose both lamella and filopodia (Fig 
4.4c). Following 30 min stimulation with ephrin-A5, Y27632-treated RGCs 
completely lose lamella, but still retain filopodia, demonstrating that ephrin-A5-Fc- 
induced loss of growth cone filopodia, is prevented by inhibiting ROCK, not simply 
delayed. Quantification of these experiments confirms this conclusion (Fig 4.4e). 
Y27632 significantly reduces the percentage of RGCs that totally collapse in 
response to ephrin-A5 (21.7 ± 1.0%) compared with RGCs stimulated with ephrin- 
A5 alone (73.5 ± 4.3, p<0.004; Student’s T-Test for 2-tailed data of unequal 
variance). The majority (59.7 ± 4.3%) of Y27632-treated RGCs lose lamella but 
retain filopodia in response to ephrin-A5, compared to 9.7 ± 4.3% of RGC axons 
treated with ephrin-A5 alone (p<0.002; Student’s T-Test for 2-tailed data of unequal 
variance).
Although the persistence of RGC growth cone filopodia following ephrin-A5 
addition correlates with lack of axon retraction (see Chapter 3), the above data do not 
conclusively prove that inhibiting ROCK activity prevents RGC axon retraction in
125
Figure 4.4 The ROCK inhibitor Y27632 does not prevent the loss of 
RGC growth cone lamellae in response to soluble 30 min stimulation 
with ephrin-A5, but does prevent loss of growth cone filopodia.
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Y27632 does not delay ephrin-A5-induced loss of RGC filopodia. Phalloidin staining 
shows that control (a) and Y 27632-treated (b) RGCs treated with anti-Fc control for 
30 minutes have full growth cones with spread lamella and filopodia 30 minutes after 
addition of anti-Fc as control. 30 minutes stimulation with ephrin-A5 (lpg/m l) 
triggers loss of growth cone lamella and filopodia (c). Y27632 prevents the loss of 
filopodia, but not lamella, following 30 minutes stimulation with-ephrin-A5 (d). 
Quantification of the effect of Y27632 on ephrin-A5-treated RGCs demonstrates that 
pre-treatment with Y27632 (lOpM ) significantly reduces the percentage of RGCs 
that lose both filopodia and lamella (Total collapse) in response to 30 minutes 
stimulation with ephrin-A5-Fc (lpg/m l) (e, * p < 0.004, student’s T-test for 2-tailed 
data of unequal variance). After 30 minutes stimulation with ephrin-A5 the majority 
(59.7 ± 4.2%) of Y27632-treated RGCs lose lamella but not filopodia.
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response to soluble ephrin-A5. Time-lapse stills showing the response of a Y27632- 
treated RGC axon to stimulation with lpgm r1 ephrin-A5-Fc are shown in Fig 4.5. 
Following ephrin-A5 addition the RGC growth cone lamella is lost, although this is 
delayed compared to control RGC growth cones. On average Y27632-treated RGCs 
completely lose lamella 6.1 ± 1.4 min after ephrin-A5 addition (n=6) compared to 
2.5 ± 0.5 min in the control situation (n=6, p<0.001; Student’s T-Test for 2-tailed 
data of unequal variance). Despite the loss of lamellaethe RGC axon retains filopodia 
(Fig 4.5 arrows), and the axon fails to retract even after 16 min after ephrin-A5 
addition (Fig 4.5). Of the 6 Y27632-treated RGC axons filmed, none retract within 
15 min of ephrin-A5 stimulation, whereas all 6 control RGC axons retract within 3.5 
min of ephrin-A5 addition (p<0.003, Fisher’s exact test of independence). Taken 
together, the above data demonstrate that ROCK activity mediates ephrin-A-induced 
RGC axon retraction, but not loss of lamella^ in response to both soluble and 
membrane-tethered ephrin-A.
4.2.3. The Src family kinase inhibitor PP2 does not prevent the RGC 
repulsive response to contact with an ephrin-A-expressing cell.
In order to investigate the role of Src family kinases in the RGC repulsive response 
to stimulation with ephrin-A, I have used PP2, a selective inhibitor of Src kinases 
(Hanke et al., 1996). Treatment of primary neurons in culture with 10p.M PP2 
completely inhibits phosphorylation of endogenous Src family substrates, and this 
concentration of PP2 has been used to implicate Src kinases in a variety of signalling 
pathways that influence the neuronal cytoskeleton (Crossthwaite et al., 2004; 
Hoffman-Kim et al., 2002; Manzerra et al., 2001; Suter and Forscher, 2001; 
Williamson et al., 2002). Co-cultures of retinal explants and Swiss 3T3 fibroblasts 
were therefore incubated with lOpM PP2 for 20-30 min prior to cell-cell contact.
An example of the interaction between a RGC growth cone and an ephrin-A- 
expressing fibroblast following incubation with PP2 is shown in Fig 4.6. Pre­
treatment with PP2 does not prevent the rapid loss of lamellae in response to contact 
with the fibroblast; the lamella is completely lost by 7 min after contact (Fig 4.6A). I 
have included the image shown in Fig 4.6B, which is a larger field of view at 25 min 
after contact, to demonstrate that the repulsive RGC response is not a result of the 
fibroblast rounding up and detaching. Analysis of 15 RGC-fibroblast interactions
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Figure 4.5 The ROCK inhibitor Y27632 prevents ephrin-A5-induced
loss of RGC filopodia and axon retraction, but not loss of lamella.
Time-lapse stills showing that incubation with Y27632 (lOpM) for 20 minutes prior 
to stimulation with ephrin-A5 (lpg/m l) prevents loss of RGC filopodia and axon 
retraction, but not loss of lamella. Times shown are relative to ephrin-A5 addition. 
The RGC growth cone lamella is completely lost by 5 minutes stimulation with 
ephrin-A5, but the axon does not retract within 16 minutes of stimulation with ephrin. 
The RGC axon retains filopodia following loss of lamella (see arrows). Scale bar = 
20pm
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Figure 4.6. PP2 does not prevent the RGC repulsive response to 
contact with an ephrin-A-expressing fibroblast.
A. Time-lapse stills showing that PP2 does not prevent loss of RGC lamella or axon 
retraction in response to contact with an ephrin-A-expressing fibroblast. PP2 (lOpM ) 
was added 20-30 minutes prior to cell contact and times shown are relative to initial 
contact. The RGC growth cone lamella is completely lost by 7 minutes after contact 
with the fibroblast. The RGC axon begins to retract after 20 minutes of contact 
(arrows), significantly later than in the control situation (see text). B. The Swiss 3T3 
fibroblast is actively migrating following 25 minutes contact with the RGC axon. 
Scale bars = 20pm.
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reveals that 80.0% of PP2-treated RGCs lose lamellaewithin 10 min, compared with 
76.7% of control RGCs (p>0.9 Fisher’s exact test for independence, see Table 4.2). 
The RGC axon in Fig 4.6 does not begin to retract after 20 min of contact (Fig 4.6 
arrows). Pre-treatment with PP2 significantly delays the onset of RGC axon 
retraction induced by contact with an ephrin-A-expressing fibroblast (18.5 ± 6.1 min) 
compared with control (9.27 ± 6.0 min, p<0.002; Student’s T-Test for 2-tailed data of 
unequal variance). Despite this delay, inhibition of Src kinases with PP2 does not 
prevent RGC axon retraction induced by contact with an ephrin-A-expressing 
fibroblast, since 46.6% of PP2-treated axons retract within 20 min of contact 
compared with 43.3% of control axons (p>0.9 Fisher’s exact test for independence, 
see Table 4.2).
4.2.4. PP2 does not inhibit ephrin-A5-induced RGC growth cone 
I collapse.
j
Addition of PP2 to the bathing medium of RGCs and Swiss 3T3 fibroblasts in co­
culture could effect either cell type. In order to confirm that the action of PP2 
specifically within RGCs has no effect on ephrin-A-induced growth cone collapse, 
RGCs were stimulated with soluble ephrin-A5 in the presence and absence of PP2.
Incubation with 10p,M PP2 (Fig 4.7b) has no effect on the actin morphology of RGC 
growth cones compared with control (Fig 4.7a). PP2-treated RGC growth cones lose 
both lamella and filopodia in response to 10 min stimulation with 1 p-gmT1 ephrin-A5 
(Fig 4.7d), similar to RGC growth cones treated with ephrin-A5 alone (Fig 4.7c). 
Quantification of these experiments (Fig 4.7e) confirms that pre-treatment with PP2 
does not significantly reduce the percentage of RGC axons that totally collapse in 
response to ephrin-A5 (70.8 ± 6.9%) compared with ephrin-A5 alone (71.6 ± 7.3%, 
p>0.8; Student’s T-Test for 2-tailed data of unequal variance). These data suggest 
that Src family kinase activity is not required for the RGC repulsive response to 
stimulation with ephrin-A.
4.2.5. PP3 inhibits ephrin-A5-induced RGC growth cone collapse.
While investigating the effect of PP2 on ephrin-A5-induced RGC growth cone 
collapse I used PP3, a structural analogue of PP2 that does not inhibit Src kinases 
(Traxler et al., 1996), as a control. Intriguingly, pre-treatment with PP3 significantly
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Figure 4.7. PP2 does not inhibit ephrin-A5-induced RGC growth 
cone collapse.
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PP2 does not prevent ephrin-A5-Fc-induced loss of RGC growth cone lamella or 
filopodia. Phalloidin staining shows that control (a) and PP2-treated (lOpM  for 20 
minutes {b}) RGCs have full growth cones with spread lamella and filopodia after 
addition of anti-Fc control for 10 minutes. Stimulation with ephrin-A5-Fc (lpg/m l) 
for 10 minutes triggers loss of growth cone lamella and filopodia (c) and this is 
unchanged by pre-treatment with PP2 (d). Quantification of the effect of PP2 on 
ephrin-A5-treated RGCs demonstrates that pre-treatment with PP2 (10pM) has no 
effect on the percentage of RGCs that lose both filopodia and lamella (Total 
collapse) in response to stimulation with ephrin-A5-Fc (lpg/m l) for 10 minutes (e, 
* p >0.8, student’s T-test for 2-tailed data of unequal variance).
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Table 4.2.
Cell type and treatment
(n)
RGCs showing loss of 
lamella within 10 min 
of contact.
RGCs showing axon 
retraction within 20 min 
of contact.
Swiss 3T3 fibroblast (30) 76.7% 43.3%
Swiss 3T3 fibroblast + 
PP2 (15)
80.0% (12) 46.6% (7)
Swiss 3T3 fibroblast + 
PP3 (12)
33.3% (4) 8.3% (1)
inhibits RGC growth cone collapse induced by ephrin-A5-Fc (Fig 4.8). Incubation 
with 10p,M PP3 alone (Fig 4.8b) has no effect on the actin morphology of RGC 
growth cones compared to control (Fig 4.8a) but prevents both loss of lamellae and 
filopodia induced by ephrin-A5-Fc (Fig 4.8c and d). The inhibition of collapse is 
statistically significant; only 22.1 ±3.1% of PP3-treated RGCs exhibit total collapse 
in response to stimulation with ephrin-A5, compared with 71.6 ± 7.3% of RGCs 
treated with ephrin-A5 alone (p<0.007; Student’s T-Test for 2-tailed data of unequal 
variance).
4.2.6. PP3 inhibits the RGC repulsive response to contact with an 
ephrin-A-expressing fibroblast.
In order to determine whether the effects of PP3 are conserved in the response of 
RGCs to contact with ephrin-A-expressing fibroblast, RGCs and Swiss 3T3 
fibroblasts in co-culture were incubated with lOpM PP3 for 20-30 min prior to cell­
cell contact. Fig 4.9 shows an example of a RGC-fibroblast interaction following 
incubation with 10p,M PP3. The RGC growth cone does not lose lamella upon 
contact with the ephrin-expressing fibroblast, but continues to advance. The lamella 
remains intact for greater than 15 min after initial contact with the fibroblast, and the 
RGC axon does not retract within this time. Only 33.3% of PP3-treated RGCs lose 
lamellae within 10 min of contact with an ephrin-expressing fibroblast, compared to 
76.7% of control RGCs (p<0.02 Fisher’s exact test for independence, see Table 4.2),
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Figure 4.8. PP3 inhibits ephrin-A5-induced RGC growth cone 
collapse.
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PP3 prevents ephrin-A5-Fc-induced loss of RGC growth cone lamella and filopodia. 
Phalloidin staining shows that control (a) and PP3-treated (lOpM  {b}) RGCs have 
full growth cones with spread lamella and filopodia after addition of anti-Fc control 
for 10 minutes. Stimulation with clustered ephrin-A5-Fc (lpg/m l) for 10 minutes 
triggers loss of growth cone lamella and filopodia (c). RGCs incubated with PP3 for 
20 minutes prior to stimulation with ephrin-A5 retain both spread lamella and 
filopodia (d). Quantification of the effect of PP3 on ephrin-A5-treated RGCs 
demonstrates that pre-treatment with PP3 (lOpM) significantly reduces the 
percentage of RGCs that lose both filopodia and lamella (Total collapse) in response 
to stimulation with ephrin-A5-Fc (lpg/m l) for 10 minutes (e, * p <0.007, student’s 
T-test for 2-tailed data of unequal variance).
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Figure 4.9. PP3 prevents the RGC repulsive response to contact with 
an ephrin-A-expressing fibroblast.
Time-lapse stills showing that PP3 prevents loss of RGC lamella and axon retraction 
in response to contact with an ephrin-A-expressing fibroblast. PP3 (10pM) was 
added 20-30 minutes prior to cell contact and times shown are relative to initial 
contact. The RGC growth cone lamella is retained for more than 15 minutes after 
contact with the ephrin-expressing fibroblast (arrow), and the axon does not retract. 
Scale bar =20|im.
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and only 8.3% of PP3-treated RGC axons retract within 20 min, compared with 
43.3% of control axons (p<0.04 Fisher’s exact test for independence, see Table 4.2).
4.2.7. Neither PP2 nor PP3 inhibit Eph receptor activity.
Of the known receptor tyrosine kinase families, the ErbB/EGF receptor family is 
most closely related to the Eph receptor family, and the EGFR inhibitor PD153035 
has been shown to inhibit Eph receptor autophosphorylation (Ben-Shlomo et al., 
2003; Sturz et al., 2004). Since PP3 is a known inhibitor of EGF receptor (Traxler et 
al., 1996) it is possible that PP3 inhibits ephrin-A-induced RGC repulsive responses 
by preventing Eph receptor activation. In addition PP2 has recently been shown to 
inhibit EphB4 activity in vitro and in primary endothelial cells (Sturz et al., 2004). I 
have therefore investigated whether PP2 or PP3 inhibit Eph receptor phosphorylation 
in RGCs in response to stimulation with ephrin-A5.
Isolated RGCs were incubated with 10p,M PP2 or PP3 for 20 min prior to stimulation 
with lp g m l1 ephrin-A5 for 10 min. Ephrin-A5 treatment results in phosphorylation 
of Eph receptors, and this phosphorylation is not inhibited by incubation of RGCs 
with 10p,M PP3 (Fig 4.10A) or PP2 (Fig 4.10B). This antibody specifically 
recognises Eph receptor phosphorylation at the conserved juxtamembrane tyrosines, 
which correlates with Eph kinase activity (Binns et al., 2000; Marston et al., 2003; 
Shamah et al., 2001). These data therefore demonstrate that PP3 and PP2 have no 
effect on ephrin-A5-stimulated Eph kinase activity in RGCs.
4.2.8. PP3 inhibits Semaphorin3A-induced DRG growth cone 
collapse.
Since PP3 does not inhibit ephrin-A5-stimulated Eph receptor activity, it must be 
inhibiting the ephrin-A-induced RGC repulsive response by some other mechanism. 
To determine whether the effects of PP3 are specific for the repulsive response 
induced by ephrin-A stimulation, I have investigated the effect of 10p,M PP3 on 
growth cone collapse induced by a repulsive axon guidance cue unrelated to the 
ephrins, Semaphorin3A (Sema3A). E8 chick RGCs do not express the appropriate 
receptors for Sema3A, or collapse in response to Sema3A in vitro (Fournier et al., 
2000; Takagi et al., 1995; Takahashi et al., 1998), whereas Sema3A induces growth 
cone collapse of chick dorsal root ganglion (DRG) neurons in culture Luo et al.,
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Figure 4.10. Neither PP3 nor PP2 inhibits ephrin-A5-induced Eph
receptor activation.
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Isolated RGCs were pre-treated with either inhibitor (lOpM) or carrier for 20 
minutes. RGCs were then stimulated with lpg/m l ephrin-A5-Fc (A5) or anti-Fc 
(Control) for 10 minutes. Cells were lysed with RIPA buffer and lysates were 
separated by SDS-PAGE and blotted with anti-phospho-Eph receptor antibody (A 
and B) to monitor receptor activity or anti-tubulin (C and D) to control for protein 
loading. Stimulation with ephrin-A5 for 10 minutes results in increased receptor 
phosphorylation (A and B, arrows), which is not inhibited by pre-treatment with PP3 
(A) or PP2 (B).
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1995). Fig 4.11 demonstrates that pre-treatment with PP3 significantly inhibits the 
percentage of DRG axons that lose both lamella and filopodia in response to 
stimulation with Sp-gml'1 Sema3A (total collapse; 25.2 ± 5.1%,) compared to 
Sema3A treatment alone (62.0 ± 4.3%, p<0.001; Student’s T-Test for 2-tailed data of 
unequal variance). These data suggest that PP3 has a general effect on neuronal 
signalling pathways that trigger growth cone collapse.
4.3. Discussion.
In Chapter 4 I have presented evidence that inhibition of ROCK activity in RGCs 
specifically prevents RGC axon retraction in response to stimulation with ephrin-A. 
Treatment with the ROCK-specific inhibitor Y27632 prevents RGC axon retraction, 
both in response to contact with an ephrin-A-expressing fibroblast, and to stimulation 
with soluble ephrin-A5-Fc. Loss of RGC growth cone lamella, in response to 
membrane-tethered or soluble ephrin-A is not prevented by treatment with Y27632 
however. The observation that ROCK inhibition does not prevent ephrin-induced 
loss of lamellaeis novel, since previous investigations into the effect of ROCK 
inhibition on ephrin-A-induced RGC growth cone collapse have not classified loss of 
RGC growth cone lamellae.separately from loss of filopodia (Cheng et al., 2003; 
Wahl et al., 2000). In addition I have presented evidence that the Src family kinase 
inhibitor PP2 does not prevent RGC growth cone collapse or axon retraction in 
response to stimulation with ephrin-A. Unexpectedly the structurally related 
compound PP3, which does not inhibit Src family kinases, prevents RGC growth 
cone collapse and axon retraction in response to both ephrin-A and Sema3A.
4.3.1. The ROCK inhibitor Y27632 prevents RGC axon retraction, 
but not loss of lamellae, in response to stimulation with ephrin-A.
The data presented in this chapter demonstrate that treatment of RGCs with 10p.M 
Y27632 prevents axon retraction in response to stimulation with soluble ephrin-A5- 
Fc (Figs 4.3, 4.4 and 4.5). Rho and ROCK have previously been implicated in the 
response of chick RGCs to soluble ephrin-A5 (Cheng et al., 2003; Wahl et al., 2000). 
Wahl and colleagues have reported that incubation of retinal explants with 10p,M 
Y27632 significantly reduces the percentage of RGCs that exhibit growth cone 
collapse in response to stimulation with lp.gml'1 soluble ephrin-A5 (Wahl et al.,
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Figure 4.11. PP3 inhibits Semaphorin3A-induced DRG growth cone
collapse.
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FYe-treatment with PP3 (10|iM) for 20 minutes significantly reduces the percentage 
of DRGs that lose both filopodia and lamella (Total collapse) in response to 
stimulation with Sema3A (5pg/ml) for 10 minutes (e, * p <0.0008, student’s T-test 
for 2-tailed data of unequal variance).
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2000). However the definition of growth cone collapse in the published study is 
complete loss of both filopodia and lamella; the authors did not investigate the loss 
of lamellae versus filopodia, or ephrin-A5-induced axon retraction by time-lapse 
microscopy. The results presented in this chapter agree with the conclusion of the 
Wahl and colleagues, since incubation with Y27632 significantly reduces the 
percentage of RGC growth cones that lose both lamellae and filopodia (“Total 
collapse”) in response to stimulation with soluble ephrin-A5 for 10 or 30 min (Figs 
4.3 and 4.4). I have also extended the conclusions of the published study by 
investigating the response to ephrin-A5 dynamically and in greater detail, to 
demonstrate that the loss of RGC growth cone lamelladn response to ephrin-A5 is 
not inhibited by Y27632, while loss of growth cone filopodia and axon retraction are 
(Figs 4.3,4.4,4.5).
The specific effect of ROCK inhibition on loss of filopodia and axon retraction is 
conserved during the response of RGC growth cones to contact with an ephrin-A- 
expressing fibroblast, arguably a more relevant assay for the study of Eph receptor 
signalling during axon guidance (see Chapter 3). During the course of this thesis a 
related study was published investigating the role of ROCK activity on the behaviour 
of RGC growth cones following contact with posterior tectal neurons (Thies and 
Davenport, 2003). The authors did not address whether the RGC growth cone 
collapse and axon retraction induced by contact with a tectal neuron is due to Eph 
receptor-ephrin interaction, but report that Y27632 reduces the percentage of RGCs 
that lose both lamellae and filopodia following cell-cell contact, as well as the 
incidence of axon retraction, confirming the data I have described in Chapter 4 
(Thies and Davenport, 2003).
ROCK can increase MLC phosphorylation, and thus stimulate it’s ATPase activity, 
directly as well as indirectly by phosphorylating and inactivating MLCP (Amano et 
al., 1996; Kimura et al., 1996). These effects are potentiated by the presence of active 
Rho (Amano et al., 1996; Kimura et al., 1996), and thus ROCK activity is thought to 
mediate the formation of RhoA-induced stress fibres, regulating the contractility of 
non-muscle cells (Fukata et al., 2001). In neuronal cells the Rho-ROCK-MLC 
pathway has been shown to mediate axon retraction. Microinjection of constitutively 
active RhoA or ROCK into neuronal cell lines is sufficient to cause rapid withdrawal 
of neurites, as is injection of a MLC mutant, which mimics phosphorylation by
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ROCK (Amano et al., 1998; Katoh et al., 1998; Kozma et al., 1997). ROCK activity is 
sufficient to trigger neurite retraction under conditions when Rho activity is inhibited, 
demonstrating that ROCK acts downstream of Rho during axon retraction (Katoh et al.,
1998). It must be noted that, although Wahl and colleagues have demonstrated that treatment 
of E7 chick RGCs with lOpM Y27632 for 1 hour is sufficient to completely inhibit ROCK 
activity in these neurons, I have not directly addressed whether ROCK activity is inhibited 
under the conditions used in this chapter. Y27632 also inhibits the Rho-dependent kinases 
PRK1 and PRK2 at similar concentration to ROCK (Amano et al., 1999; Davies et al., 
2000). To date there is no evidence that these kinases play a role in growth cone collapse, 
although they are known regulators of the cytoskeleton.
The Rho family GEF Ephexin is expressed in RGC growth cones, and when co-expressed 
with EphA4 in COS cells, Ephexin increases the proportion of cells that exhibit stress fibres, 
indicative of Rho activation (Shamah et al., 2001). Although the authors did not investigate 
the effect of Eph receptor activation on Ephexin’s GEF activity towards Rho, the observation 
that dominant negative Ephexin inhibits ephrin-A-induced growth cone collapse lead them to 
the conclusion that ephrin-A-induced increase in Rho activity in RGCs is mediated by 
Ephexin (Shamah et al., 2001). Inhibition of Rho and ROCK result in similar levels of 
inhibition of ephrin-A5-induced growth cone collapse (Wahl et al., 2000) suggesting that 
ROCK is the major Rho effector during neuronal repulsive responses to ephrin-A. Since 
ephrin-A5 stimulation of RGCs leads to an increase of active Rho (Wahl et al., 2000) and 
inhibition of ROCK activity prevents ephrin-A-induced RGC axon retraction (Figs 4.1, 4.2,
4.5, Table 4.1) it is likely that ephrin-A stimulation activates the Rho-ROCK-MLC pathway 
to trigger axon retraction. The Rho-ROCK-MLC pathway has been implicated in axon 
retraction induced by G-protein coupled receptor agonists such as lysophosphotidic acid 
(LPA). LPA treatment of NE1-115 neuroblastoma cells increases both Rho activity and 
ROCK-dependent phosphorylation of MLC (Hirose et al., 1998; Kranenburg et al., 1999), 
and inhibition of Rho or ROCK prevents LPA-induced neurite retraction in a number of 
neuronal cell lines (Amano et al., 1998; Hirose et al., 1998; Jalink et al., 1994; Tigyi et al.,
1996). In addition there is evidence that repulsive axon guidance cues other than ephrin-A 
stimulate the Rho-ROCK pathway to trigger growth cone collapse. For example Stimulation 
of Robo-expressing cells with Slit, the ligand for Robo, induces activation of Rho (Wong et 
al., 2001). Expression of dominant negative Rho in Drosophila significantly enhances the 
aberrant CNS axon guidance phenotype in both Slit and Robo mutants (Fan et al., 2003; Fritz 
and VanBerkum, 2002), implying that increased Rho activation may be required for the 
repulsive response to Slit/Robo interaction, although to date this has not been tested directly. 
Activation of PlexinB molecules, receptors for the class 4 Semaphorins, increases the
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cellular levels of active Rho (Aurandt et al., 2002; Hu et al., 2001; Oinuma et al., 
2003; Perrot et al., 2002), and expression of a dominant negative Rho GEF inhibits 
Semaphorin4D-induced growth cone collapse of hippocampal neurons (Swiercz et 
al., 2002). By contrast growth cone collapse induced by Sema3A involves Rac 
signalling (Jin and Strittmatter, 1997; Kuhn et al., 1999; Vastrik et al., 1999) but is 
independent of the Rho-ROCK pathway (Arimura et al., 2000; Goshima et al., 1995). 
Together these data suggest that activation of the Rho-ROCK-MLC pathway is a 
mechanism by which many, but not all, inhibitory axon guidance cues effect their 
repulsive neuronal responses.
4.3.2. The ROCK inhibitor Y27632 prevents loss of RGC growth 
cone filopodia.
Treatment of RGCs with Y27632 prevents the loss of filopodia in response to soluble 
and membrane tethered ephrin-A stimulation. As discussed in Chapter 3 the RGC 
repulsive response to ephrin-A is sequential, and the RGC growth cone filopodia 
appear to be dragged away as the axon retracts. If axon retraction is directly 
responsible for the loss of RGC growth cone filopodia, it is possible that inhibition of 
axon retraction by Y27632 is sufficient to prevent ephrin-A-induced loss of 
filopodia.
The observations that expression of constitutively active ROCK leads to down- 
regulation of integrin adhesions in leukocytes, and that Y27632-treatment stimulates 
the formation of new vinculin-positive focal complexes in fibroblasts (Rottner et al., 
1999b; Worthylake et al., 2001) could provide an additional explanation for ROCK 
inhibition preventing ephrin-A-induced loss of filopodia. Growth cones of neurons 
on laminin exhibit cell-matrix adhesions that contain many of the same proteins as 
focal complexes seen in fibroblasts (Renaudin et al., 1999). Vinculin-positive 
adhesions are seen on growth cone filopodia, but not lamella (Renaudin et al., 1999). 
ROCK activity may downregulate these filopodial adhesions during ephrin-A- 
induced growth cone collapse and axon retraction, and therefore Y27632 would 
increase these adhesions, preventing the loss of filopodia, but not lamella.
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4.3.3. The ROCK inhibitor Y27632 delays ephrin-A-induced loss of
RGC lamellae.
Although inhibition of ROCK activity does not prevent loss of RGC lamella in 
response to contact with an ephrin-A-expressing fibroblast, or soluble ephrin-A5, 
there is a significant delay in the loss of lamellaeof Y27632-treated RGC growth 
cones following stimulation with ephrin-A. One potential explanation for this 
observation is that ROCK activity contributes to loss of lamellae.through the 
regulation of actomyosin contraction in the lamella itself. However, treatment of 
goldfish RGCs with a peptide inhibitor of MLCK leads to a dramatic reduction of 
lamellaeprotrusion (Schmidt et al., 2002), suggesting that the Rho-ROCK-MLC 
pathway does not act to limit lamellaeprotrusion, at least during axon outgrowth.
Recently it has been demonstrated that Y27632 increases Rac activation in 
fibroblasts treated with LPA (Tsuji et al., 2002). Soluble ephrin-A stimulation of 
RGCs leads to a transient decrease in Rac activity (Jumey et al., 2002; Wahl et al.,
2000), and it is therefore possible that inhibition of ROCK antagonises this inhibition 
of Rac, allowing Y27632-treated RGC growth cone lamellae to persist for longer 
during ephrin-A stimulation. Since expression of constitutively active Rac in DRG 
neurons does not inhibit ephrin-A-induced growth cone collapse (Jurney et al.,
2002), Y27632-mediated dis-inhibition of Rac activity would not be predicted to 
prevent loss of RGC lamelladn response to stimulation with ephrin-A, which agrees 
with the data presented in this chapter.
ROCK can activate LIM kinase, and expression of constitutively active LIM kinase 
in DRG neurons results in growth cones that specifically lose lamellae^Aizawa et al., 
2001; Ohashi et al., 2000; Sumi et al., 2001). Treatment of RGC with Y27632 may 
therefore partially inhibit LIM kinase-mediated loss of lamellae although LIM kinase 
has not been implicated in ephrin-A-induced growth cone collapse. However, LIM 
kinase activity is required for Sema3A-induced growth cone collapse, which is a 
ROCK-independent event (Aizawa et al., 2001; Arimura et al., 2000; Goshima et al., 
1995). LIM kinase is also activated by the Rac/Cdc42 effector, PAK (Edwards et al.,
1999), and together with the observation that ephrin-A stimulation leads to activation 
of Rho but inhibition of Rac, this makes predicting the effect, if any, of LIM kinase 
on ephrin-A-induced RGC lamelladoss difficult. Overall the data presented in this
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chapter strongly suggest that ROCK activity is critically involved in ephrin-induced 
axon retraction, but another pathway must be involved in ephrin-induced loss of 
lamellae.
4.3.4. PP2 delays axon retraction in response to contact with an 
ephrin-expressing fibroblast.
Incubation with PP2 does not prevent loss of RGC growth cone lamellae and axon 
retraction in response to ephrin-A stimulation. However it does significantly delay 
the onset of RGC axon retraction following contact with an ephrin-A-expressing 
fibroblast. It is possible that the PP2-dependent delay in axon retraction is a result of 
Src kinase regulation of cell-matrix adhesions.
Migrating fibroblasts lacking Src, Fyn and Yes assemble new cell-matrix contacts at 
the leading edge normally, but show much reduced adhesion disassembly, assayed by 
loss of fluorescent paxillin (Webb et al., 2004). Expression of kinase dead Src, or 
treatment with PP2 also reduces the rate of adhesion disassembly (Webb et al., 
2004). Paxillin-containing adhesions on the filopodia of neuronal growth cones 
plated on laminin also contain FAK (Renaudin et al., 1999). As discussed in section 
1.6.2, Src activity is thought to mediate adhesion disassembly by degradation of FAK 
(Carragher et al., 2001; Carragher et al., 2003; Fincham et al., 1995). Fyn is found 
co-localised with FAK in filopodia-substrate adhesions (Renaudin et al., 1999), and 
by analogy with the role of Src family kinases in non-neuronal cells, may act to 
disassemble these paxillin-containing adhesions. Since EphA activation in non­
neuronal cells can result in an increase in Fyn activity (Sharfe et al., 2003) it is 
possible that incubation of RGCs with PP2 inhibits ephrin-A-induced Fyn activity 
and subsequent disassembly of matrix adhesions along the filopodia. Integrin- 
mediated adhesions containing FAK and paxillin are also present on the axons of 
chick retinal neurons grown on laminin (de Curtis and Malanchini, 1997) and it is 
therefore possible that PP2 might antagonise ephrin-A-induced loss of axonal 
adhesions. These effects on matrix adhesions may delay axon retraction until the 
Rho-ROCK pathway is stimulated sufficiently to overcome the filopodial adhesion. 
In support of this hypothesis, ephrin-A stimulation of non-neuronal cells does reduce 
cell-matrix adhesion (Miao et al., 2000), although the role of Src family kinases in 
ephrin-A-induced loss of adhesion has not been addressed.
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It should be noted that a recently published study reports that PP2 inhibits ephrin-A5- 
induced RGC growth cone collapse (Wong et al., 2004). Wong and colleagues 
include temporal RGCs in their study, whereas I have only used nasal RGCs. 
Temporal RGCs express higher levels of EphA3 than nasal RGCs (Cheng et al., 
1995; Connor et al., 1998; Monschau et al., 1997) and express a higher level of 
“available” EphA4 (Hornberger et al., 1999). It is therefore possible that different 
Eph receptors mediate the collapse response reported by Wong and colleagues, and 
described in this thesis. Temporal RGCs are more sensitive to ephrin-A5 than nasal 
RGCs (Nakamoto et al., 1996) and I find that the collapse response of nasal RGCs 
saturates at around lpgml"1, which raises the possibility that 25pgml'1 ephrin-A5 (as 
used by Wong and colleagues) may activate additional, low-affinity Eph receptors. It 
is therefore possible that the signalling pathways activated by stimulation of a 
mixture of nasal and temporal RGCs with 25pgml'1 ephrin-A5 (Wong et al., 2004) 
differ from those activated by treatment of nasal RGCs with 1 pgmT1 ephrin-A5 (this 
chapter). This would account for the former being sensitive to PP2, especially at a 
concentration of 25 pM (Wong et al., 2004), while the latter are not sensitive to 
lOpM PP2 (Fig 4.7). The use of PP2 at 25 pM also has potential implications for the 
conclusion drawn by Wong and colleagues, that Src family kinase activity is required 
for ephrin-A5-induced RGC growth cone collapse. lOpM PP2 inhibits ligand- 
induced EphB activity (Sturz et al., 2004). I have shown that lOpM PP2 does not 
inhibit Eph receptor activity in response to lpgml'1 ephrin-A5 (Fig 4.10), but 25 pM 
PP2 may interfere with the activity of Eph receptors activated by 25pgml'1 ephrin- 
A5. This was not addressed in the published study (Wong et al., 2004).
One example of a PP2-sensitive signalling intermediate that might be differentially 
activated by different levels of Eph receptor activity is pl90RhoGAP. pl90RhoGAP 
has preferential GAP activity for Rho in vitro (Ridley et al., 1993) and is expressed at 
high levels in the developing mammalian nervous system (Brouns et al., 2001). Src 
and Fyn can directly phosphorylate pl90RhoGAP in vitro and in vivo (Brouns et al., 
2001; Haskell et al., 2001; Roof et al., 1998; Wolf et al., 2001), and there is evidence 
that this phosphorylation event mediates pl90RhoGAP-induced loss of stress fibres 
(Haskell et al., 2001). Together these observations suggest that in the nervous system 
Src and Fyn may down-regulate Rho signalling via increased pl90RhoGAP activity, 
and this is one explanation for the observation that while inhibition of the Rho-
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ROCK pathway with Y27632 prevents the ephrin-A-induced axon retraction reported 
in this chapter, PP2 does not have the same effect. However, Eph receptors also have 
the potential to increase pl90RhoGAP phosphorylation via Src family kinases. Src 
and Fyn can activate LMW-PTP and cause an associated decrease in pl90RhoGAP 
phosphorylation (Bucciantini et al., 1998; Rigacci et al., 1996; Tailor et al., 1997). 
Since there is a correlation between pl90RhoGAP phosphorylation and reduced Rho 
activity (Arthur et al., 2000), it is possible that Src or Fyn activation could contribute 
to increased Rho activation via LMW-PTP-mediated reduction in pl90RhoGAP 
activity. A variety of Eph receptors have been shown to activate Src and Fyn (Sharfe 
et al., 2003; Steinle et al., 2002; Takasu et al., 2002; Vindis et al., 2003), and it is 
therefore possible that stimulation of RGCs with 25pgml'1 ephrin-A5 activates a Src- 
dependent increase in Rho activity, mediated by Eph receptors that are not activated 
by lpgm l'1 ephrin-A5. This might explain why growth cone collapse in response to 
25pgml'1 ephrin-A5 is sensitive to PP2 (Wong et al., 2004), while loss of lamella and 
axon retraction in response to contact with an ephrin-A-expressing fibroblast or 
lpgm l'1 ephrin-A5 are not.
I have not addressed whether Src family kinase activity is inhibited in RGCs 
following incubation with lOpM PP2. Incubation with this concentration of PP2 
significantly delays RGC axon retraction following contact with an ephrin- 
expressing fibroblast, but does not prevent it, which presents the possibility that 
inhibition of Src family kinases by lOpM PP2 may be incomplete. Although 
treatment of Aplysia neurons with lOpM PP2 significantly reduces repulsive growth 
cone responses, further inhibition can be achieved with 25pM PP2 (Suter and 
Forscher, 2001). I have been unable to determine the effect of higher concentrations 
of PP2 on ephrin-A-induced growth cone collapse and axon retraction, because PP2 
at concentrations higher than lOpM induce RGC growth cone collapse and axon 
retraction independent of ephrin-A stimulation. lOpM PP2 is sufficient to inhibit 
phosphorylation of Src family substrates in other types of primary neuron in culture 
(Crossthwaite et al., 2004; Manzerra et al., 2001), and therefore the results presented 
in this chapter suggest that Src family kinases do not play a major role in ephrin-A- 
induced RGC repulsive responses. However in order to confirm this conclusion I 
would have to investigate the effect of other pharmacological inhibitors of Src family 
kinases on ephrin-A-induced growth cone collapse and axon retraction. SU 6656 has
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different non-specific effects to PP2, and is therefore a good candidate for 
confirming that Src family kinase activity is not required for ephrin-A-induced 
growth cone collapse and axon retraction (Bain et al., 2003; Blake et al., 2000)
4.3.5. PP3 prevents the repulsive RGC response to stimulation with 
ephrin-A.
Surprisingly the structural analogue of PP2, PP3, has a dramatic inhibitory effect on 
the growth cone collapse and axon retraction induced by stimulation with soluble and 
membrane-tethered ephrin-A (Fig 4.8, 4.9). PP3 must therefore influence a major 
mediator of the RGC repulsive response. One obvious possibility is that PP3 
interferes with ephrin-A-induced Eph receptor activation. This was an intriguing 
possibility as to date there are no pharmacological tools available that inhibit EphA 
kinase activity, but incubation of isolated RGCs with 10p,M PP3 for 20 min has no 
effect on the level of Eph receptor phosphorylation induced by stimulation with 
ephrin-A5-Fc (Fig 4.10). In agreement with this, the effect of PP3 is not specific to 
Eph receptor-mediated growth cone collapse, because 10p,M PP3 also significantly 
inhibits DRG growth cone collapse induced by Sema3A (Fig 4.11).
PP3 inhibits casein kinase 1 delta (CK16) in vitro (Bain et al., 2003) and this enzyme 
has recently been shown to increase phosphorylation of the microtubule associated 
protein tau in vivo (Li et al., 2004). Interestingly tau phosphorylation is greatly 
increased in RGCs following stimulation with ephrin-A5, and in DRGs after 
Sema3A stimulation (Cheng et al., 2003; Sasaki et al., 2003). Pharmacological 
inhibition of Cdk5, which phosphorylates tau, inhibits growth cone collapse induced 
by both guidance cues, although the authors did not investigate whether neuronal tau 
phosphorylation is inhibited under these conditions (Cheng et al., 2003; Sasaki et al.,
2003). PP3 significantly inhibits both ephrin-A5 and Sema3A-induced growth cone 
collapse of RGCs and DRGs respectively. One possibility therefore is that PP3 
inhibits CK16 in these neurons, preventing ephrin-A or Sema3A-induced tau 
phosphorylation, and interfering with the microtubule rearrangements that occur 
during growth cone collapse (Fan et al., 1993; Meima et al., 1997a; Meima et al., 
1997b). However, PP2 also inhibits CK16 in vitro, with approximately 8-fold higher 
potency compared to PP2 (Bain et al., 2003) yet PP2 does not prevent RGC growth 
cone collapse or axon retraction in response to ephrin-A.
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Other kinases known to be inhibited by PP3 are EGF receptor and Bmx, but again 
these kinases are also inhibited by PP2 with a higher potency (Traxler et al., 1996; 
J.A. Cooper, personal communication). It is therefore difficult to interpret the results 
presented in this chapter demonstrating that PP3 prevents both RGC growth cone 
collapse and axon retraction in response to stimulation with ephrin-A. The 
observation that PP3 also inhibits Sema3A-induced growth cone collapse, known to 
involve a different mechanism to ephrin-A-induced growth cone collapse, could 
imply that PP3 interferes with common cytoskeletal machinery, and therefore is non­
specific with regards to ephrin-A-induced growth cone collapse.
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Chapter 5. The role of Abl in ephrin-A- 
induced RGC repulsive responses.
5.1. Introduction.
In Chapter 4 I have presented evidence that ROCK mediates ephrin-A-induced RGC 
axon retraction, but not loss of RGC growth cone lamella, and therefore other 
signalling molecules must mediate this aspect of the ephrin-A-induced RGC 
repulsive response. As discussed in section 1.7 the non-receptor tyrosine kinase Abl, 
implicated in axon guidance decisions in vivo, induces rearrangement of the neuronal 
actin cytoskeleton, and regulates the activity of Mena, a member of the Ena/VASP 
family of proteins that regulate actin dynamics within the lamella (Bear et al., 2002; 
Hsouna et al., 2003; Wills et al., 1999; Wills et al., 2002; Woodring et al., 2002). Abl 
has been shown to interact with EphA4, which is expressed by chick RGC growth 
cones in vitro, and is required for the repulsive response of nasal RGC axons to 
ephrin-A5 (Monschau et al., 1997; Walkenhorst et al., 2000; Yu et al., 2001). Abl 
kinase can be activated by direct phosphorylation of it’s activation loop by 
exogenous kinases, and Eph receptors have been shown to directly phosphorylate 
Abl (Yu et al., 2001). It is therefore possible that EphA-activation stimulates Abl 
kinase activity, and thus induces the actin rearrangements that underlie ephrin-A- 
induced growth cone collapse.
In Drosophila, D-abl mutants show defects in CNS axon pathfinding, and this 
phenotype is suppressed by mutations in Ena, the Drosophila homologue of Mena 
(Hsouna et al., 2003; Wills et al., 1999; Wills et al., 2002). Mena is an Abl substrate, 
and is also required for correct axon guidance during development (Lanier et al., 
1999; Tani et al., 2003). Mena-deficient mice show defects in the guidance of 
cortical axons that would normally form the corpus callosum; these axons reach the 
midline but do not cross to the|contraeral cortex (Lanier et al., 1999). This phenotype 
is very similar to that seen in EphA5 mutant mice (Hu et al., 2003), although to date 
no genetic or biochemical interactions have been reported between Mena and Eph 
receptors.
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In mammalian cells Mena is localised to the very edge of protruding lamella 
(Nakagawa et al., 2001; Rottner et al., 1999a). Ena/VASP family proteins at the 
leading edge of fibroblast lamellipodia directly influence the organisation of actin 
filaments within the lamella, and the accumulation of Ena/VASP proteins at the 
leading edge directly correlates with the rate of lamella protrusion (Bear et al., 2002; 
Rottner et al., 1999a). Mena is highly enriched in the growth cone lamella of primary 
neurons in culture, and since Mena-deficient neurons extend axons normally in vitro 
(Lanier et al., 1999), Mena is therefore a good candidate for regulating actin 
dynamics in the growth cone lamella in response to axon guidance cues.
Genetic evidence suggests that D-abl antagonises Ena function. If Abl negatively 
regulates Mena function in lamella protrusion, it is possible that Abl links EphA 
activity to loss of RGC lamella. In this chapter I have used a pharmacological 
inhibitor of Abl kinase activity, STI571 (Gleevec, Novartis), to investigate the role of 
Abl in ephrin-A-induced growth cone collapse. I have determined the effect of this 
inhibitor on the behaviour of RGC axons following stimulation with ephrin-A, and 
have demonstrated that STI571 prevents both the loss of RGC lamellae and axon 
retraction in response to contact with an ephrin-A-expressing Swiss-3T3 fibroblast, 
and following addition of ephrin-A5-Fc. The effect of STI571 is specific to Eph 
receptor signalling, as STI571 does not inhibit Sema3A-induced DRG growth cone 
collapse. In addition I have demonstrated an interaction between active Eph receptors 
and endogenous Abl and Mena in COS cells, and shown that STI571 disrupts this 
complex.
5.2. Results.
5.2.1. The Abl kinase inhibitor STI571 prevents the repulsive 
response to contact with an ephrin-A-expressing cell.
To determine the role of Abl kinase in the repulsive response of RGCs to ephrin-A 
stimulation I have investigated the effect of STI571 on the behaviour of RGCs 
following contact with Swiss-3T3 fibroblasts, which endogenously express ephrin- 
As (see Chapter 3). Co-cultures of retinal explants and Swiss-3T3 fibroblasts were 
incubated with lOpM STI571 for 20-30 min prior to cell-cell contact. An example of 
the interaction between a RGC growth cone and a Swiss-3T3 fibroblast after STI571
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treatment is shown in Fig 5.1 (see also movie 5.1). Following contact with the 
fibroblast the RGC growth cone continues to advance, retaining a large spread 
lamella for more than 15 min after initial contact (Fig 5.1, movie 5.1). At later time- 
points the RGC growth cone shown in Fig 5.1 preferentially extends lamella at sites 
of cell-cell contact (Fig 5.1, arrowheads). As discussed in chapter 3, control RGC- 
Swiss-3T3 fibroblast interactions result in rapid loss of RGC growth cone lam ella 
and axon retraction (Fig 3.2). Fig 5.1 demonstrates that incubation with the Abl 
kinase inhibitor STI571 prevents both these aspects of the RGC repulsive response to 
contact with an ephrin-A-expressing Swiss-3T3 fibroblast.
Analysis of 15 STI571-treated RGC-fibroblast interactions reveals that STI571 
significantly reduces the percentage of RGCs that lose lamellatand retract following 
contact with a Swiss-3T3 fibroblast. Only 13.3% of STI571-treated RGCs lose 
lamella within 10 min of contact with a Swiss-3T3 fibroblast, compared with 76.7% 
of control RGCs (see Table 5.1, p<0.0001; Fisher’s exact test for independence) and 
none of the STI571-treated RGC-fibroblast interactions induce RGC axon retraction 
(see Table 5.1, p<0.002; Fisher’s exact test for independence). These data 
demonstrate that incubation with STI571 prevents the loss of RGC lamellatand axon 
retraction induced by contact with an ephrin-A expressing Swiss-3T3 fibroblast.
In the example shown in Fig 5.1 the lamella of the RGC growth cone advances a 
short distance across the lamella of the Swiss-3T3 fibroblast and the two lamellae 
overlap for more than 5 min before the fibroblast withdraws slightly (Fig 5.1 arrows). 
The majority (69.2%) of STI571-treated RGCs that do not lose growth cone lamellae 
in response to contact extend lamellaaover the surface of the fibroblast for more than 
5 min after contact (n=13). Interestingly none of the control RGCs that do not lose 
lam ella in response to contact with a Swiss-3T3 fibroblast extend growth cone 
lamellaeover the fibroblast surface (n=5), suggesting that the lamellasLoverlap shown 
in Fig 5.1 is a result of STI571 treatment. An extreme example of an STI571-treated 
RGC extending growth cone lamella over the surface of a Swiss-3T3 fibroblast is 
shown in Fig 5.2 (see also movie 5.2). Following contact the RGC growth cone 
lamella extends over the lamella of the fibroblast (Fig 5.2, arrow) and the growth 
cone advances so that the RGC axon extends across the fibroblast surface (Fig 5.2, 
movie 5.2). At later time-points, as the RGC growth cone reaches the substrate on the 
far side of the fibroblast, the RGC protrudes lamella along the portion of the axon
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Figure 5.1. STI571 prevents the RGC repulsive response to contact 
with an ephrin-A-expressing Swiss-3T3 fibroblast.
Time-lapse stills showing that STI571 inhibits loss of RGC growth cone lamella and 
axon retraction in response to contact with an ephrin-A-expressing Swiss-3T3 
fibroblast. STI571 (lOpM ) was added 20-30 minutes prior to cell contact and times 
shown are relative to initial contact. The RGC growth cone lamella is not lost 
following contact with the fibroblast, and at early time-points the RGC growth cone 
lamella extends over the surface of the fibroblast (+1, +2 and +5 min, arrows). In 
addition STI571 prevents RGC axon retraction in response to contact with the 
fibroblast, and the axon continues to advance across the substrate. Note that as the 
fibroblast begins to withdraw, the RGC growth cone preferentially extends lamella at 
the remaining sites of contact with the fibroblast (+15 min, arrowheads). Scale bar = 
20pm.
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Figure 5.2. STI571 treatment may not result in a neutral response 
of RGCs to contact with an ephrin-A-expressing Swiss«3T3 
fibroblast.
Time-lapse stills showing that STI571 inhibits loss of RGC lamella and axon 
retraction in response to contact with an ephrin-A-expressing Swiss-3T3 fibroblast. 
STI571 (10|iM ) was added 20-30 minutes prior to cell contact and times shown are 
relative to initial contact. The RGC growth cone lamella is not lost following contact 
with the fibroblast but extends lamella over the surface of the fibroblast (+1 min, 
arrow) and then continues to advance so that the entire growth cone is in contact with 
the fibroblast (+7 min, arrow). The axon advances across the Swiss-3T3 fibroblast and 
back onto the substrate, protruding lamella along the distal portion of the axon that is 
still in contact with the cell (+15 min, arrowheads). Scale bar = 20|iim
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Table 5.1
Cell type and treatment RGCs showing loss of RGCs showing axon
(n) lamella within 10 min retraction within 20
of contact (n). min of contact (n).
Swiss 3T3 fibroblast (30) 76.7% 43.3%
Swiss 3T3 fibroblast + 13.3% 0.0%
STI571 (15)
still in contact with the ephrin-A-expressing fibroblast (Fig 5.2, +15 min, between 
arrowheads), which, as discussed in section 5.3, might reflect an attractive response. 
Together the data described above demonstrate that STI571 prevents loss of RGC 
growth cone lamellae, and axon retraction in response to contact with an ephrin-A- 
expressing fibroblast, and suggest that Abl kinase in involved in mediating the 
ephrin-A-induced RGC repulsive response.
5.2.2. STI571 inhibits ephrin-A5-Fc-induced RGC growth cone 
collapse.
Since STI571 treatment of co-cultured RGCs and Swiss-3T3 fibroblasts could effect 
either cell type it is important to determine that the inhibition of RGC repulsive 
response by STI571 is cell autonomous. The effect of STI571-treatment of RGCs 
stimulated with ephrin-A5-Fc was therefore investigated.
Typical examples of the actin morphology of RGC growth cones treated with ephrin- 
A5-Fc and/or STI571 are shown in Fig 5.3. Incubation with 10p,M STI571 has no 
effect on the actin morphology of RGC growth cones compared to control; both have 
spread lamellaeand filopodia (Fig 5.3a and b). The loss of growth cone lamellaeand 
filopodia induced by ephrin-A5-Fc (Fig 5.3c) are both prevented by incubation of 
RGCs with STI571 prior to stimulation with ephrin-A5 (Fig 5.3d). Figs 5.3e and 5.3f 
show examples of STI571- and ephrin-A5-treated RGCs that have lamellae protruding 
along the axon behind the growth cone. This lamella extends along the axon for a 
distance of more than twice the growth cone width (Fig 5.3e and f), similar to the 
lamella protrusion of the RGC axon in contact with an ephrin-A-expressing
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Figure 5.3. STI571 inhibits ephrin-A5-Fc-induced RGC growth cone
collapse.
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STI571 inhibits ephrin-A5-Fc-induced growth cone collapse of RGCs. Phalloidin 
staining shows that RGCs treated with anti-Fc control have full growth cones with 
spread lamella and filopodia (a). Treatment with STI571 ( 10(iM) alone for 20 minutes 
has no effect on the F-actin morphology of growth cones (b). Stimulation with ephrin- 
A5-Fc (lpg/m l) for 10 minutes triggers loss of lamella and filopodia (c) that is 
inhibited by pre-treatment with STI571 for 20 minutes (d). A subset (approximately 
10 %) of STI571/ephrin-A5-treated RGCs exhibit lamella protrusion along the distal 
portion of the axon (see arrows e, f). Quantification of STI571-dependent inhibition 
of ephrin-A5-induced RGC growth cone collapse shows that pre-treatment with 
STI571 (IOjiM) for 20 minutes significantly reduces the percentage of RGCs that lose 
both filopodia and lamella (Total collapse) in response to stimulation with ephrin-A5- 
Fc (lpg/m l) for 10 minutes (g, * p < 0.0001, student’s T-test for 2-tailed data of 
unequal variance).
fibroblast shown in Fig 5.2. This morphology is rare, occurring in less than 10% of 
STI571-treated axons stimulated with ephrin-A5-Fc, but is never seen in RGCs 
treated with STI571 alone, and therefore might be indicative of an attractive response 
to ephrin-A (see section 5.3). Quantification of the STI571-dependent inhibition of 
ephrin-A5-induced growth cone collapse is shown in Fig 5.3g. Incubation with 
STI571 has no effect on the percentage of RGC axons with a full growth cone 
(control = 74.4 ± 3.7%, STI571 = 79.9 ± 7.2%, p>0.1; Student’s T-Test for 2-tailed 
data of unequal variance). Stimulation of RGCs in culture with ephrin-A5-Fc induces 
total collapse of 75.0 ± 2.5% of RGC axons, but pre-treatment of RGCs with STI571 
significantly reduces the percentage of RGCs that exhibit total collapse in response 
to ephrin-A5 (14.9%, p<0.0001; Student’s T-Test for 2-tailed data of unequal 
variance, Fig 5.3g). To date, pharmacological inhibitors that have been reported to 
inhibit ephrin-A5-induced RGC growth cone collapse have only a partial effect 
(Cheng et al., 2003; Wahl et al., 2000). The STI571-mediated inhibition of ephrin- 
A5-induced RGC growth cone collapse described in this chapter is complete, as the 
percentage of STI571-treated axons that exhibit total collapse in response to ephrin- 
A5 is not significantly different from the percentage of control RGC axons without 
lamella and filopodia (p>0.2 ; Student’s T-Test for 2-tailed data of unequal variance).
To estimate the IC50 of STI571 for ephrin-A5-induced RGC growth cone collapse 
RGCs were incubated with increasing concentrations of STI571 for 20 min prior to 
stimulation with lp-gml'1 ephrin-A5-Fc. Fig 5.4 shows that low micromolar 
concentrations of STI571 have very little effect on ephrin-A5-induced growth cone 
collapse, and fitting the curve using MicroCal Origin provides an estimate of the IC50 
for inhibition of collapse of 5.7pM (with 95% confidence limits). Abl kinase activity 
is inhibited by STI571 in vitro with an IC50 in the sub-micromolar range, but intact 
cells require treatment with STI571 at concentrations between 5 and 10p,M in order 
to completely inhibit Abl kinase activity, as assayed by autophosphorylation 
(Buchdunger et al., 1996; Carroll et al., 1997; Corbin et al., 2002; Okuda et al.,
2001). STI571 is routinely used at concentrations between 5 and lOpM to inhibit 
Abl-dependent cytoskeletal changes in many cell types, including neuronal cells 
(Burton et al., 2003; Finn et al., 2003; Lu et al., 2002; Master et al., 2003). Inhibition 
of ephrin-A5-induced RGC growth cone collapse is complete but not saturated at
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Figure 5.4. Dose-response curve of ephrin-A5-induced RGC growth
cone collapse in the presence of STI571.
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RGCs were treated with increasing concentrations of STI571 for 20 minutes prior to 
stimulation with ephrin-A5-Fc (lpg/m l) for 10 minutes. Ephrin-A5-induced collapse 
is inhibited by STI571 with an IC50 of 5.7pM  (see red line). Maximum collapse is 
the response induced in RGCs stimulated with lpg/m l ephrin-A5-Fc in the absence 
of STI571.
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lOpM (Fig 5.4), therefore the use of lOpM STI571 in the preceding and subsequent 
experiments is justified.
5.2.3. STI571 does not inhibit Semaphorin3A-induced growth cone 
collapse.
To determine whether the effects of STI571 are specific for the repulsive response 
induced by ephrin-A stimulation, I have investigated the effect of 10p,M STI571 on 
DRG growth cone collapse induced by Sema3A (Fig 5.5). Sema3A induces total 
collapse of approximately 60-70% of DRG growth cones (68.1 ± 2.6% in response to 
Sp-gmT1 Sema3A, 66.9 ± 5.2% in response to lpigml'1 Sema3A). Treatment of DRG 
neurons with STI571 alone does not affect the percentage of growth cones with full 
lamellatand filopodia compared with control DRG axons (Fig 5.5, full growth cone 
control = 67.3 ± 4.2%, STI571 = 72.4 ± 3.6%, p>0.2; Student’s T-Test for 2-tailed 
data of unequal variance). In contrast to ephrin-induced collapse of RGCs, STI571 
does not significantly reduce the percentage of DRGs that totally collapse in 
response to Sp-gmT1 Sema3A (Sema3A = 68.1 ± 2.6%, + STI571 = 66.1 ± 2.7%, 
p>0.1; ; Student’s T-Test for 2-tailed data of unequal variance) or ljxgml'1 Sema3A 
(Sema3A = 66.9 ± 5.2%, + STI571 = 69.5 ± 3.5%, p>0.1; Student’s T-Test for 2- 
tailed data of unequal variance). These data suggest that the effect of STI571 is 
specific to growth cone collapse mediated by EphA receptor signalling.
5.2.4. STI571 does not inhibit ligand stimulated Eph kinase activity.
STI571 was designed as a tyrosine kinase inhibitor, and in addition to Abl has been 
shown to inhibit PDGF receptor, and the stem cell factor receptor c-kit, both receptor 
tyrosine kinases (Buchdunger et al., 2000; Carroll et al., 1997). In order to rule out 
any effects of STI571 on Eph kinase activity isolated RGCs were incubated with 
10p,M STI571 prior to stimulation with ephrin-A5-Fc for various times (Fig 5.6). 
Stimulation of RGCs with ephrin-A5 induces a rapid and sustained increase in Eph 
receptor phosphorylation, which is not inhibited by pre-treatment with STI571 (Fig
5.6, compare lane 3 with lane 4, and lane 5 with 6). Since this antibody specifically 
recognises Eph receptor phosphorylation at the conserved juxtamembrane tyrosines, 
which correlates with Eph kinase activity (Binns et al., 2000; Marston et al., 2003; 
Shamah et al., 2001), Fig 5.6 demonstrates that STI571 does not inhibit ephrin-A5-
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Figure 5.5. STI571 does not inhibit Semaphorin3A-induced DRG
growth cone collapse.
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Treatment with STI571 (10|iM ) for 20 minutes has no effect on the percentage of 
DRG axons that lose both filopodia and lamella (Total collapse) in response to 
stimulation with Sema3A (lpg/m l or 5pg/ml) for 10 minutes (* p > 0.7, ** p > 0.4, 
student’s T-test for 2-tailed data of unequal variance).
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Figure 5.6. STI571 does not inhibit ephrin-A5-induced Eph receptor
activation.
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Isolated RGCs in culture were stimulated with lug/ml ephrin-A5-Fc for the time 
indicated after incubation with STI571 (lOuM {+}) or DMSO control (-) for 20 
minutes. Cells were lysed with RIPA buffer and lysates were seperated by SDS- 
PAGE and blotted with anti-phospho-Eph receptor antibody (left panel) to monitor 
receptor activity. Treatment of RGCs with STI571 has no effect on ephrin-A5- 
induced Eph receptor phosphorylation. Cell lysates were blotted with anti-tubulin 
antibody (right panel) as a control for protein levels.
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stimulated Eph kinase activity in RGCs and is therefore inhibiting ephrin-A-induced
loss of lamella and axon retraction by some other mechanism.
5.2.5. STI571 inhibits the association of Mena with active Eph 
receptors.
Since STI571 is known to inhibit the activity of Abl kinase, it is possible that Abl 
kinase activity is required for ephrin-A-induced growth cone collapse. Interaction 
between Eph receptors and Abl has been described previously (Yu et al., 2001) and 
therefore one possible mechanism by which ephrin-A5 stimulates growth cone 
collapse and axon retraction of RGCs is via EphA-mediated activation of Abl kinase 
activity.
The mammalian Ena/VASP family member Mena is localised to the growth cone of 
neurons in culture, and can be tyrosine phosphorylated by Abl (Lanier et al., 1999; 
Tani et al., 2003). Given the role for Ena/VASP proteins, including Mena, in the 
regulation of lamellanactin dynamics (Bear et al., 2002; Loureiro et al., 2002; Rottner 
et al., 1999a), Mena is therefore a potential link between Abl kinase activity and 
actin dynamics in the growth cone following EphA activation. To investigate 
whether Abl activity is increased following EphA activation an attempt was made to 
analyse the levels of phosphorylated Mena in isolated RGCs following ephrin-A5 
stimulation. Unfortunately attempts to detect either total or tyrosine phosphorylated 
Mena in RGC lysates, whether treated or untreated with ephrin-A5-Fc, failed. It is 
likely that the amounts of material are limiting for this experiment. In order to 
address this issue therefore, I have used COS cells transiently transfected with 
EphA4. EphA4 is expressed by chick nasal RGCs in culture, and has been reported 
to interact with the Abl SH2 domain (Monschau et al., 1997; Yu et al., 2001). 
Expression of dominant negative EphA4 abolishes the repulsive response of chick 
nasal RGC axons to ephrin-A5 in vitro, demonstrating that this receptor is required 
for ephrin-A5-induced signals in these neurons (Walkenhorst et al., 2000).
COS cells transfected with empty vector (COSmock) do not exhibit detectable levels 
of phosphorylated Eph receptor when unstimulated, and there is no detectable 
increase in the level of Eph receptor phosphorylation following stimulation of these 
cells with lp-gml1 ephrin-A5-Fc for 10 min (Fig 5.7A lanes 1 and 4). This suggests 
that COSmock cells do not express significant levels of endogenous EphA receptors,
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Figure 5.7. COS cells transiently transfected with EphA4 express 
high levels of active Eph receptor.
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A. COS cells were transiently transfected with EphA4 (COSEphA4 {lanes 2,3,5,6}), 
or empty vector (COSmock {lanes 1,4}), and proteins expressed for 24 hours. Cells 
w ere then treated with control IgG (lanes 1-3) or stimulated with clustered ephrin-A5- 
Fc (lpg/m l {lanes 4-6}) for 2 minutes (lanes 1,2,5) or 10 minutes (lanes 3 ,4 , 6). The 
cells were lysed with RIPA buffer and lysates were separated by SDS-PAGE. Cell 
lysates were blotted with anti-phospho-Eph receptor antibody (A) to monitor receptor 
activity, or anti-tubulin antibody (B) for protein loading control. COSmock cells do 
not express detectable levels of phosphorylated Eph receptors following control or 
ephrin-A5-Fc treatment.. COSEphA4 express highly phosphorylated Eph receptors 
with or without ephrin-A5-Fc addition.
B. 1 = COSmock , 2 = COSEphA4 control 2 min, 3 = COSEphA4 control 10 min,
C. 4  = COSmock + ephrin-A5-Fc 10 min, 5 = COSEphA4 + ephrin-A5-Fc 2 min,
D. 6 = COSEphA4 + ephrin-A5-Fc 10 min.
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making them a suitable cell line for use in this study. COS cells transfected with a 
plasmid encoding EphA4 (COSEphA4) exhibit high levels of phosphorylated Eph 
receptor compared to mock-transfected cells (Fig 5.7 lanes 2 and 3). Expression of 
EphA4 has previously been shown to lead to Eph autophosphorylation irrespective of 
ligand stimulation (Ogita et al., 2003). In agreement with this, stimulation of 
COSEphA4 with ephrin-A5-Fc does not lead to a detectable increase in 
phosphorylation of Eph receptor above unstimulated levels (Fig 5.7 lanes 5 and 6). 
These results demonstrate that transfection of COS cells with EphA4 results in 
expression of active Eph receptors, and that ligand stimulation of these cells does not 
further increase this Eph receptor activity. For this reason the following experiments 
were carried out on COSEphA4 cells in the absence of exogenous ligand stimulation.
Initial experiments were performed to determine whether endogenous Mena is 
phosphorylated in cells in which EphA4 is active. Abl phosphorylates Mena on a 
single tyrosine residue (Tani et al., 2003) but phospho-specific antibodies against 
Mena are not commercially available. Instead I used an anti-Mena antibody to 
immuno-precipitate endogenous Mena from COSmock and COSEphA4 cells, and 
then blotted these immuno-precipitates with an antibody against phosphorylated 
tyrosine residues. Fig 5.8A shows that a tyrosine-phosphorylated protein of greater 
than lOOkD in size is present in Mena immuno-precipitates from COSEphA4 cells 
but not in Mena immuno-precipitates from COSmock cells (Fig 5.8A lanes 1 and 2). 
This tyrosine-phosphorylated protein is not present in Mena immuno-precipitates 
from STI571-treated COSEphA4 cells (Fig 5.8A).
Three isoforms of Mena are present in vivo, of molecular weights 140, 88, and 80 kd 
(Gertler et al., 1996),*, all three isoforms are expressed in COS (Fig 5.8D arrows) and 
therefore the phosphotyrosine-positive band seen in the Mena immuno-precipitates 
from COSEphA4 cells could correspond to the largest isoform of Mena, which is the 
only isoform tyrosine-phosphorylated in vivo (Gertler et al., 1996). However 
phosphorylated Eph receptors are also around this size (Fig 5.8C) (Marston et al., 
2003; Ogita et al., 2003; Shamah et al., 2001). Initially I attempted these immuno- 
precipitations using a fairly high stringency lysis buffer, containing an ionic 
detergent and a high salt concentration, but this approach failed to yield detectable 
levels of Mena in COS lysates. The results shown in Fig 5.8 were obtained using a 
low salt lysis buffer containing a non-ionic detergent (see IP buffer, see section
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Figure 5.8. STI571 disrupts the interaction between Mena anc active
Eph receptors in COS cells transiently transfected with EphM.
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ip: mena blot: pY ip: mena blot: pEphR
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A. COSmock (lane 1) and COSEphA4 cells with (lane 3) or without (lane 2) STI571 
treatment (lOpM, 2 hours) were lysed using IP buffer. Mena was then immuno- 
precipitated using an anti-Mena antibody. Mena immuno-precipitates were separated 
by SDS-PAGE and blotted with antibodies against phosphotyrosine (A), phospho-Eph 
receptor (B), or Mena (D). COSEphA4 Mena immuno-precipitates blotted for 
phospho-tyrosine show a single band at 110-140kD, which is inhibited by treatment 
with STI571. Mena immuno-precipitates show a single band at a similar molecular 
weight when blotted for active Eph receptor. Blotti ng Mena immuno-precipitates for 
Mena shows bands at around 140, 88 and 80kD (D, arrows). Blotting whole cell 
lysates (C) demonstrates that STI571-treatment does not inhibit Eph receptor 
phosphorylation.
B. 1 = COSmock, 2 = COSEphA4,3 = COSEphA4 + STI571
220  —
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2.1.3). It is therefore possible that protein complexes within the cell are not disrupted 
under these conditions and that the phospho-tyrosine signal in Mena immuno- 
precipitates from COSEphA4 comes at least in part from phosphorylated Eph 
receptor. To investigate this possibility Mena immuno-precipitates were blotted with 
anti-phospho Eph receptor antibody (Fig 5.8B). Fig 5.8 shows that active Eph 
receptor associates with Mena in COSEphA4 cells, and that treatment of these cells 
with STI571 inhibits this interaction. The total level of phosphorylated Eph receptor 
in the cells is unchanged by incubation with STI571 (Fig 5.8C) demonstrating that 
treatment of COS cells with STI571 specifically disrupts the association of active 
Eph receptor with endogenous Mena.
5.2.6. STI571 inhibits the association of Abl with active Eph 
receptors.
Abl kinase activity towards exogenous substrates is stimulated by 
autophosphorylation at several sites, as well as direct phosphorylation of Abl’s 
activation loop by exogenous kinase activity (Brasher and Van Etten, 2000; Tanis et 
al., 2003). Since Abl can associate with EphA4, and is directly phosphorylated by 
EphB2 in vitro (Yu et al., 2001), it is possible that EphA receptor activity could lead 
to the phosphorylation and activation of Abl kinase. To determine whether Abl 
phosphorylation correlates with Eph receptor activity, Abl immuno-precipitates from 
COSmock and COSEphA4 were blotted with an anti-phospho-tyrosine antibody (Fig 
5.9A). This approach yielded poor results under a variety of experimental conditions, 
but a representative example of the results I was able to achieve is shown in Fig 
5.9A. Abl immuno-precipitates from COSEphA4 lysates contain a tyrosine- 
phosphorylated protein, and the presence of this protein is inhibited by STI571 (Fig 
5.9A lanes 2 and 3). This band is approximately the correct size to be phosphorylated 
Abl (Compare Fig 5.9A with Fig 5.9D), but again is likely to be at least in part 
phosphorylated Eph receptor, since blotting Abl immuno-precipitates with anti 
phospho-Eph receptor antibody reveals the presence of active Eph receptor in the 
Abl immuno-precipitate (Fig 5.9B). Treatment of COSEphA4 cells with STI571 
inhibits the association between Abl and phosphorylated Eph receptors (Fig 5.9B), 
although the total level of phosphorylated Eph receptor is unaffected by the presence 
of STI571 (Fig 5.9C, see also 5.8C). These results demonstrate that treatment of
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Figure 5.9. STI571 disrupts the interaction between Abl and active
Eph receptors in COS cells transiently transfected with EphA4.
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COSmock (lane 1) and COSEphA4 cells with (lane 3) or without (lane 2) STI571 
treatment (10\)M, 2 hours) were lysed using IP buffer. Abl was then immuno- 
precipitated using an anti-Abl antibody. Abl immuno-precipitates were separated by 
SDS-PAGE and blotted with antibodies against phosphotyrosine (A), phospho-Eph 
receptor (B), or Abl (D). COSEphA4 Abl immuno-precipitates blotted for phospho­
tyrosine show a single band at 110-120kD, which is inhibited by treatment with 
STI571. Abl immuno-precipitates show a single band at a similar molecular weight 
when blotted for active Eph receptor. Blotting Abl immuno-precipitates for Abl 
shows a band at a similar molecular weight that is present in all conditions. Blotting 
whole cell lysates (C) demonstrates that STI571-treatment does not inhibit Eph 
receptor phosphorylation.
1 = COSmock, 2 = CO SEphA 4,3 = COSEphA4 + STI571
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C0SEphA4 with STI571 abolishes the association between active Eph receptors and 
endogenous Abl. From the above results I cannot conclude that the phosphorylation 
state of Abl or Mena changes with activation of EphA receptors, since the 
phosphorylated protein present in Abl or Mena immuno-precipitates from 
COSEphA4 cells could correspond to active Eph receptors. Overall the data 
presented above demonstrate that incubation of COSEphA4 cells with STI571 
inhibits the association between active Eph receptors and both Abl and Mena.
5.3. Discussion.
In Chapter 5 I have presented evidence that the Abl kinase inhibitor STI571 prevents 
the repulsive response of RGC growth cones to stimulation with ephrin-A. Treatment 
of RGCs with STI571 dramatically inhibits RGC loss of lamella?and axon retraction, 
both in response to contact with an ephrin-A-expressing cell and to soluble ephrin- 
A5-Fc. This inhibition is specific to ephrin-A-induced growth cone collapse, as the 
same concentration of STI571 has no effect on Sema3A-induced collapse of DRG 
growth cones. The presence of STI571 inhibits signalling downstream of EphA 
receptor activation, since STI571 does not affect ephrin-A5-induced Eph receptor 
activation in isolated RGCs. Active Eph receptors are associated with Abl and Mena 
in COSEphA4 cells, and treatment of these cells with STI571 disrupts these 
interactions, suggesting that an Abl-Mena-Eph receptor complex is necessary for the 
EphA-mediated loss of RGC lamellatand axon retraction. To my knowledge this is 
the first report of Mena associating with Eph receptors and the first evidence that Abl 
has a role in ephrin-induced cellular responses.
5.3.1. STI571 prevents association of Eph receptors with Abl and 
Mena.
Treatment of COSEphA4 cells with lOpM STI571 specifically disrupts the 
association of Abl and Mena with active Eph receptors, without affecting the levels 
of Eph receptor phosphorylation (Figs 5.8 and 5.9). Abl can adopt an inactive 
conformation mediated by a series of intramolecular interactions involving its SH2- 
and SH3- domains. The Abl SH3 domain interacts with the SH2-kinase linker region 
and the Abl SH2 domain interacts with the C-terminal kinase lobe, rendering the 
kinase inactive (Nagar et al., 2003). STI571 is thought to inhibit Abl kinase activity
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by binding and stabilising the inactive conformation of Abl, since mutation of sites 
specifically involved in maintaining the auto-inhibited conformation confer 
resistance of Abl kinase to STI571 (Azam et al., 2003; Smith et al., 2003). Studies 
using the yeast two-hybrid system have revealed that the intracellular tail of EphA4 
interacts with the Abl SH2 domain (Yu et al., 2001). STI571 -mediated stabilisation 
of the auto-inhibited conformation, in which the Abl SH2 domain interacts with the 
Abl kinase domain, might preclude interaction between Abl and active EphA4. This 
would explain the absence of active Eph receptor in Abl immuno-precipitates from in 
COSEphA4 cells treated with STI571. It should be noted that the results presented in 
Fig 5.9 do not address whether Abl is found in association with inactive Eph 
receptors. Full-length Abl can interact with kinase-dead EphB2 when co-transfected 
in 293 cells, but the association is weaker than with wild-type EphB2 (Yu et al.,
2001), suggesting that the Eph-Abl interaction may at least in part be regulated by 
Eph receptor activity.
Fig 5.8 demonstrates that Mena also associates with active Eph receptor in 
COSEphA4 lysates. To date no direct interaction between any Ena/VASP family 
member and Eph receptors has been reported, but Abl SH3 binds Mena directly 
(Gertler et al., 1996), therefore it is possible that Abl mediates the interaction 
between Mena and active Eph receptors. Since Mena binds the Abl SH3 domain Abl 
could act as an adaptor, using it’s SH2 domain to bind EphA4 and it’s SH3 domain 
to bind Mena. STI571 stabilisation of the inactive conformation of Abl, in which Abl 
SH3 domain is occupied due to intramolecular interactions, might preclude Abl 
binding to Mena and therefore prevent the formation of a trimolecular complex 
containing Abl, Mena and active Eph receptor. This would explain the absence of 
active Eph receptor in Mena immuno-precipitates from EphA4 COS cells treated 
with STI571.
5.3.2. STI571 blocks RGC lamellaecollapse in response to ephrin-A 
stimulation.
The STI571-dependent disruption of the association between Abl and Mena with 
active Eph receptors correlates with the ability of STI571 to completely inhibit loss 
of RGC lamellae in response to an ephrin-A-expressing cell (Figs 5.1 and 5.2, table 
5.1) and following stimulation with ephrin-A5-Fc (Fig 5.3). These results suggest
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that Abl kinase activity and/or association of active Eph receptor with Abl and Mena 
may be required for ephrin-A-induced loss of RGC lamellae.Recent evidence has 
shown that mammalian Ena/VASP family members bind to the barbed ends of actin 
filaments, promoting their elongation by antagonising actin capping proteins, and 
this is thought to underlie the direct correlation between the accumulation of 
Ena/VASP proteins at the very tip of the extending lamellae and the rate of lamellae, 
protrusion (Bear et al., 2002; Rottner et al., 1999a). It is possible that recruiting Mena 
to Eph receptor-Abl complexes allows capping proteins access to the barbed ends of 
filaments, antagonising the role of Mena on actin filament elongation during lamellae 
protrusion. STI571, by excluding Mena from the Eph receptor-Abl complex may 
lead to the persistent protrusion of lamellaeeven in the presence of active EphA 
receptors. It has been shown that sequestering Ena/VASP proteins away from the 
membrane results in slow protrusion of persistent lamella^ but this behaviour was 
investigated after stable expression of a peptide sequence that targets Ena/VASP 
proteins to abnormal cellular locations (Bear et al., 2002). Acute introduction of a 
peptide which sequesters Mena from it’s correct subcellular location results in rapid 
loss of Ptk2 cell lamellae.(Gertler et al., 1996; Southwick and Purich, 1994). Although 
the mechanism by which this lamella loss occurs is unknown, these observations 
provide evidence that rapid sequestering of Mena from F-actin in the growth cone 
lamella, by ephrin-A-induced association of Mena with Eph receptors, might induce 
RGC lamella collapse.
Alternatively it is possible that recruitment of Mena to Eph receptor-Abl complexes 
enhances M ena’s activity on actin filament elongation by increasing Mena 
localisation at the membrane. Fibroblasts in which Ena/VASP proteins are 
sequestered at the membrane, where active Eph receptor-Abl complexes are located, 
exhibit rapid lamellaaprotrusion and retraction, which is thought to reflect instability 
of the long, unbranched actin filaments (Bear et al., 2002; Krause et al., 2002). It is 
possible that Eph receptor activation promotes the formation of unstable actin 
filaments by recruiting Mena to the membrane, and that in combination with ROCK- 
mediated retraction (Chapter 4 and see section 5.3.3) and possible EphA-mediated 
loss of adhesion (see section 1.5.2), the instability of these filaments underlies 
ephrin-induced loss of RGC growth cone lamellae. Since STI571 prevents Mena 
association with active Eph receptors, either of the above mechanisms could explain
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the observations present in this chapter, that STI571 prevents ephrin-A-induced loss 
of RGC growth cone lamellae.
From the results presented in this chapter, it is not clear whether Abl kinase activity 
is required for ephrin-A-mediated growth cone collapse. Although phosphorylation 
by cyclic-dependent kinases regulates Mena’s association with F-actin, no 
information is available on the effect of Abl-mediated phosphorylation on Mena’s 
activity in actin filament elongation. It is possible that Abl kinase activity is required 
for the formation of an Abl-Mena-Eph receptor complex, for example if the 
autophosphorylated conformation is necessary to bind to Eph receptors and/or Mena. 
Abl SH2 domain alone can bind to full length EphB2, suggesting that Abl activity is 
not required for this interaction (Yu et al., 2001). In addition it is not clear whether 
Mena phosphorylation is correlated with Eph receptor activation. Abl can 
phosphorylate Ena in the polyproline-rich region, inhibiting it’s binding to Abl SH3 
domain (Ahem-Djamali et al., 1999; Comer et al., 1998). Although none of the Abl 
phosphorylation sites in Ena are conserved in Mena, the Abl phosphorylation site 
does lie in the proline-rich domain of Mena (Gertler et al., 1996; Tani et al., 2003), 
suggesting that phosphorylation here may also disrupt binding to SH3 domain- 
containing ligands. It is therefore possible that the complex does not contain high 
levels of phosphorylated Mena, as this might antagonise Mena binding to Abl.
Expression of EphA4 in COS cells does not correlate with a shift in Mena’s 
electrophoretic mobility (Fig 5.8D) whereas a significant change in mobility is seen 
after phosphorylation of Mena on two serine residues (Gertler et al., 1996; Loureiro 
et al., 2002). It is possible that the resolution of the gel shown in Fig 5.8D is not 
sufficient to reveal a detectable shift in Mena mobility following phosphorylation of 
a single tyrosine residue by Abl. It is likely however that the resolution of the gel in 
Fig 5.8A would be sufficient to expose a doublet if both tyrosine-phosphorylated 
Mena (approximately 140kD (Gertler et al., 1996) and phosphorylated EphA4 
(approximately llOkD (Becker et al., 1995) were present in COSEphA4 lysates, 
suggesting that the phosphorylation state of Mena may not change in response to Eph 
receptor activation. Interestingly mutation of all Abl phosphorylation sites in Ena 
leads to only a small reduction in Ena function (Comer et al., 1998) suggesting that 
Abl may regulate Ena in ways other than by phosphorylation. Recent evidence from 
Drosophila suggests that Abl modulates the actin cytoskeleton by regulating Ena’s
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subcellular localisation (Grevengoed et al., 2003). It is therefore possible that 
activation of RGC EphA receptors does not change the phosphorylation state of 
Mena, but leads to reorganisation of the cytoskeleton by recruiting Mena to Eph 
receptor complexes.
5.3.3. STI571 blocks RGC axon retraction in response to ephrin-A 
stimulation.
The results presented in this chapter demonstrate that incubation with lOpM STI571 
completely inhibits both the loss of lamella and axon retraction of RGCs in response 
to ephrin-A stimulation. I have shown in chapter 4 that axon retraction is dependent 
on ROCK activity, suggesting that STI571 may somehow regulate the Rho-ROCK 
pathway in these neurons.
The SH2/SH3-containing adaptor protein Crk is an Abl binding partner and substrate 
(Feller et al., 1994: Ren et al., 1994). Expression of the viral Crk homologue leads to 
increased Rho and ROCK activity in 293 cells, and induces the formation of 
contractile actin cables in neuronal cells (Altun-Gultekin et al., 1998; Iwahara et al., 
2003; Tsuda et al., 2002). Recently it has been shown that Crk is required for Rho- 
mediated cytoskeletal rearrangements downstream of active EphA3. Ephrin-A5-Fc 
stimulation of Eph A3-expressing cells results in the retraction of cellular processes, 
and this response depends on the activity of both Rho and ROCK (Lawrenson et al.,
2002). Expression of SH3-mutated Crk blocks ephrin-A5-induced process retraction, 
and abolishes the ephrin-A5-induced increase in Rho activity in these cells 
(Lawrenson et al., 2002), suggesting that Rho activation is downstream of Crk. Abl 
can bind to Crk SH3 domain and phosphorylate a tyrosine residue close to the Crk 
SH3 domain (Feller et al., 1994; Ren et al., 1994). Phosphorylation of Crk on this 
residue allows intramolecular binding to Crk SH2 domain (Rosen et al., 1995), and 
therefore the traditional model has been that Abl phosphorylation negatively 
regulates Crk dependent signalling by preventing Crk binding to SH2 and/or SH3 
binding partners. Although mutating the Abl phosphorylation site increases Crk 
binding to some partners, this mutation does not increase Crk dependent signalling, 
as would be expected if Abl phosphorylation negatively regulates Crk (Abassi and 
Vuori, 2002). There is evidence that translocation of Crk to the plasma membrane 
requires phosphorylation at the Abl site, and that this in turn is required for Crk-
170
mediated actin rearrangements (Abassi and Vuori, 2002), which suggests that Abl 
phosphorylation can positively regulate Crk-dependent signalling. In addition Crk 
phosphorylation has been shown to lead to a switch in binding partners (Khwaja et 
al., 1996), suggesting that Abl phosphorylation of Crk activates Crk-dependent 
signalling pathways by regulating the localisation and/or binding partners of Crk.
It is possible that EphA activation induces Abl-mediated Crk phosphorylation, and 
this in turn activates the Rho-ROCK pathway to induce axon retraction. How Crk 
expression leads to RhoA and ROCK activation is unclear. To date Crk has not been 
shown to interact with a Rho GEF, but the N-terminal SH3 domain of Crkll has been 
shown to bind the GEFs C3G and SOS (Knudsen et al., 1994; Okada and Pessin, 
1996; Tanaka et al., 1994; Uemura et al., 1997), raising the possibility that an as yet 
unidentified Rho GEF may interact with this region of Crk. The observation that a 
mutation of Crk SH3 domain alone prevents ephrin-A5-induced Rho activation 
supports this theory (Lawrenson et al., 2002). The Rho family GEF Ephexin is found 
constitutively associated with EphA4, and has been implicated in ephrin-A-induced 
growth cone collapse (Shamah et al., 2001). This study did not investigate the 
mechanism by which Ephexin’s GEF activity towards Rho is stimulated by EphA 
activation, and although to date no functional or biochemical interactions between 
Ephexin and Crk have been shown, it is tempting to speculate that Crk may be 
involved in Abl-mediated axon retraction in response to ephrin-A.
As discussed above it is not clear that STI571 prevents axon retraction via inhibiting 
Abl kinase activity, but does disrupt Abl and Abl substrates interacting with active 
Eph receptors. Interestingly Crk specifically associates with active EphA3, and there 
is some evidence that this interaction is mediated by another molecule (Lawrenson et 
al., 2002). Since Abl can bind to both Eph receptors and Crk, it is possible that Abl- 
Crk interaction at the site of active Eph receptors contributes to the RGC response to 
ephrin-A stimulation. Interestingly disrupting Abl-Crk interaction leads to loss of 
constitutive Rho-dependent stress fibres, and prevents serum-induced stress fibres 
(Nakashima et al., 1999), suggesting that interfering with Abl-Crk binding 
antagonises RhoA signalling. If STI571 prevents Abl-Crk interaction by imposing 
structural constraints on Abl this may have a similar effect on Rho-induced 
contractile filaments within the axon, inhibiting Rho-dependent axon retraction 
following EphA activation. It would be interesting to investigate whether Crk is
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present in the Abl-Eph receptor complex in COS cells, and whether STI571 has any 
effect.
5.3.4. STI571 specifically inhibits ephrin-A-induced growth cone 
collapse.
Although treatment of RGCs with lOpM STI571 completely inhibits ephrin-A5-Fc- 
induced growth cone collapse (Figs 5.3 and 5.4) it has no effect on Sema3A-induced 
DRG growth cone collapse (Fig 5.5). These results suggest that Eph receptors and 
the plexinA/Neuropilin complex required to mediate Sema3A-induced growth cone 
collapse activate different intracellular signalling cascades. Cdk5 is an Abl substrate 
that is phosphorylated following ephrin-A5 stimulation of RGCs (Cheng et al., 2003; 
Zukerberg et al., 2000). Since introduction of a non-phosphorylatable mutant of 
Cdk5 inhibits ephrin-A5-induced growth cone collapse of RGCs (Cheng et al., 
2003), one possible mechanism by which EphA receptor activation leads to growth 
cone collapse is via Abl phosphorylation of Cdk5. Sema3A-induced DRG growth 
cone collapse is also inhibited by the non-phosphorylatable mutant of Cdk5 however 
(Sasaki et al., 2002). Therefore it is unlikely that STI571 inhibits ephrin-A5-induced 
growth cone collapse by interfering with Abl phosphorylation of Cdk5.
Ephrin-A and Sema3A-induced growth cone collapse also share a dependence on the 
Rac signalling pathway. Expression of dominant negative Rac, or disruption of Rac 
interaction with effectors, inhibits both ephrin-A-induced RGC growth cone collapse 
and Sema3A-induced DRG collapse (Jin and Strittmatter, 1997; Jumey et al., 2002; 
Vastrik et al., 1999). Abl has been reported to increase Rac activity (Burton et al.,
2003), but expression of constitutively active Rac in RGCs does not cause growth 
cone collapse (Jumey et al., 2002). Together with the observation that STI571 has no 
effect on Sema3A-induced growth cone collapse, this suggests that STI571 does not 
inhibit ephrin-A-induced growth cone collapse by inhibiting Abl-mediated Rac 
activation.
Ephrin-A5 stimulation of RGCs has been shown to increase Rho activity and 
inhibiting Rho activity has previously been reported to inhibit RGC growth cone 
collapse in response to soluble ephrin-A5 (Wahl et al., 2000) Although Sema3A- 
induced growth cone collapse of DRGs is inhibited by function blocking antibodies 
against the ROCK substrate CRMP (Collapsin response mediator protein), inhibition
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of Rock activity with Y27632 or introduction of a dominant negative does not inhibit 
Sema3A-induced growth cone collapse (Arimura et al., 2000; Goshima et al., 1995). 
This suggests that, unlike Semaphorin4D, Sema3A-induced growth cone collapse 
does not involve the Rho-ROCK pathway. Since ephrin-A-induced axon retraction is 
mediated by ROCK (see Chapter 4) these observations further support the hypothesis 
that STI571 inhibits ephrin-A-induced RGC axon retraction by antagonising the 
Rho-ROCK pathway.
5.3.5. Eph receptor regulation of Abl kinase activity.
As discussed above I have no evidence to suggest that Abl kinase activity is 
regulated by Eph receptor activation, and it is possible that the Abl kinase inhibitor 
STI571 inhibits the repulsive response of RGC axons to ephrin-A stimulation by 
disrupting Abl association with active Eph receptors rather than inhibiting an ephrin- 
A-induced increase Abl kinase activity. It has previously been reported that ligand 
stimulation of EphB-expressing cells reduces the in vitro kinase activity of 
endogenous Abl (Yu et al., 2001). If STI571 is acting to prevent ephrin-A-induced 
lamella collapse and axon retraction via it’s ability to inhibit Abl kinase activity, it 
would be predicted that EphA receptor activation stimulates Abl kinase activity, 
which is in contrast to the effect of EphB activation. However the effect of EphA 
activation on Abl kinase activity has not been investigated (Yu et al., 2001). Growth 
cone collapse induced by ephrin-B ligands is significantly slower than that induced 
by ephrin-As, and has a different effect on filamentous actin (Meima et al., 1997b) 
although to my knowledge no direct comparison has been made between the 
signalling pathways downstream of EphA and EphB receptors that are involved in 
growth cone collapse. Interestingly, while EphA receptor activation induces Crk- 
dependent process retraction, EphB activation has been shown to cause Crk- 
dependent lamella extension (Lawrenson et al., 2002; Nagashima et al., 2002). Given 
that Abl phosphorylation of Crk may lead to a switch in signalling pathways it is 
possible that EphA and EphB receptors have opposite effects on Abl activity, and 
thus stimulate Crk dependent repulsive/retractive responses or attractive/protrusive 
responses respectively.
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5.3.6. STI571-induced switch to attraction.
The soluble collapse and co-culture assays used in this thesis are powerful assays 
with which to identify potential signalling molecules involved in the repulsive 
response to axon guidance cues. These assays cannot distinguish between conditions 
in which the repulsive response to ephrin-A stimulation is replaced by a neutral 
response, and conditions that may convert the repulsive response to an attractive 
response. There are hints from the data presented in this chapter that STI571 
treatment of RGCs does not simply induce a permissive response to ephrin-A 
stimulation. For example RGCs extend growth cone lamellae.over the contacting 
fibroblast in the presence of STI571, but this is never seen in the control situation, 
and in the example shown in Fig 5.1 RGC growth cone lamella preferentially spreads 
at sites of contact with the fibroblast. In Fig 5.2 the RGC protrudes lamella along the 
portion of its axon in contact with the ephrin-A-expressing fibroblast, and STI571- 
treated RGCs extend lamellatalong the axon only after stimulation with ephrin-A5- 
Fc. Since stimulation of neuronal cells in vitro with attractive axon guidance cues 
induces the formation of lamellae and filopodia (Goldberg et al., 2000; Shekarabi and 
Kennedy, 2002), aberrant protrusion of lamella in response to ephrin-A may be 
indicative of an attractive response in the presence of STI571.
A growing body of evidence now indicates that the intracellular activity of cyclic 
nucleotide-dependent kinases can modulate the in vitro response to axonal guidance 
cues (Song and Poo, 2001). Recently it has been shown that ephrin-A5-induced 
collapse of Xenopus neurons is inhibited by reducing PKG activity, although again 
the assay used cannot distinguish between a passive response and an attractive 
response (Mann et al., 2003). Given that PKG and/or PKA activity can modulate the 
neuronal response to a number of axonal guidance cues, it is tempting to speculate 
that Eph receptor signalling may be similarly affected.
This idea is particularly intriguing given the ability of PKA and PKG to modulate the 
biological activity of Ena/VASP family members. All three vertebrate members have 
conserved sites for PKA/PKG, and phosphorylation of these sites in Mena is required 
for Mena function during cell migration (Butt et al., 1994; Gertler et al., 1996; 
Lambrechts et al., 2000; Loureiro et al., 2002). Phosphorylation of the equivalent site 
in EVL and VASP prevents interaction with Abl (Howe et al., 2002; Lambrechts et 
al., 2000). If Mena association with Abl and Eph receptors is required for ephrin-A-
174
induced growth cone collapse, it would be interesting to investigate whether Abl- 
Mena interaction is inhibited by PKG phosphorylation of Mena. This might be a 
mechanism whereby PKG switches ephrin-A-induced repulsion to attraction. Since 
STI571 prevents Mena interaction with Abl and active Eph receptors, it would be 
very interesting to investigate whether STI571 can convert the RGC response to 
ephrin-A from repulsion to attraction, for example using the stripe assay or the 
growth cone turning assay.
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Chapter 6. General Discussion
In this thesis I have developed a novel assay with which to investigate signalling 
pathways that mediate EphA receptor-dependent contact repulsion of RGCs. Axon 
guidance by ephrin-As in vitro is traditionally studied by the related phenomenon of 
growth cone collapse, and using the physiologically relevant co-culture assay 
described in this thesis, in combination with the traditional soluble collapse assay, I 
have identified the non-receptor tyrosine kinase Abl as key mediator of both ephrin- 
A-induced lamella loss and axon retraction, and have more clearly defined the 
function of the Rho effector ROCK in RGC responses to stimulation with ephrin-A.
Since ephrin-As are membrane-bound molecules they guide RGCs in vivo by contact 
repulsion. I have shown that in response to contact with an individual Swiss-3T3 
fibroblast, which expresses endogenous ephrin-As, nasal RGCs exhibit rapid loss of 
growth cone lamella followed by axon retraction. These cellular responses are robust 
and reproducible, and can be quantified individually. Contact with a Swiss-3T3 
fibroblast induces activation of Eph receptors on the RGC growth cone, and 
disruption of the EphA-ephrin-A interaction prevents the contact-induced loss of 
RGC growth cone lamellae and axon retraction. Together with the observation that 
overexpression of ephrin-A5 in a cell type that does not endogenously express 
ephrin-A is sufficient to induce the repulsive response, these data provide strong 
evidence that the RGC response to contact with a Swiss-3T3 fibroblast is mediated 
by neuronal EphA signalling, and is therefore an appropriate assay with which to 
investigate signalling pathways activated by ephrin-A stimulation.
I have shown that inhibition of ROCK activity in RGCs prevents axon retraction 
induced by contact with an ephrin-A-expressing fibroblast, and by soluble ephrin- 
A5. However, ephrin-A-induced loss of RGC growth cone lamella^ although delayed, 
is not prevented by inhibition of ROCK. These observations extend previously 
published work investigating the role of ROCK in ephrin-A-induced RGC responses, 
in which the authors did not quantify these cellular events separately, or describe the 
RGC response dynamically (Wahl et al., 2000) and the data presented in this thesis 
therefore demonstrate that ROCK is not the sole mediator of ephrin-A-induced RGC 
repulsive responses in vitro. The Src family kinase inhibitor PP2 does not prevent
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ephrin-A-induced RGC repulsive responses, but interestingly PP3, a structural 
analogue of PP2 that does not inhibit Src family kinases, prevents both the RGC loss 
of lamellaLand axon retraction induced by membrane tethered and soluble ephrin-A, 
without affecting Eph receptor activity.
Finally I have shown that the Abl kinase inhibitor STI571 prevents both the ephrin- 
A-induced loss of RGC growth cone lamellae and axon retraction in response to 
membrane-tethered and soluble ephrin-A. STI571 does not affect ligand-induced Eph 
receptor activation, and its effects are specific to ephrin-A-induced neuronal 
responses, as STI571 does not inhibit Sema3A-induced DRG growth cone collapse. 
STI571 prevents the association of active Eph receptors, Abl and Mena in transfected 
COS cells, suggesting that this complex is required for ephrin-A-induced loss of 
RGC growth cone lamellaeand axon retraction. It is not clear that Abl kinase activity 
is required to mediate ephrin-A-induced RGC loss of lamellatand axon retraction, 
and it is possible that Abl has a kinase-independent role in transducing EphA- 
mediated signalling in RGCs.
6.1. ROCK activity mediates ephrin-A-induced RGC axon 
retraction, but not loss of lamellae.
In this thesis I have reported the novel observation that inhibiting ROCK activity in 
RGCs specifically prevents the axon retraction normally seen in response to 
membrane-tethered and soluble ephrin-A. Previous studies have reported that 
inhibition of ROCK in RGCs inhibits the percentage of RGCs that exhibit total 
collapse in response to soluble ephrin-A5-Fc (Cheng et al., 2003; Wahl et al., 2000). 
The data presented in this thesis agree with these reports, but extend the published 
observations by describing the effect of inhibiting ROCK in greater detail and 
dynamically, to provide evidence that ROCK activity is not critically involved in loss 
of lamella, but it is necessary for axon retraction.
The Rho-ROCK-MLC pathway has been shown to mediate axon retraction in a 
variety of neuronal cells (Amano et al., 1998; Katoh et al., 1998; Kozma et al., 1997) 
and inhibition of ROCK reduces the incidence of RGC axon retraction induced by 
contact with isolated tectal cells (Thies and Davenport, 2003)]. ROCK activity can 
increase MLC phosphorylation directly, as well as indirectly via downregulation of
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MLCP, and this in turn induces the assembly of contractile stress fibres in non­
neuronal cells (Amano et al., 1996; Fukata et al., 2001; Kimura et al., 1996, Riento 
and Ridley, 2003). Increasing contractility in neurons is likely the mechanism by 
which ROCK mediates axon retraction, as it has been shown that expression of 
active Rho or ROCK or a MLC mutant that mimics phosphorylation by ROCK are 
all sufficient to induce neurite retraction in vitro (Amano et al., 1998; Katoh et al., 
1998; Kozma et al., 1997). Genetic studies have also implicated the Rho-ROCK- 
MLC pathway in axon retraction in vivo, and provide evidence that this pathway is 
negatively regulated pl90RhoGAP (Billuart et al., 2001). This study also provides 
evidence that Src activity might positively influence the Rho-ROCK-MLC pathway 
in vivo by antagonising pl90RhoGAP activity (Billuart et al., 2001). In vitro Src and 
Fyn, both of which are present in RGC growth cones and can be activated by Eph 
receptors (Burden-Gulley and Lemmon, 1996; Maness et al., 1988; Sharfe et al., 
2003; Sorge et al., 1984; Steinle et al., 2002; Takasu et al., 2002; Vindis et al., 2003), 
might mediate ROCK-dependent axon retraction in response to ephrin-A via LMW- 
PTP-induced dephosphorylation of pl90RhoGAP (Bucciantini et al., 1998; Rigacci 
et al., 1996; Tailor et al., 1997). However I have presented data demonstrating that 
the Src family kinase inhibitor PP2 does not prevent ephrin-A-induced axon 
retraction. It has recently been reported that a higher concentration of PP2 (25piM) 
than is used in this thesis inhibits ephrin-A5-induced RGC growth cone collapse 
(Wong et al., 2004) but since PP2 can inhibit EphB kinase activity (Sturtz et al.,
2004), it is therefore possible that the reported inhibition of ephrin-A5-induced RGC 
response is due to inhibition of Eph receptor activity rather than inhibition of Src 
family kinases. I have shown that lOjtM PP2 does not affect ephrin-A5-induced Eph 
receptor activation, and at this concentration the ephrin-A-induced RGC axon 
retraction is significantly delayed, but not prevented. It is possible that the delay in 
axon retraction reflects incomplete inhibition of Src family kinase activity, but I find 
higher concentrations of PP2 induce RGC growth cone collapse in the absence of 
ephrin-A5, which makes it impossible to titrate the effects of PP2 on ephrin-A- 
induced axon retraction. Other studies have demonstrated that phosphorylation of Src 
substrates in primary neurons is completely inhibited by lOpiM PP2 (Crossthwaite et 
al., 2004; Manzerra et al., 2001), and taken together with the in vitro evidence that 
Src and Fyn may antagonise the Rho-ROCK pathway by direct phosphorylation of 
pl90RhoGAP (Brouns et al., 2001; Haskell et al., 2001; Roof et al., 1998; Wolf et
al., 2001), it seems unlikely that Src family kinases contribute to the ROCK- 
mediated, ephrin-A-induced RGC axon retraction.
6.2. Abl is a key regulator of ephrin-A-induced repulsive 
RGC responses.
The data presented in this thesis demonstrate that the Abl kinase inhibitor STI571 
prevents both the loss of RGC growth cone lamellae,and axon retraction induced by 
ephrin-A. This is the first report of a functional link between Eph receptor signalling 
and Abl to date. I have also demonstrated the existence of a complex containing 
active Eph receptors, Abl and Mena, which is disrupted in the presence of STI571, 
which suggests that this complex may be required for ephrin-A-induced loss of RGC 
lamellaiand axon retraction.
Abl has been reported to bind Eph receptors via its SH2 domain, and Mena via its 
SH3 domain (Gertler et al., 1996; Yu et al., 2001) and could therefore act as a 
scaffolding protein to assemble Eph receptor-Abl-Mena complexes. STI571 could 
disrupt the Eph receptor-Abl-Mena complex by stabilising the inactive conformation 
of Abl, in which both it’s SH2 and SH3 domains are involved in intramolecular 
interactions (Azam et al., 2003; Nagar et al., 2003; Smith et al., 2003). The ability of 
STI571 to inhibit ephrin-A-induced RGC loss of lamella and axon retraction 
correlates with its ability to disrupt the Eph receptor-Abl-Mena complex. 
Concentrating Mena at the plasma membrane, by recruiting it to active Eph receptor- 
Abl complexes, might potentiate Mena’s activity towards actin filament elongation, 
leading to the formation of long unbranched actin filaments in the RGC growth cone 
lamellae^Bear et al., 2002). The instability of these filaments may underlie the rapid 
loss of growth cone lamellaein response to ephrin-A (Bear et al., 2002, Krause et al.,
2002). Alternatively recruitment of Mena to active Eph receptor-Abl complexes 
might sequester it from its site of action at the ends of actin filaments in the growth 
cone lamellae and that this could result in rapid collapse of the lamella (Southwick 
and Purich, 1994). By excluding Mena from associating with active Eph receptors, 
STI571 could antagonise Mena-mediated loss of lamelladn response to ephrin-A by 
either mechanism. From the data presented in this thesis it is not clear that Abl 
phosphorylation of Mena is required for ephrin-A-induced loss of RGC lamella, but 
it is difficult to predict whether this might contribute to Abl-mediated loss of lamella,
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since to date no information is available regarding the effect of Abl-mediated Mena 
phosphorylation on Mena’s role in actin dynamics.
STI571 also prevents ephrin-A-induced axon retraction, which I have shown to be 
dependent on ROCK activity. This may reflect Abl's ability to interact with Crk, 
which mediates both the increase in Rho activity and ROCK-dependent process 
retraction induced by ephrin-A5-stimulation of non-neuronal cells (Feller 1994; 
Lawrenson et al., 2002; Ren et al., 1994). Disruption of Abl-Crk interaction by 
STI571-mediated constraints on Abl conformation might be sufficient to inhibit the 
Rho-ROCK pathway that underlies ephrin-A-induced RGC axon retraction 
(Nakashima et al., 1999). STI571 is an inhibitor of Abl kinase activity, and Mena and 
Crk are both Abl substrates (Feller 1994; Tani et al 2003), but from the data 
presented in this thesis it is not clear that EphA receptor activation stimulates Abl’s 
kinase activity. EphB activation reduces Abl activity and induces Crk-dependent 
lamella protrusion (Nagashima et al., 2002; Yu et al., 2001), whereas EphA- 
activation might increase Abl activation and induce Crk to switch binding partners to 
cause ROCK-mediated axon retraction (Khwaja et al., 1996; Lawrenson et al., 2002). 
I have discussed evidence that the effect of STI571 on Abl conformation is sufficient 
to prevent ephrin-A-induced loss of RGC growth cone lamella and axon retraction, 
suggesting that the role of Abl in ephrin-A-induced RGC repulsive responses may be 
kinase independent. Focal adhesion kinase FAK can act in a kinase-independent 
manner as a scaffolding protein to mediate assembly of a large signalling complex, 
setting a precedent for such a role for Abl (Carragher et al., 2003). However it would 
be interesting to investigate whether Abl activity, as well as phosphorylation of Mena 
and Crk, is increased following ephrin-A stimulation of RGCs.
The data presented in this thesis comprise the first functional demonstration of a role 
for mammalian Abl in transducing axon guidance signals. There is genetic evidence 
that D-abl is involved in mediating repulsive axon guidance cues in vivo (Hsouna et 
al., 2003; Wills et al., 2002), and therefore the data presented in this thesis, 
demonstrating a functional link between EphA signalling and Abl during contact- 
mediated RGC axon repulsion by ephrin-As in vitro, is an important contribution to 
the body of work implicating Abl in mediating axon guidance decisions.
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Fig 6.1. Model for contact-induced, EphA-mediated RGC 
repulsive response.
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Future Directions.
Several questions arise from the data presented in this thesis. Is Abl kinase activity 
required for ephrin-A-induced RGC repulsive response? Does the Eph receptor-Abl- 
Mena complex exist in a cell type that endogenously expresses Eph receptors? And 
finally, what are the effects of Abl, acting either as a kinase or as a scaffolding 
molecule, on RGC axon guidance in vivo?
In order to directly test whether Abl kinase activity changes in response to Eph 
receptor activation. Abl immuno-precipitated from COSEphA4 cells, in the presence 
and absence of STI571, could be analysed in an in vitro kinase assay. Related to this, 
in order to investigate whether the phosphorylation state of Mena changes in 
response to Eph receptor activation, and whether STI571 has any effect on this state, 
Mena immuno-precipitates from COSEphA4 cells would need to be analysed by 2D- 
gel electrophoresis.
It is important to verify that the complex containing phosphorylated Eph receptors, 
Abl and Mena, identified in COSEphA4 cells, is present in a neuronal cell type. I 
have been unable to immuno-precipitate Abl or Mena from RGC lysates, but it is 
possible that immuno-precipitation of phosphorylated Eph receptors from isolated 
RGCs in culture may allow the identification of such a complex in primary neurons 
that endogenously express Eph receptors. This approach also has the advantage that 
it could be used to investigate whether any members of the Eph receptor-Abl-Mena 
complex are constitutively associated, or whether the complex is inducible upon 
stimulation with ephrin-A. It would also be interesting to demonstrate the presence of 
an active Eph receptor-Abl-Mena complex by immunofluorescence, to investigate 
the localisation of the various components before and after ephrin stimulation. The 
growth cone collapse response to ephrin-A makes immunofluorescence studies in 
RGCs difficult, as the morphological structures in which these proteins are localised 
are rapidly lost after ephrin-A addition, but use of a neuronal cell line, such as PC 12 
cells, may circumvent this problem.
It would be interesting to investigate whether STI571 can convert the repulsive 
response of RGCs to ephrin-A into an attractive response, for example using the 
stripe assay, in which RGCs preferentially avoid growing on substrate-bound ephrin 
(Walter et al., 1987a). Since intracellular levels of cyclic nucleotides are known to
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switch the response of primary neurons to a variety of axon guidance cues (Song and 
Poo, 2001), a related question is whether inhibiting PKG, which has previously been 
shown to inhibit soluble ephrin-A5-induced growth cone collapse of Xenopus RGCs 
(Mann et al., 2003), interferes with the RGC response to contact with an ephrin-A- 
expressing cell. It would also be very interesting to investigate the effect of PKG 
inhibition on the association of Abl and Mena with phosphorylated Eph receptors, as 
it has previously been shown that phosphorylation of other members of the 
Ena/VASP family interferes with their ability to bind Abl (Howe et al., 2002; 
Lambrechts et al., 2000).
Finally, it would be very interesting to determine whether Abl plays a role in RGC 
axon guidance in vivo. Abl and Arg double knock-out mice die early from neural 
tube defects (Koleske et al., 1998), therefore an alternative approach would be to 
inject a retrovirus encoding Abl constructs into the chick optic vesicle at early stages, 
and analyse the projection pattern of RGCs expressing these constructs by 
anterograde axonal tracing (Homberger et al., 1999). Expression of a kinase-inactive 
Abl, and/or isolated Abl SH2- or SH3-domains would allow analysis of the role of 
Abl kinase activity and ligand binding respectively on the in vivo guidance of RGC 
axons.
Fig 6.1. Legend.
A. Under control conditions, contact with an ephrin-A-expressing cell induces 
formation of a protein complex including active Eph receptors, Abl and Mena. Abl 
acts as an adaptor in the complex, binding Eph receptors via its SH2 domain, and 
Mena via its SH3 domain. Recruiting Mena to this complex mediates ephrin-A- 
induced loss of growth cone lamella. Contact with an ephrin-A-expressing cell also 
triggers axon retraction, possibly via an Ephexin (Ephx) induced increase in Rho 
activity, and subsequent increase in ROCK-mediated actomyosin contraction, 
and/or possibly via Abl interaction with the adaptor Crk. B. The ROCK inhibitor 
Y27632 prevents ephrin-A-induced axon retraction, but does not affect the 
formation of an Eph receptor-Abl-Mena complex, and thus contact with an ephrin- 
A-expressing cell still induces loss of growth cone lamella. C. The Abl kinase 
inhibitor STI571 <☆> stabilises Abl in a conformation in which both its SH2 and 
SH3 domains are occupied by intramolecular interactions, thereby preventing the 
formation of an Eph receptor-Abl-Mena complex (and possibly also interfering 
with Abl-Crk interaction) preventing both ephrin-A-induced loss of growth cone 
lamella, and axon retraction.
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